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"It was the best of times, it was the worst of times, it was the age of wisdom, it was 
the age of foolishness, it was the epoch of belief, it was the epoch of incredulity, it 
was the season of light, it was the season of darkness, it was the spring of hope, it was 
the winter of despair"...  
(Charles Dickens, A Tale of Two Cities) 
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1.1 History and classification  
Earlier researchers demonstrated that intranuclear inclusion bodies in the salivary 
glands of mice could be used to infect healthy mice [1]. The intranuclear inclusions 
were later identified as Murine cytomegalovirus (MCMV). MCMV, also known as 
Murid herpesvirus 1, was first isolated in mouse tissue culture in 1954 by Margaret 
Smith from the salivary gland of infected laboratory mice [2]. The term 
cytomegalovirus was introduced by Weller and colleagues [3].  
According to their biological properties and genome content and organization, the 
Herpesviridae family (Herpesvirales order) is subdivided into three distinct 
subfamilies: the Alphaherpesvirinae, the Betaherpesvirinae, and the 
Gammaherpesvirinae (Table 1) [4, 5]. Alphaherpesvirinae are characterized by a 
variable host range, rapid spread in culture, relatively short replication cycle, efficient 
destruction of infected cells by cell lysis, and ability to establish latent infections 
typically in sensory neurons [4, 6]. This subfamily consists of four genera 
(Simplexvirus, Varicellovirus, Mardivirus and Iltovirus) and unassigned species. 
Betaherpesvirinae have a restricted host range and a long reproductive cycle that is 
reflected by the slow infection progress in cultures [4, 6]. Typically, infected cells 
enlarge (cytomegalia). Latent infection can be established in various distinct 
tissues/cell types such as secretory glands, kidneys, spleen, lymphoreticular cells. The 
subfamily Betaherpesvirinae consists of four genera (Cytomegalovirus, 
Muromegalovirus, Roseolovirus and Proboscivirus) and unassigned species. MCMV 
and Murid herpesvirus 2 (rat cytomegalovirus), together with the cytomegaloviruses 
of human, guinea pig and other species, belong to the Betaherpesvirinae [5]. 
Gammaherpesvirinae prefer to enter the latency program instead of leading to a 
productive replication [4, 6]. This subfamily consists of four genera 
(Lymphocryptovirus, Rhadinovirus, Macavirus and Percavirus) and unassigned 
species.  
Despite their differences at the level of genome composition, host range and duration 
of the productive cycle, Herpesviridae share four significant biological properties: (1) 
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they intrinsically encode for a variety of enzymes involved in the process of nucleic 
acid metabolism, DNA synthesis and protein processing, (2) viral DNA synthesis and 
capsid assembly occur in the nucleus, whereas final processing of the virion takes 
place in the cytoplasm, (3) productive infection leads to cell destruction, (4) the 
herpesviruses can establish latency in their natural hosts [4]. 
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Table 1. Taxonomy classification of the family Herpesviridae of the order Herpesvirales.  
Subfamily Genus 
Representative virus 
Formal name (acronyms) Common name 
Alphaherpesvirinae Simplexvirus Human herpesvirus 1 (HHV-1) Herpes simplex virus type 1 
 Varicellovirus Human herpesvirus 3 (HHV-3) Varicella-zoster virus 
 Mardivious Gallid herpesvirus 2 (GaHV-2) Marek’s disease virus type 1 
 Iltovirus Gallid herpesvirus 1 (GaHV-1) Infectious laryngotracheitis virus 
 Unassigned species Chelonid herpesvirus 6 (ChHV-6) Lung-eye-trachea disease-associated virus 
Betaherpesvirinae Cytomegalovirus Human herpesvirus 5 (HHV5) Human cytomegalovirus 
 Muromegalovirus Murid herpesvirus 1 (MuHV1) Mouse cytomegalovirus 
 Roseolovirus Human herpesvirus 6 (HHV-6) Human herpesvirus 6 
 Proboscivirus Elephantid herpesvirus 1 (ElHV-1) Elephant endotheliotropic herpesvirus 
 Unassigned species Suid herpesvirus 2 (SuHV-2) Pig cytomegalovirus 
Gammaherpesvirinae Lymphocryptovirus Human herpesvirus 4 (HHV-4) Epstein-Barr virus 
 Rhadinovirus Human herpesvirus 8 (HHV-8) Kaposi’s sarcoma-associated herpesvirus 
 Macavirus Alcelaphine herpesvirus 1 (AlHV-1) Malignant catarrhal fever virus 
 Percavirus Equid herpesvirus 2 (EHV-2) Equine herpesvirus 2 
 Unassigned species Equid herpesvirus 7 (EHV-7) Asinine herpesvirus 2 
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1.2 Virus characteristics 
1.2.1 Structure of the cytomegalovirus  
A mature MCMV virion consists of four morphologically distinct elements: the core, 
capsid, tegument, and envelope (Fig. 1). The core includes the double stranded DNA 
genome, which is packaged into the capsid. The tegument is a poorly defined layer of 
proteinaceous material between the capsid and envelope. The envelope is a lipid 
bilayer containing a number of different integral viral (glyco)proteins [5].   
 
Figure 1. A cartoon depicting the structure of the cytomegalovirus virion. The 
double-stranded DNA is contained within a polyhedral viral capsid. The viral capsid is surrounded 
by the tegument. The membranous envelope surrounds the tegument. (Image adapted from 
(http://www.virology.net/big_virology/ bvdnaherpes.html website) with courtesy of Dr. Marko 
Reschke in Marburg, Germany).   
1.2.2 Genome organization 
Mature fully assembled MCMV is about 230 nm in size. The DNA molecule of the 
MCMV genome is a linear double strand of approximately 230 kbp. The genome of 
the Smith strain has an overall G+C content of 58.7% and consists of 230,278 bp [7], 
which is similar in size to the genomes of HCMV [8]. In total, the MCMV genome 
has 204 open reading frames based on comparative genomics and new predicting 
algorithms [7, 9]. Unlike HCMV, MCMV does not contain large internal repeats but 
is arranged as a single unique sequence bounded by short (31 bp) terminal direct 
6 
 
repeats not represented elsewhere in the genome (Fig. 2) [7].  
 
Figure 2. Comparison of HCMV and MCMV genome structures. MIE: major immediate-early 
genes; IE: Immediate-early genes; TRL: long terminal repeat; IRL: long internal repeat; IRS: short 
internal repeat; TRS: short terminal repeat. (Image obtained from Vanda Juranić Lisnić’s Ph.D 
dissertation, 2013 [10]) 
1.2.3 Structural proteins 
MCMV contains three kinds of structural proteins: capsid, tegument and envelope 
proteins. The capsid encloses the viral genome, consists of 162 capsomeres and 
exhibits icosahedral symmetry. Information on MCMV capsid proteins is mostly 
coming from their homology with the proteins of HCMV. The capsid of MCMV is 
composed of seven proteins: the major capsid protein (MCP) (encoded by M86), the 
minor capsid protein (encoded by M85), the minor capsid binding protein (encoded 
by M46), the smallest capsid protein (encoded by M48.5) and three distinct 
assembly-related proteins (encoded by M80, M80a and M80.5) [11]. The MCP is the 
most strongly conserved protein among herpesviruses [11].     
The tegument of MCMV has an ordered structure, particularly proximal to the capsid 
as demonstrated by electron microscopy. Five genes encoding the tegument proteins 
of MCMV have homologues in HCMV: M32 (pp150), M48 (large tegument protein), 
M83 (pp65), M99, and M82 [11]. Nevertheless, the individual tegument proteins are 
conserved in the Betaherpesvirinae but are not shared with members of Alpha- and 
Gammaherpesvirinae.  
The envelope of MCMV is a lipid bilayer derived from cellular membranes obtained 
during virion maturation and egress, and is spiked with virally encoded glycoproteins. 
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The major glycoprotein is the glycoprotein B (gB), which is one of the most highly 
conserved herpesvirus proteins and the target of many neutralizing antibodies [12]. 
MCMV gB has 45% similarity in amino acid sequence with HCMV gB [13]. 
Additionally, MCMV forms various gH/gL virion envelope glycoprotein complexes 
that serve as entry mediators and determinants of cell tropism in vitro. In vivo, the 
gH/gL/gO complex (encoded by M115, M75 and m74, respectively) is critical for 
establishing infection by efficient entry into diverse cell types, such as liver 
macrophages, endothelial cells and hepatocytes. Nonetheless, it is dispensable for 
intra-tissue spread [14]. The alternative complex gH/gL/MCK-2 (encoded by M115, 
M75 and m131-129, respectively) is required for intra-tissue virus spread only in the 
absence of the gH/gL/gO complex [14]. In vivo infection was abolished at all sites 
when both complexes were lacking gO and MCK-2 in double-knockout virus [14]. 
MCK-2 determines MCMV pathogenicity by involving a mechanism for virions to 
hijack CX3CR1hi patrolling monocytes to serve as vehicles [15, 16].   
  
8 
 
1.3 Replication cycle 
An overview of the CMV replication cycle is described in Figure 3.  
 
Figure 3. Productive replication cycle of cytomegalovirus. (1) Viral glycoproteins bind on the 
cell membrane of host cells. (2) The viral envelope fuses with the cell membrane and releases the 
nucleocapsid into the cytoplasm. (3) The nucleocapsid associates with cytoskeletal elements and 
translocates to the nucleus where the nucleocapsid interacts with nuclear pores and releases the 
viral genome into the nucleus. (4) The viral DNA is transcribed into early mRNAs which are then 
transported to the cytoplasm for early protein synthesis. (5) These early proteins are imported into 
the nucleus and promote viral DNA replication. (6) The viral DNA is then transcribed into the late 
mRNAs which are responsible for late viral protein synthesis (capsid and envelope proteins). (a–d) 
The viral envelope proteins (pink, green, and blue dots) are processed in the endoplasmic 
reticulum (ER) and Golgi complex. (7) The capsid proteins are imported into the nucleus and then 
encapsidate the newly replicated genomes. (8–10) These capsids egress from the nucleus and bud 
into the exocytotic vesicles. (11) The virion containing vesicles migrate to and fuse with the cell 
membrane. (12) Infectious viruses are then released from the cell. (Image adapted from reference 
[17]).   
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1.3.1 Entry 
The replication cycle of MCMV is initiated with the binding of the viruses to cellular 
receptors on permissive cells. It is very well possible that more than one receptor is 
involved. Epidermal growth factor receptor (EGFR) was considered to be an HCMV 
receptor [18, 19], but later a study directly demonstrated no discernible role for EGFR 
in virus entry or signaling in a range of cell types containing fibroblasts, epithelial 
cells and endothelial cells [20]. Heparan sulfate proteoglycans contribute to MCMV 
binding and entry [21], and also to the binding of HCMV to susceptible cells [22]. In 
addition, MHC class I [23] and beta-2-microglobulin [24] have been shown to 
facilitate the binding of MCMV in vitro. After the process of membrane fusion or 
endocytosis and fusion, viral nucleocapsids enter the cytoplasm and DNA is 
transported through nuclear pores to the nucleus [25].  
1.3.2 Replication and transcription 
Once the genome enters the nucleus through the nuclear pore, it circularizes. Next, 
transcription is initiated and gene expression occurs in a cascade manner. All 
betaherpesviruses [26] including MCMV [27] have three gene families: α, β and γ, 
which are temporally regulated. The first genes that are transcribed are designated 
immediate early (IE) or α genes and are involved in the regulation of transcription and 
translation of early proteins. They do not require de novo protein synthesis but are 
controlled by the major IE promoter (MIEP) [28]. In MCMV, the MIEP controls 
expression of the IE1 (m123) and IE3 (M122) genes [29, 30]. MCMV IE1 (pp89) and 
IE3 are transcriptional activators [31]. The IE3 gene is essential for MCMV 
replication [32]. In contrast, the IE2 gene is not essential for MCMV replication either 
in vitro or in vivo [33]. After IE genes, early (E) or β genes are expressed, which 
requires the IE gene expression for regulation [34]. E genes are mostly involved in 
virus DNA replication [35]. Finally, last expressed are the late (L) or γ genes that 
encode proteins needed for virus assembly and egress, and their transcription requires 
proteins synthesized during the E phase of replication [11]. L phase genes mostly 
encode structural proteins.      
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1.3.3 Assembly and release 
The formation of capsids and the packaging of viral DNA occurs in the nucleus of 
infected cells [36]. Capsid proteins that are produced in the cytoplasm are transported 
back to the nucleus across the nuclear membrane. Viral DNA is packaged into 
complete capsids and transported to the cytoplasm via the nuclear membrane, where 
the capsids acquire their primary envelope as they bud through the inner nuclear 
membrane. There are two herpesvirus genes (UL31 and UL34) that are involved in 
this process. Similar homologues (M53/p38 and M50/p35) are also identified in 
MCMV [37-39]. M50/M53 recruit cellular kinases like protein kinase C to degrade 
the inner nuclear membrane, especially the nuclear lamina that is a filamentous 
network that prevents budding [37]. Cellular kinases lead to phosphorylation and 
degradation of the lamina and increases egress of the virus from the nucleus.   
The mechanism of egress of herpesviruses from infected cells remains incompletely 
understood. The envelope and tegument of perinuclear virions differ from those of 
mature virions [40, 41]. The major envelope glycoprotein complex (gp52/105/150) of 
MCMV have been characterized [42], which is encoded by the gB gene [13, 43]. A 
different ultrastructure has been observed between primary enveloped virions and 
mature virions, indicating a secondary envelopment. Nevertheless, the mechanism by 
which the virus loses the primary envelope and tegument and acquires the mature 
tegument and envelope is still not fully known. Recent studies with α- and 
β-herpesviruses suggest that the primary enveloped virus fuses with the outer nuclear 
membrane, there by losing its primary envelope and reordering the cytoplasm as a 
naked capsid [44]. Afterwards, the virus possibly migrates to the trans Golgi network, 
where the virions gain their tegument and final envelope [44, 45]. The mature 
enveloped virions are now present in secretory vesicles that are transported to the 
plasma membrane, where they are released into the extracellular space by exocytosis.  
The formation of multicapsid virions, which appears to be unique to MCMV infection, 
is also not well understood [11]. It has been postulated that they are formed when 
capsids exit the nucleus via nuclear pores and form cytoplasmic aggregates of capsids 
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[46]. These capsids then receive an envelope via budding into extended cytoplasmic 
vacuoles derived from the Golgi apparatus. The multicapsid virions are also believed 
to be released from the cell by exocytosis [46].  
1.4 Epizootiology  
1.4.1 Natural history 
In order to understand the genetics and the evolution of MCMV it is useful to have an 
understanding of the origins of the commonly used MCMV strains and the genetic 
backgrounds of the mice from which these strains were isolated. The natural host for 
MCMV is considered to be the Mus musculus domesticus (musculus domesticus), 
since to date the majority of low passage strains of MCMV were derived from these 
mice [47]. So far, there are 12 individual strains of MCMV, whose genomes have 
been completely sequenced (Table 2). Two laboratory strains of MCMV (Smith and 
K181) are in widespread use. The Smith strain was isolated in 1954 by Margaret 
Smith from the salivary glands of an infected laboratory mouse [2]. The K181 strain 
of MCMV was isolated in the 1970s by June Osborne [47]. Recently, comparing the 
Smith derived clone of MCMV, WT1 [48], with the sequence of Smith [7] and K181 
[49] suggest that the early stocks of Smith were a mix of both Smith and K181 strains.   
  
12 
 
Table 2. Twelve fully sequenced MCMV strains 
a : WT1 is a variant of Smith strain MCMV, possibly a recombinant of Smith and K181 strains. 
1.4.2 Host range 
Cytomegaloviruses have a strict species-specificity. Indeed, MCMV only infects mice, 
rat CMV only infects rat, hamster CMV only infects hamster, HCMV only infects 
human [4, 56].  
1.4.3 Modes of Transmission 
Horizontal transmission - Salivary glands are believed to be the important sites for 
horizontal transmission, since the virus can be shed in saliva of both mice and human 
for a long time period [57, 58]. Three different salivary glands exist: submandibular 
glands, parotid glands and sublingual glands. Each gland has a single excretory duct 
terminating in the oral cavity. All three glands can be infected by MCMV. 
Nonetheless, virus infection appears to be more pronounced in the submandibular 
glands, followed by the sublingual and parotid glands [59]. The acinar epithelial cells 
are the major site of MCMV replication in the salivary gland, from which the virus is 
Strain Location of isolation Genome size (bp) Genbank No. Year Ref. 
Smith 
K181 
WT1a 
N1 
G4 
C4A 
C4B 
C4C 
C4D 
WP15B 
AA18D 
N07 
St. Louis, USA 
Wisconsin, USA 
USA 
Nannup, Australia 
Geraldton, Australia 
Canberra, Australia 
Canberra, Australia 
Canberra, Australia 
Canberra, Australia 
Walpeup, Australia 
Macquarie Island, Australia 
Beacon Island, Australia 
230,278 
230,301 
230,408 
229,884 
230,227 
230,111 
230,154 
229,924 
229,935 
230,118 
229,543 
229,452 
NC_004065 
AM886412 
GU305914 
HE610454 
EU579859 
EU579861 
HE610452 
HE610453 
HE610456 
EU579860 
HE610451 
HE610455 
1954 
1976 
2010 
1993 
1993 
2006 
2006 
2006 
2006 
2008 
2013 
2013 
[50] 
[51] 
[48] 
[52] 
[52] 
[53] 
[53] 
[53] 
[53] 
[54] 
[55] 
[55] 
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shed into ducts leading to the mouth [60]. There are at least two viral genes m133 
(sgg1) and m131/129 (MCK-2) determining the salivary gland tropism of MCMV. 
The sgg1 seems to specifically control the growth of MCMV in acinar cells [61]. In 
contrast, MCK-2 encodes a CC chemokine to facilitate the hijacking of patrolling 
monocytes to serve as vehicles transporting MCMV to salivary glands [16]. 
Additionally, M33 and M43 genes are also required for MCMV replication within the 
salivary glands [62, 63]. Besides saliva, infectious virus can be detected in tears, milk, 
urine and sperm [64-66], which are also sources for horizontal transmission.  
Vertical transmission - Congenital HCMV infection affects 0.2-2.5% of the newborn 
infants [67]. While the majority of congenital HCMV infections are asymptomatic, it 
has been estimated that 5 to 10% of congenitally HCMV infected neonates exhibit 
symptomatic, generalized cytomegalic inclusion disease [68]. Typical clinical features 
of cytomegalic inclusion disease include petechiae, hepatosplenomegaly, jaundice and 
microcephaly [67]. Additional manifestations at birth are intrauterine growth 
retardation, prematurity, chorioretinitis, and central nervous system diseases such as 
intracranial calcifications, ventriculomegaly, lissencephaly, pachygyria, 
dysmyelination, paraventricular cysts and calcifications [69, 70]. Because CMV 
exhibits strict species-specificity, it has not been possible to use HCMV to create 
heterologous experimental animal models of congenital HCMV infection [71]. 
Vertical transmission of CMV can be induced in guinea pigs [72] and rhesus macaque 
monkey [73], however not yet in mice. This might be due to different anatomical 
features of the mouse placenta [74]. The anatomy of the mouse placenta differs in a 
number of aspects from that found in other mammalian orders. In particular, the 
structure of the trophoblastic layers of the murine chorioallantoic placenta is 
exceptional in that maternal blood is separated from fetal blood by three 
(hemotrichorial) trophoblast layers, a basement membrane, and a layer of fetal 
vascular endothelial cells. In contrast, there is only one trophoblast (monochorial) 
layer in other mammalian orders [74]. Possibly, the two extra layers of trophoblastic 
cells between the maternal and fetal blood in mice could provide a physical barrier 
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that may serve to limit the vertical transfer of MCMV from the mother to the 
conceptus. Other possible explanations may be the inoculation dose, the age of the 
embryo and the timing of infection. Overall, further studies will be needed to address 
the MCMV intrauterine infection in mice.  
1.5 Pathogenesis 
1.5.1 Genetic control of host resistance or susceptibility to MCMV  
Inbred mouse strains have a different susceptibility to MCMV infection. In order to 
find the basis for susceptibility and resistance to MCMV infection, genes related to 
the control of MCMV replication were compared by Grundy et al. and Chalmer et al. 
[75, 76]. Their data revealed that both H-2 associated and non-H-2 associated genes 
determine resistance to the lethal effects of MCMV, as discussed below.     
H-2 associated genes - First, CBA and C3H mice having H-2k haplotype were found 
more resistant to lethal MCMV infection than BALB/c or C57BL mice after 
intraperitoneal inoculation with MCMV [75, 76]. Secondly, using BALB/c congenic 
strains carrying H-2b, H-2g, or H-2k haplotypes rather than the H-2d haplotype of 
BALB/C mice, resistance was found to be associated with H-2k [76]. Finally, in a 
more detailed study using LD50 analysis, it was shown that the H-2k haplotype 
rendered BALB/c mice 10.2 times more resistant to MCMV than H-2d BALB/c [75]. 
Taken together, the H-2k haplotype plays a critical role in host resistance to MCMV 
infection.  
Non-H-2 associated genes - Comparison between two mice strains bearing the H2b 
haplotype (BALB.B and C57BL/10) showed that C57BL/10 mice were more resistant 
to MCMV than BALB.B mice, which showed that besides H-2 associated genes, 
non-H-2 associated genes were responsible for resistance in C57BL/10 mice [75]. 
Later, it was found that NK cells play important roles in the genetically controlled 
resistance, since the NK cell response was activating within 24 hours after MCMV 
infection in genetically resistant strains but not in susceptible strains [77]. In addition, 
MCMV titers were higher in beige mutant C57BL/6 and other strains in which NK 
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cell activity is abrogated [78, 79]. The ability of mouse strains to trigger an effective 
NK cell response is controlled by the Cmv I locus, positioned inside the NK gene 
complex on mouse chromosome 6. The alleles of the Cmv I locus can either confer 
susceptibility (Cmv Is, a recessive allele) or resistance (Cmv Ir, a dominant allele) to 
MCMV [80]. The latter allelic form restricts early MCMV replication in the spleen of 
resistant strains [81, 82]. The Ly49h gene has been identified as the gene that 
mediates the Cmv I phenotype [83, 84]. Ly49h binds specifically to a protein encoded 
by the MCMV m157 gene, which has a structural homology to MHC class I. 
Recognition of viral m157 protein by NK-cell receptor Ly49H will lead to destruction 
of infected cells by release of NK cell perforin [80, 85, 86].  
1.5.2 Effect of inoculation dose and route       
Dose and route of inoculation significantly influence the outcome of MCMV infection. 
With a fourfold increase of the inoculum titer, the mortality increases from 0 to 100% 
in susceptible animals [87]. So far most researchers have used intraperitoneal or 
intravenous virus inoculation, which results in a rapid spread to the liver and spleen, 
after which the virus is disseminated to other organs such as submandibular glands 
[88, 89]. Intrafootpad (i.f.) inoculation leads to a lymph dissemination towards the 
draining lymph nodes [90]. The oronasal inoculation is considered as the best way to 
mimic natural infection. Unfortunately, there have only been a few studies on 
intranasal inoculation and all mice were under anesthesia/sedation during inoculation 
[91-95]. As the inoculum also reaches the lungs in anesthetized/sedated mice due to 
the absence of the swallowing/sneezing reflex, this inoculation cannot be accepted as 
a natural way of infection, and hence the primary replication site of the virus upon 
oronasal inoculation remains elusive.  
1.5.3 Systemic dissemination of MCMV by patrolling monocyte-associated 
viremia  
Cell free CMV has never been detected in blood of infected humans [96, 97] and mice 
[98], regardless of their immune status. The virus in blood is fully cell-associated, and 
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these infected peripheral blood leukocytes (PBLs) may cause transfusion-transmitted 
CMV infection both in humans [99, 100] and mouse [98, 101]. Mocarski and his team 
[16] recently demonstrated that patrolling monocytes (PM) carry MCMV during the 
dissemination stage of infection [16]. Afterwards, transmission occurs in a 
cell-associated way in between monocytic cells (direct transfer via viral synapses or 
fusion in internal lymphoid organs such as spleen), and then to tertiary shedding sites, 
such as the salivary glands [90]. Although the liver can also be infected, MCMV 
produced in the hepatocytes does neither contribute significantly to secondary viremia 
nor to the dissemination of the infection to other organs [102].   
1.5.4 Virus distribution and replication in parenchymal organs  
In models for systemic MCMV infection (i.e. after intraperitoneal inoculation), 
multiple organs have been reported to become infected, such as salivary glands, lungs, 
spleen, liver, kidneys and central nervous system.  
Salivary glands - Virus replication is localized in the serous acinar cells of 
submandibular, parotid and sublingual glands [103, 104]. The intranuclear 
development of the virus is typical for herpesviruses; in contrast the cytoplasmic 
inclusions are different. They are composed of vesicles that sometimes contain more 
than 100 enveloped virions. These vesicles fuse with the plasma membrane and 
liberate the virions into the lumen, from which they are presumably transported along 
the ducts into the oral cavity as part of the salivary secretions [105]. The infected cells 
do not appear to be damaged. It looks like the virus simply utilizes the cell’s normal 
secretory mechanism as a means of exit. The unusual cytoplasmic development of the 
virus explains why multicapsid virions are not present in these tissues, since each 
virion matures and leaves the cell as an individual entity, in contrast to the situation in 
other tissues [105]. Epithelial cells are identified as the main susceptible cell type in 
salivary glands [106].  
Lungs - Pneumonitis is easily established after intranasal inoculation of anesthetized 
mice [107]. Afterwards, virus spreads to other organs via blood, while the virus in the 
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lungs becomes cleared [108]. Type 2 alveolar epithelial cells are highly susceptible to 
MCMV; additionally stromal cells such as fibroblasts can also be infected [107, 109, 
110]. Alveolar macrophages can phagocytose virus or debris of infected cells, but 
they are not productively infected [110].  
Spleen - The spleen is commonly involved in MCMV infection. In recent studies, the 
susceptible target cells were identified as macrophages and dendritic cells [103, 104, 
111, 112], sinus-lining cells and reticular fibroblasts [88, 113], endothelial cells and 
hematopoietic cells [109, 114]. The reticular fibroblasts were identified as a reservoir 
for later reactivation [113].  
Other lymphoid tissues - Several lymph nodes are also involved in the course of 
MCMV infection. It is interesting that various cells are found to be susceptible to the 
virus, such as subcapsular sinus macrophages in the mediastinal lymph nodes [88], 
medullary sinus macrophages and reticular fibroblasts in popliteal lymph nodes [90]. 
Subcapsular sinus macrophages take up the virus and are important in controlling its 
dissemination [90].   
Liver - The liver is one of the first tissues infected after intraperitoneal inoculation. 
Hepatocytes [88, 102], hepatic endothelial cells [102, 109] and to some extent 
Kupffer cells [105] are permissive for virus replication. Nuclear inclusions represent 
the sites of assembly of nucleocapsids, while the cytoplasmic bodies are clusters of 
virions embedded in or associated with a densely staining matrix [105]. Nevertheless, 
the significance of the dense bodies is unknown, but their presence does not correlate 
with destruction of virus.  
Kidneys - MCMV replicates in the kidneys during infection, resulting in shedding of  
MCMV in the urine [115]. In the kidneys, the endothelial cells [109], glomerular cells 
and renal tubules cells [103, 109] are susceptible cells.  
Central nervous system - Most of the work reported on central nervous system 
involvement has used intracranial or intraorbital inoculation. A generalized 
encephalitis occurs with considerable necrosis and inflammatory response. Several 
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types of cells including neurons, macrophages and glial cells, can be infected and 
show typical nuclear and cytoplasmic inclusions [105].  
1.5.5 Symptoms in immunocompetent, immunocompromised and immature mice  
Symptoms in immunocompetent mice - Intraperitoneal or footpad injection of adult 
immunocompetent mice with 105 PFU tissue culture MCMV (TC MCMV) is usually 
asymptomatic and it is not associated with serious damage to organ systems [57, 90]. 
This is consistent with the fact that very little infectious virus can be detected in 
tissues of infected mice, with the exception of salivary glands, which support 
prolonged virus replication. On the other hand, injection of a similar dose of salivary 
gland-derived MCMV (SG MCMV) results in damage to multiple organs and tissues 
and high mortality even in fully immunocompetent hosts, which might in part be due 
to cytokines accounting for its virulent manifestations [57]. The primary features of 
an acute infection with SG MCMV include high levels of virus replication in the liver 
and spleen, with loss of liver function [116] and immunosuppression [117]. The 
extent of damage to the spleen and suppression of immune responses appears to be 
closely linked with the degree of liver dysfunction. This tissue damage ultimately 
leads to the death of infected mice [80].  
Symptoms in immunocompromised mice - CMVs in general cause asymptomatic 
infections in immunocompetent hosts but are important opportunistic viruses affecting 
immunodeficient hosts. For example, HCMV infection is harmful to AIDS patients 
and causes variable clinical manifestations including pneumonitis, hepatitis, retinitis, 
cardiovascular disease and adrenalitis [11, 118]. Similarly, infection of 
immunocompromised mice with TC MCMV is associated with a high level of virus 
replication and multiple organ damage, resulting in high morbidity and mortality. 
Interstitial pneumonia can be established in γ-irradiated mice [119] or in adult Balb/c 
mice intranasally inoculated with 8x104 PFU of MCMV, followed by a single dose of 
cyclophosphamide [93]. MCMV-induced hepatitis in mice has been widely used as a 
model of hepatitis induced by HCMV in immunocompromised patients. Several 
studies have shown that severe hepatitis is caused by lethal doses of MCMV in 
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   Introduction | 19	  
 
	  
susceptible strains of mice via intraperitoneal or intravenous inoculation. [116, 120]. 
Retinitis can only be induced when the virus is administered intraocularly via the 
supraciliary route [121]. MCMV can also be used as a model of HCMV infection in 
immunocompromised patients causing other disease, such as cardiovascular disease 
[122] and adrenalitis [123].    
Symptoms in immature mice - The clinical and histological outcome of an MCMV 
infection of neonatal mice represents well that of a congenital HCMV infection [124]. 
In contrast to HCMV, MCMV cannot be transmitted transplacentally but can be 
transmitted to newborn mice during birth or afterwards by breast-feeding and saliva 
[125]. Unlike adult mice acutely infected with MCMV, in which productive infection 
is stopped within several weeks, newborn mice that survive an MCMV infection have 
a long-lasting persistence in salivary glands and shed the virus in saliva for several 
months before establishment of latency [126]. Antigen positive cells were found in a 
wide range of tissues and organs, such as salivary glands, lungs, liver and heart 
muscle [125]. MCMV infection in newborn mice is also characterized by virus 
dissemination within the central nervous system [127].  
1.5.6 MCMV infection in mice as a model for HCMV infection in humans  
Due to the strict species-specificity of CMV, it is not possible to study HCMV in 
experimental animals. Therefore, it is necessary to set up animal models for the study 
of HCMV. Up till now, a number of CMV infections in various animal species have 
been utilized for modeling HCMV infection in humans. Among the animal CMVs, 
pathogenesis studies have been reported for rhesus macaque CMV, porcine CMV, 
guinea pig CMV, rat CMV and murine CMV [80, 128-131]. MCMV infections in 
mice is the most commonly and widely used animal model for HCMV study due to 
the following reasons: (1) MCMV shares many features with HCMV [71], (2) the 
genomes of mice and MCMV are fully sequenced [7, 132] and (3) the small size, 
cheap price, short life span, ease of handling and high reproductive rate of mice make 
them most suitable.  
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MCMV has now been successfully used to investigate many pathological facets of 
CMV infection, including humoral/cellular immunity, host responses to congenital 
CMV infection and infection in immunosuppressed hosts. Additionally, various 
deletion mutants were constructed by application of bacterial artificial chromosome 
(BAC) mutagenesis [133] depending on the accuracy of genomic maps, which have 
been used to identify and characterize a multitude of immune evasion genes and 
functions of specific genes.    
1.6 The immune response to MCMV infection   
Immune responses in mice infected with MCMV involve both the innate and adaptive 
branches of the immune system. To establish persistent infection, MCMV has evolved 
mechanisms to modulate immune responses. In this section, a brief review on 
innate/adaptive immune responses and immune evasion are given.  
1.6.1 Innate immunity  
Innate immunity is the first and most ancient line of defense. It is immediate, but also 
non-specific. Indeed, innate effector cells, such as myeloid cells (dendritic cells (DCs) 
and monocytes/macrophages), and natural killer cells, recognize structurally 
conserved, self or non-self molecular patterns with the help of their germ-line 
encoded receptors.  
Myeloid cells - Myeloid cells such as DCs and monocytes/macrophages are the 
primary sensors of MCMV infection via a number of innate immune receptors.    
DCs are dispersed throughout the body and are mainly known for their professional 
antigen-presentation capacities [134]. DCs are distributed in lymphoid organs as well 
as peripheral tissues like skin, lungs, liver, kidneys, and intestinal tract. Immature 
DCs have a great capacity for endocytosis and antigen degradation, but express low 
levels of MHC-I, MHC-II, and co-stimulatory molecules [135]. Therefore, they are 
poor antigen-presenting cells. DC activation is mainly mediated by toll-like receptor 
(TLR) ligation and proinflammatory cytokines such as TNF-α and IL-1β [136]. These 
signals, together with the engagement of the CD40 receptor, stimulate DC maturation 
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and migration to secondary lymphoid organs. In contrast to the immature DCs, mature 
DCs are less endocytic, but become more potent in antigen presentation to 
T-lymphocytes. Besides that, mature DCs enables the initiation of adaptive immunity, 
and secretion of IFN-α/β [137]. DCs produce proinflammatory cytokines (IL-2, IL-12, 
IL-15, IL-18) needed for optimal NK-cell activity and for the regulation of adaptive 
immune responses [136]. CMVs can infect DCs and impair their functions such as 
antigen uptake and degradation, as well as maturation and migration [138, 139]. 
Infections also reduce the expression of MHC-I, co-stimulatory molecules and 
cytokine secretion [140].  
Monocytes and tissue macrophages play a pivotal role in the pathogenesis of MCMV 
infection [141]. Both HCMV and MCMV use monocytes for their dissemination 
throughout the body [142-144]. Monocytes are recruited to sites of inflammation upon 
sensing a chemokine gradient (CCL2, CCL7 and CCL12), molecules whose 
expression are stimulated by infection. Once migrating inside tissues, monocytes 
differentiate into macrophages or DCs. Macrophages produce inflammatory cytokines, 
possess a great ability for pathogen recognition, and play a role in antigen 
presentation. They can identify foreign antigens via TLRs and other innate receptors. 
In addition, macrophages are also important mediators of innate and adaptive immune 
responses by their secretion of proinflammatory cytokine such as TNF-α, IL-1 and 
IL-12. When macrophages are infected with MCMV, their expression of MHC-II 
molecules decreases making them poor antigen-presenting cells [145].   
The type I IFN response - Effective control of MCMV replication has long been 
associated with an increase in type I IFN secretion in the spleen, liver and serum 
during the first 48 hpi [146]. Type I IFNs can be produced by almost all nucleated 
cells; they belong to a large cytokine family, which includes type II IFN (IFN-γ) and 
type IIIs (IFN-λ1, IFN-λ2, IFN-λ3). Type I IFNs themselves include 16 members: 
IFN-β, IFN-ε, IFN-κ, IFN-ω and 12 subtypes of IFN-α. Thus far, virus-infected cells 
have been shown to preferentially produce IFN-α, IFN-β and IFN-ω [147]. Type I 
IFN secretion is biphasic in the infected animals. The first wave peaks at 8 hpi, while 
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the second does so at approximately 36 hpi. Each wave is associated with a particular 
cell type that recognizes the infection via specific receptors. The first wave of IFN-α/β 
secretion is initiated by lymphotoxin α and lymphotoxin β ligating with their cognate 
receptor, lymphotoxin β receptor (LTβR). Afterwards, the non-canonical NF-κB 
pathway is activated in the LTβR-bearing cell. Lymphotoxin α/β (LTα/β) expression 
is restricted to activated T-lymphocytes, NK cells, and a subset of follicular B-cells, 
whereas LTβR expression can be detected on a variety of cell types, including 
follicular DCs, high endothelial venules (HEVs), conventional DCs (cDCs), and 
macrophages [148]. Furthermore, it was demonstrated that the interaction between 
LTα/β+ B-cells and LTβR+ MCMV-infected stromal cells led to production of type I 
IFNs in the early hours following infection [149]. The second wave of IFN-α/β 
secretion mainly rests upon the recognition of viral pathogen-associated molecular 
pattern (PAMP) by TLRs expressed on plasmocytoid DCs (pDCs) [147]. These pDCs, 
also known as natural IFN-producing cells, are morphologically similar to plasma 
cells and secrete most of type I IFN following viral infection. The activated pDCs 
release IFN-α/β and IL-12. IFN-α/β increases the resistance of bystander cells to 
infection and stimulates NK-cell cytotoxicity, while IL-12 stimulates the secretion of 
IFN-γ by NK cells [147].   
Natural killer cells - The crucial role of NK cells in controlling MCMV infection is 
best illustrated by the numerous evasion mechanisms devised by the virus to escape 
the NK-cell response (more details in chapter 1.6.3). Depletion of NK cell activity in 
adult mice using antibodies to asialo-GM1 or NK1.1 monoclonal antibodies rendered 
C5BL/6 mice susceptible to MCMV [81, 150, 151]. Infection of newborn mice with 
MCMV is usually lethal. However, the adoptive transfer of cloned NK cells or NK 
cell-enriched fractions from naive adults to neonatal mice prevented mortalities by 
reducing splenic viral titers [152-154]. Genetic susceptibility to infection by MCMV 
correlates with the inability to mount a sufficient NK cell response [77, 79]. NK cells 
mediate their function by the secretion of cytokine, the induction of target cell 
apoptosis via cell surface receptors, and the release of cytotoxic granules (granzymes 
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and perforin) [147].  
1.6.2 Adaptive immunity  
B cell-mediated immune responses - The primary roles of antibodies are to prevent 
infection and/or reduce the overall viral burden in the host. There are two types of 
antibodies detected during MCMV infection, namely neutralizing antibodies and 
non-neutralizing antibodies [155]. Serum IgM antibodies were detected in mice as 
early as 3-5 days, while IgG antibody was detected between 5-7 days, reaching peak 
levels at 20 days p.i. [156]. IgA antibodies were not detected in the sera of 
MCMV-infected mice [156]. Antibodies are not critical to control primary MCMV 
infection, since high antibody titers are detected with significant viral titers in organs 
[156]. However, they do play important roles in protection from infection. A number 
of early studies with MCMV using adoptive transfer of serum from infected mice 
showed obviously lower virus titers in organs following viral challenge [156, 157]. 
Later on, transfer of mAbs has been used to explore protection from subsequent 
infection. In 1990, several mAbs with highly divergent in vitro neutralizing activity 
have been used to demonstrate protection from a lethal challenge dose [158].  
Antibodies are raised against a lot of viral proteins including structural and 
nonstructural components of the virion [159]. The major targets for induction of 
virus-neutralizing antibodies during natural infection have been identified: gB, gH, gL, 
gM, and gN [160]. 
T cell-mediated immune responses - Both CD4+ and CD8+ T cells play critical roles 
in the immune response to MCMV. The role of T cells in protective immunity was 
initially observed in T cell-deficient nude mice, which are very susceptible to MCMV 
[161, 162].  
CD4+ T lymphocytes are required for viral clearance in certain organs such as salivary 
glands [163, 164]. CD4+ T cells can compensate for the absence of CD8+ T cells. 
IFN-γ is required for CD4+ T cell activity in the salivary glands [164]. The response 
to MCMV in the salivary glands is intriguing, it is likely that the cellular compartment 
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in salivary glands colonized by virus during early days post infection is under the 
control of CD8+ T cells; nevertheless, the CD4+ T cells become essential when the 
virus reaches the acinar glandular epithelial cells [165].  
Adoptive transfer of the sensitized CD8+ T cells plays pivotal roles in protecting mice 
against lethal disease, limiting MCMV dissemination and preventing tissue 
destruction [166, 167]. Cytotoxic T lymphocytes are crucial for the clearance of acute 
MCMV infection in Balb/c mice. However, CD8+ T cell responses are not essential 
for the early control of MCMV replication in the presence of effective NK cell 
responses, such as those observed in genetically resistant C57BL/6 and CBA mice 
[168].   
1.6.3 Immune evasion by MCMV 
The most-studied immune evasion genes of MCMV are those that restrict NK cell 
responses. NK cell receptors may deliver either an activating or inhibitory signal into 
the cell. Several NK receptors bind MHC-I or MHC-like molecules (Fig. 4) [169, 
170].  
 
Figure 4. MCMV subverts NK cell receptors by different molecular mechanisms. Most of 
MCMV immune-evasion mechanisms are aimed to prevent surface expression of ligands for 
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activating NK cell receptors or include MHC I manipulation to avoid the ‘missing self’ 
recognition [165]. Activating receptor NKG2D is subverted by downregulation of ligands required 
for their engagement. In case of NKG2D, the downregulation is mediated by MCMV proteins that 
target either plasma membrane resident ligands (m138) or ligand maturation (m152). Inhibitory 
Ly49 receptors are subverted either by expression of MHC homologues (m157) or proteins 
mediating surface repopulation of MHC class I (m04). (Image adapted from reference [171]) 
Inhibitory Ly49 (A, C & I)-MHC-I axis - Inhibitory receptors bind MHC-I molecules 
expressed on virtually all cells, maintaining NK cells in the state of inhibition. The 
majority of NK cells express at least one of the inhibitory Ly49 receptors (Ly49A, 
Ly49C and Ly49I).   
Modulation of MHC-I expression The virus can avoid cytotoxic cell detection by 
modulating the expression of MHC-I molecules on the surface of infected cells [172]. 
Nonetheless, the changes in MHC-I expression should be sensed by NK cells and in 
the case of down-regulation of MHC-I molecules should render the infected cells 
sensitive to NK-cell control via the ‘missing self’-mediated mechanism, namely 
interactions between inhibitory Ly49 receptors and MHC-I molecules [173]. MCMV 
encodes three proteins (m04/gp34, m06/gp48 and m152/gp40) that tamper with the 
expression of MHC-I molecules. The m04/gp34 binding of MHC class I in the 
endoplasmic reticulum (ER) does not inhibit its expression on the cell surface, but 
escorts MHC-I molecules to the cell surface as a complex where gp34/MHC-I 
complexes may silence NK cells by serving as ligands for inhibitory Ly49 receptors 
[174]. The m06/gp48 protein interferes with the MHC class I pathway of antigen 
presentation by binding to complexes of MHC class I molecules and antigenic 
peptides, targeting them for degradation in the lysosome [175]. The reduced cell 
surface expression of these complexes results in reduced recognition and killing of 
these cells by CD8+ T cells [174-176], but enhancing NK cells killing these cells via 
the missing-self mediated mechanism. The m152/gp40 prevents the transport of class 
I molecules to the cell surface, causing them to be retained in the ER-Golgi 
intermediate compartment (ERGIC) [175, 177]. Therefore, it leads to reduced 
recognition and killing of these cells by CD8+T cells, but increasing the missing-self 
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mediated mechanism of NK cells to kill these infected cells.  
Activating Ly49H/NKG2D receptor axis - Activating receptors such as NKG2D and 
Ly49H are well-studied. The other activating receptors are not discussed here.  
Ly49H-m157 axis C57BL/6 mice have strong resistance to MCMV infection due to 
their expression of the activating receptor Ly49H on the surface of their NK cells [178, 
179]. The product of the m157 gene is the exclusive ligand of Ly49H [180]. This 
direct ligation initiates an activating signaling cascade, resulting in clonal 
proliferation of Ly49H+ NK cells, killing of infected cells, and secretion of cytokines 
(IFN-γ and TNF-α) [147]. Recently, m157 in particular has become the focus of much 
investigation. Sequence analysis of m157 derived from MCMV samples isolated from 
the wild showed that its sequence is highly variable. Intriguingly, the protein encoded 
by m157 has also been shown to serve as a ligand of the inhibitory Ly49I receptor.  
Escape from NKG2D-mediated recognition The importance of NKG2D in the 
immune response against MCMV infection is best illustrated by the fact that MCMV 
has developed numerous immune evasion mechanisms against this receptor [181]. 
Indeed, four MCMV genes (m138, m152, m155, m145) encode proteins that 
downregulate the expression of ligands (MHC-I-like molecule RAE-1 [182, 183], 
MULT-1 [184] and H-60 [185]) of the NKG2D receptor [186].  
The m138 protein has been shown to interfere with the recycling of the intracellular 
portion of MULT-1, resulting in its subsequent lysosomal degradation; H-60 surface 
expression is also downregulated by the gene product of m138 [187]. The m152 gene 
product gp40 inhibits NK cells by down-regulating the expression of the MHC-I-like 
molecule RAE-1. The m152/gp40 protein retains immature RAE-1 proteins in the 
endoplasmic reticulum-Golgi intermediate compartment in vitro [183, 188]. The 
products of m145 and m155 down-regulate the expression of MULT-1 and H-60, 
respectively, and deletion of these genes from MCMV enhances clearance of the virus 
due to NK cell-specific effects [183, 189-191].  
In conclusion, understanding the role of immune evasion in vivo is complicated by a 
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number of factors. First, different inbred mouse strains have different Ly49 
haplotypes, which leads to a high inter-mouse variation upon infection with the same 
virus strain. For example, the product of the m157 gene plays an important role in 
activating receptor Ly49H+ on the surface of NK cells in C57BL/6 mice, but does not 
have the same effect in Balb/c mice since they are Ly49H-. That is the reason why 
C57BL/6 mice are more resistant to MCMV infection than Balb/c mice. Second, 
certain viral genes exhibit dual functions. The m152/gp40 protein cannot only prevent 
the transport of MHC-I molecules to the cell surface but also downregulates the NK 
cell ligand RAE-I. Therefore, this viral gene has an inhibitory effect on both CD8+ T 
cells and NK cells. Furthermore, new isolates of MCMV exhibit polymorphisms in a 
number of immune evasion genes. The MCMV G4 isolate encodes a variant of m157 
that does not activate Ly49H [192]. Hence, Ly49H+ mouse strains are as susceptible 
to G4 as the Ly49H- mouse strains. Given the complexity of MCMV immune evasion, 
knowing the genomes of both virus and mouse strain is of significant importance to 
understand the mechanism and impact of immune evasion by MCMV.     
1.7 Anatomy of oral & nasal cavities and lymph nodes associated with 
alimentary & respiratory tracts in mice 
In the present Ph.D thesis, oronasal inoculation without anesthesia will be used to 
mimic natural MCMV infection. In order to identify viral target cells in oral and nasal 
cavities, it is essential to have a full understanding of the anatomy of the oral and 
nasal cavities of mice. In addition, it is also necessary to know the anatomy of various 
lymph nodes associated with alimentary and respiratory tracts. They may be involved 
in virus transmission upon oronasal inoculation, since mucosal surface, 
mucosa-associated lymphoid tissues and mucosa-draining LN constitute the inductive 
sites for mucosal immunity against exogenous pathogens [193-195].  
1.7.1 Anatomy of oral and nasal cavities of mice  
The lips, teeth, oral mucosa, tongue and salivary glands consist of the basic 
components of the oral cavity, which all are engaged in the process of digestion (Fig. 
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5). The oral cavity contains the labial, palatine, buccal and gingival mucosa, which is 
lined by variably orthokeratinized squamous epithelium [196]. The thickness of the 
keratin layer varies with diet and frequency of ingestion. Remarkably, mice do not 
have tonsils in the oral cavity. 
 
Figure 5. Mouse oral cavity. The hard palate extends from the incisors to the posterior of the 
third molars and has eight ridges. (Image obtained from reference [196])   
The nose is the portal of entry for the respiratory system. In addition to serving as the 
sensory organ for smell (olfaction), the nose also functions as an air conditioner and a 
defender of the lower respiratory tract by humidifying, heating and filtering the 
inhaled air. Besides that, it protects the delicate gas-exchange regions of the lung by 
effectively absorbing water-soluble and reactive gases and vapors, trapping inhaled 
particles, and metabolizing airborne xenobiotics.   
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In mice, evolutionary pressure on olfactory function has defined the shape of the 
turbinate and the type and distribution of the cells lining these structures. In the 
proximal nasal airway, the complex naso- and maxilloturbinates of mice are thought 
to provide protection of the lower respiratory tract due to enhanced filtration, 
absorption, and disposal of airborne particles and gases. The highly complex shape of 
the ethmoid turbinate, lined predominantly by olfactory neuroepithelium, in the distal 
half of the nasal cavity of mice is suitably designed for acute olfaction [197]. The 
complexity of the gross turbinate structure throughout the nasal airway of the adult 
laboratory mouse is illustrated in Figure 6. There are four distinct nasal epithelium 
types in mice: 1) squamous epithelium (SE), which is primarily restricted to the nasal 
vestibule; 2) ciliated, pseudostratified, cuboidal/columnar epithelium, or respiratory 
epithelium (RE), in the main chamber and nasopharynx; 3) poorly ciliated 
cuboidal/columnar epithelium, often termed transitional epithelium (TE), lying 
between SE and RE in the proximal aspect of the main chamber; and (4) olfactory 
epithelium (OE), located in the dorsal or dorsoposterior aspect of the nasal cavity.  
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Figure 6. Location of nasal epithelia: (A) right nasal passage of the murine nose with septum 
removed, exposing nasoturbinate (N), maxilloturbinate (MT), and ethmoid turbinate (E1-6); 
vertical lines indicate anterior surfaces of transverse tissue blocks (T1-T4). SE, squamous 
epithelium; TE, transitional epithelium; RE, respiratory epithelium; OE, olfactory epithelium; Na, 
naris; NP, nasopharynx; OB, olfactory bulb; HP, hard palate. (B) Cross-sectional views of T1-4. 
DM, dorsal medial meatus; LM, lateral meatus; N, nasoturbinate; MM, middle medial meatus; MT, 
maxilloturbinate; S, septum; VO, vomeronasal organ; VM, ventral meatus; HP, hard palate; DLM, 
dorsal lateral meatus; 1E, ethmoid turbinate one; 2E, ethmoid turbinate two; 3E, ethmoid turbinate 
three; 4E, ethmoid turbinate four; 5E, ethmoid turbinate five; MS, maxillary sinus; NPM, 
nasopharyngeal meatus; 6E, ethmoid turbinate six; OB, olfactory bulb; Nalt, nasal associated 
lymphoid. Asterisks = anatomical location of the lateral nasal glands (LNG). (Image obtained 
from reference [198]) 
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1.7.2 Anatomy of murine lymph nodes associated with alimentary and 
respiratory tracts  
The various lymph nodes associated with alimentary and respiratory tracts are 
nasopharynx-associated lymphoid tissues (NALT, which is at the base of the nasal 
cavity and consists of bilateral strips of lymphoid tissues [199]), superficial parotid 
lymph nodes (LN), submandibular LN, deep cervical LN, mediastinal LN, mesenteric 
LN, Peyer’s patches, thymus and spleen. Their locations are shown in Figure 7.  
 
Figure 7. Scheme showing the localization of various lymph nodes associated with 
alimentary and respiratory tracts. The ventral view of the palate is shown at the top right corner, 
and the ellipsoid areas represent the position of the NALT in the nasal cavity.    
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1.8 Homologies and differences in genetic and biological characteristics between 
MCMV and HCMV 
It is impossible to undertake experimental animal studies on the pathogenesis of 
HCMV infection due to its strict species specificity. Because MCMV infection in 
mice shares many features with HCMV infection in humans [11, 57], MCMV 
infection in mice has been widely used as an animal model for studies of HCMV 
infection. Here, an overview of homologies and differences between MCMV and 
HCMV is given.   
Genome composition and structure - MCMV and HCMV are essentially co-linear 
over the central region, with significant amino acid sequence homology of the 
proteins encoded by the 78 genes [200]. Nonetheless, the two viruses have different 
genome structures. The genome of MCMV is arranged as a single unique sequence 
with short (31- bp) terminal direct repeats but does not contain large internal repeats 
[7]. In contrast, the genome structures of HCMV are consisting of long and short 
unique sequences flanked by inverted large terminal and internal repeats [201].  
Biological characteristics - MCMV and HCMV infections are in general 
asymptomatic in the immunocompetent hosts with virus replication mainly detected in 
salivary glands, but are really harmful to the immunocompromised individuals such as 
fetus, AIDS patients and organ transplant recipients, with virus infection detected in 
salivary glands, lungs, spleen, liver, kidney, aortic wall, and adrenal glands [80, 202, 
203]. MCMV infection in mice is a suitable animal model for studying 
HCMV-related diseases: retinitis [204, 205], interstitial pneumonitis [92, 93], 
hepatitis [206-208], myocarditis [209], atherosclerosis [210, 211] and adrenalitis 
[123]. Up till now, it cannot be used to study transplacental infection since 
transplacental spread of MCMV has not been demonstrated yet.      
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   Introduction | 33	  
 
	  
References  
1. McCordock, H.A. and M.G. Smith, The visceral lesions produced in mice by the salivary 
gland virus of mice. The Journal of experimental medicine, 1936. 63(3): p. 303-310. 
2. Smith, M.G., Propagation of salivary gland virus of the mouse in tissue cultures. 
Experimental Biology and Medicine, 1954. 86(3): p. 435-440. 
3. Weller, T.H., J.B. Hanshaw, and E.S. D'Maris, Serologic differentiation of viruses responsible 
for cytomegalic inclusion disease. Virology, 1960. 12(1): p. 130-132. 
4. Mocarski, E., T. Shenk, and R. Pass, Cytomegaloviruses, in In Fields Virology, Knipe DM and 
Howley PM, Editors. 2007, Lippincott Williams &Wilkins: Philadelphia. p. 2701–2772. 
5. Andrew M.Q. King, et al., Virus Taxonomy:Classification and Nomenclature of Viruses. 
Ninth ed. 2012, United States of America: Elsevier. 111-122. 
6. Davison, A.J., et al., The order herpesvirales. Archives of virology, 2009. 154(1): p. 171-177. 
7. Rawlinson, W.D., H.E. Farrell, and B.G. Barrell, Analysis of the complete DNA sequence of 
murine cytomegalovirus. J Virol, 1996. 70(12): p. 8833-49. 
8. Chee, M., et al., Analysis of the protein-coding content of the sequence of human 
cytomegalovirus strain AD169, in Cytomegaloviruses. 1990, Springer. p. 125-169. 
9. Brocchieri, L., et al., Predicting coding potential from genome sequence: application to 
betaherpesviruses infecting rats and mice. Journal of virology, 2005. 79(12): p. 7570-7596. 
10. Lisnić, V.J., Analysis of murine cytomegalovirus transcriptome, in university of rijeka, school 
of medicine. 2013, university of rijeka: River. p. 154. 
11. Shellam, G.R., et al., Murine Cytomegalovirus and Other Herpesviruses, in The Mouse in 
Biomedical Research, J.G. Fox, et al., Editors. 2007, Academic Press: Waltham p. 1-48. 
12. Eisenberg, R.J., et al., Herpes virus fusion and entry: a story with many characters. Viruses, 
2012. 4(5): p. 800-832. 
13. Rapp, M., et al., Identification of the murine cytomegalovirus glycoprotein B gene and its 
expression by recombinant vaccinia virus. Journal of virology, 1992. 66(7): p. 4399-4406. 
14. Lemmermann, N., et al., Non-redundant and redundant roles of cytomegalovirus gH/gL 
complexes in host organ entry and intra-tissue spread. PLoS Pathog, 2015. 11(2): p. 
e1004640. 
15. Stahl, F.R., et al., Mck2-dependent infection of alveolar macrophages promotes replication of 
MCMV in nodular inflammatory foci of the neonatal lung. Mucosal Immunol, 2014. 
16. Daley-Bauer, L.P., et al., Cytomegalovirus Hijacks CX3CR1 hi Patrolling Monocytes as 
Immune-Privileged Vehicles for Dissemination in Mice. Cell host & microbe, 2014. 15(3): p. 
351-362. 
17. Li, R. and S.D. Hayward, Potential of protein kinase inhibitors for treating 
herpesvirus-associated disease. Trends in microbiology, 2013. 21(6): p. 286-295. 
18. Wang, D. and T. Shenk, Human cytomegalovirus virion protein complex required for 
epithelial and endothelial cell tropism. Proceedings of the National Academy of Sciences of 
the United States of America, 2005. 102(50): p. 18153-18158. 
19. Wang, X., et al., Epidermal growth factor receptor is a cellular receptor for human 
cytomegalovirus. Nature, 2003. 424(6947): p. 456-461. 
20. Isaacson, M.K., A.L. Feire, and T. Compton, Epidermal growth factor receptor is not 
required for human cytomegalovirus entry or signaling. Journal of virology, 2007. 81(12): p. 
34 
 
6241-6247. 
21. Price, P., et al., MHC proteins and heparan sulphate proteoglycans regulate murine 
cytomegalovirus infection. Immunology and cell biology, 1995. 73(4): p. 308-315. 
22. Compton, T., D.M. Nowlin, and N.R. Cooper, Initiation of human cytomegalovirus infection 
requires initial interaction with cell surface heparan sulfate. Virology, 1993. 193(2): p. 
834-841. 
23. Wykes, M., et al., Murine cytomegalovirus interacts with major histocompatibility complex 
class I molecules to establish cellular infection. Journal of virology, 1993. 67(7): p. 
4182-4189. 
24. Wykes, M.N., P. Price, and G. Shellam, The effects of β-2-microglobulin on the infectivity of 
murine cytomegalovirus. Archives of virology, 1992. 123(1-2): p. 59-72. 
25. Wang, D., et al., Human cytomegalovirus uses two distinct pathways to enter retinal 
pigmented epithelial cells. Proceedings of the National Academy of Sciences, 2007. 104(50): 
p. 20037-20042. 
26. Honess, R.W. and B. Roizman, Regulation of herpesvirus macromolecular synthesis I. 
Cascade regulation of the synthesis of three groups of viral proteins. Journal of virology, 
1974. 14(1): p. 8-19. 
27. Keil, G.M., A. Ebeling-Keil, and U.H. Koszinowski, Temporal regulation of murine 
cytomegalovirus transcription and mapping of viral RNA synthesized at immediate early times 
after infection. Journal of virology, 1984. 50(3): p. 784-795. 
28. Dorsch-Häsler, K., et al., A long and complex enhancer activates transcription of the gene 
coding for the highly abundant immediate early mRNA in murine cytomegalovirus. 
Proceedings of the National Academy of Sciences, 1985. 82(24): p. 8325-8329. 
29. Keil, G.M., A. Ebeling-Keil, and U.H. Koszinowski, Immediate-early genes of murine 
cytomegalovirus: location, transcripts, and translation products. Journal of virology, 1987. 
61(2): p. 526-533. 
30. Keil, G.M., A. Ebeling-Keil, and U.H. Koszinowski, Sequence and structural organization of 
murine cytomegalovirus immediate-early gene 1. Journal of virology, 1987. 61(6): p. 
1901-1908. 
31. Messerle, M., et al., Structural organization, expression, and functional characterization of 
the murine cytomegalovirus immediate-early gene 3. Journal of virology, 1992. 66(1): p. 
27-36. 
32. Angulo, A., P. Ghazal, and M. Messerle, The major immediate-early gene ie3 of mouse 
cytomegalovirus is essential for viral growth. Journal of virology, 2000. 74(23): p. 
11129-11136. 
33. Cardin, R.D., et al., Murine cytomegalovirus IE2, an activator of gene expression, is 
dispensable for growth and latency in mice. Virology, 1995. 209(1): p. 236-241. 
34. Bühler, B., et al., Characterization of the murine cytomegalovirus early transcription unit e1 
that is induced by immediate-early proteins. Journal of virology, 1990. 64(5): p. 1907-1919. 
35. Scalzo, A.A., et al., The murine cytomegalovirus M73. 5 gene, a member of a 3′ co-terminal 
alternatively spliced gene family, encodes the gp24 virion glycoprotein. Virology, 2004. 
329(2): p. 234-250. 
36. Gibson, W., Structure and assembly of the virion. Intervirology, 1996. 39(5-6): p. 389-400. 
37. Muranyi, W., et al., Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear 
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   Introduction | 35	  
 
	  
lamina. Science, 2002. 297(5582): p. 854-857. 
38. Reynolds, A.E., et al., UL31 and UL34 proteins of herpes simplex virus type 1 form a complex 
that accumulates at the nuclear rim and is required for envelopment of nucleocapsids. Journal 
of Virology, 2001. 75(18): p. 8803-8817. 
39. Fuchs, W., et al., The interacting UL31 and UL34 gene products of pseudorabies virus are 
involved in egress from the host-cell nucleus and represent components of primary enveloped 
but not mature virions. Journal of virology, 2002. 76(1): p. 364-378. 
40. Granzow, H., et al., Ultrastructural analysis of the replication cycle of pseudorabies virus in 
cell culture: a reassessment. Journal of virology, 1997. 71(3): p. 2072-2082. 
41. Gershon, A.A., et al., Intracellular transport of newly synthesized varicella-zoster virus: final 
envelopment in the trans-Golgi network. Journal of virology, 1994. 68(10): p. 6372. 
42. Loh, L.C., Synthesis and processing of the major envelope glycoprotein of murine 
cytomegalovirus. Virology, 1991. 180(1): p. 239-250. 
43. Xu, J., et al., Identification, sequencing and expression of the glycoprotein L gene of murine 
cytomegalovirus. The Journal of general virology, 1994. 75: p. 3235-3240. 
44. Mettenleiter, T.C., Herpesvirus assembly and egress. Journal of virology, 2002. 76(4): p. 
1537-1547. 
45. Mettenleiter, T.C., Budding events in herpesvirus morphogenesis. Virus research, 2004. 
106(2): p. 167-180. 
46. Weiland, F., et al., Studies on the morphogenesis of murine cytomegalovirus. Intervirology, 
1986: p. 192-201. 
47. Alec J. Redwood, Geoffery R. Shellam, and Lee M. Smith, Molecular evolution of murine 
cytomegalovirus genomes, in cytomegaloviruses: From molecular pathogenesis to 
intervention, Matthias J. Reddehase, Editor. 2013. p. 23-37. 
48. Cheng, T.P., et al., Stability of Murine Cytomegalovirus Genome after In Vitro and In Vivo 
Passage. Journal of Virology, 2010. 84(5): p. 2623-2628. 
49. Smith, L., et al., The genome of murine cytomegalovirus is shaped by purifying selection and 
extensive recombination. Virology, 2013. 435(2): p. 258-268. 
50. Smith, M.G., Propagation of salivary gland virus of the mouse in tissue cultures. Proc Soc 
Exp Biol Med, 1954. 86(3): p. 435-40. 
51. Hudson, J.B., V. Misra, and T.R. Mosmann, Properties of the multicapsid virions of murine 
cytomegalovirus. Virology, 1976. 72(1): p. 224-34. 
52. Booth, T.W., et al., Molecular and biological characterization of new strains of murine 
cytomegalovirus isolated from wild mice. Arch Virol, 1993. 132(1-2): p. 209-20. 
53. Gorman, S., et al., Mixed infection with multiple strains of murine cytomegalovirus occurs 
following simultaneous or sequential infection of immunocompetent mice. Journal of General 
Virology, 2006. 87: p. 1123-1132. 
54. Smith, L.M., et al., Laboratory strains of murine cytomegalovirus are genetically similar to 
but phenotypically distinct from wild strains of virus. J Virol, 2008. 82(13): p. 6689-96. 
55. Smith, L.M., et al., The genome of murine cytomegalovirus is shaped by purifying selection 
and extensive recombination. Virology, 2013. 435(2): p. 258-68. 
56. Kuttner, A.G. and S.-H. Wang, The problem of the significance of the inclusion bodies found 
in the salivary glands of infants, and the occurrence of inclusion bodies in the submaxillary 
glands of hamsters, white mice, and wild rats (Peiping). The Journal of experimental medicine, 
36 
 
1934. 60(6): p. 773-791. 
57. Krmpotic, A., et al., Pathogenesis of murine cytomegalovirus infection. Microbes and 
Infection, 2003. 5(13): p. 1263-1277. 
58. Campbell, A.E., V.J. Cavanaugh, and J.S. Slater, The salivary glands as a privileged site of 
cytomegalovirus immune evasion and persistence. Medical microbiology and immunology, 
2008. 197(2): p. 205-213. 
59. Mims, C. and J. Gould, Infection of salivary glands, kidneys, adrenals, ovaries and epithelia 
by murine cytomegalovirus. Journal of medical microbiology, 1979. 12(1): p. 113-122. 
60. Henson, D. and A.J. Strano, Mouse cytomegalovirus: necrosis of infected and 
morphologically normal submaxillary gland acinar cells during termination of chronic 
infection. The American journal of pathology, 1972. 68(1): p. 183. 
61. Lagenaur, L.A., et al., Structure and function of the murine cytomegalovirus sgg1 gene: a 
determinant of viral growth in salivary gland acinar cells. Journal of virology, 1994. 68(12): p. 
7717-7727. 
62. Bittencourt, F.M., et al., The M33 G Protein-Coupled Receptor Encoded by Murine 
Cytomegalovirus Is Dispensable for Hematogenous Dissemination but Is Required for Growth 
within the Salivary Gland. Journal of virology, 2014. 88(20): p. 11811-11824. 
63. Xiao, J., et al., In vitro and in vivo characterization of a murine cytomegalovirus with a 
transposon insertional mutation at open reading frame M43. Journal of virology, 2000. 74(20): 
p. 9488-9497. 
64. Neighbour, P. and L. Fraser, Murine cytomegalovirus and fertility: potential sexual 
transmission and the effect of this virus on fertilization in vitro. Fertility and sterility, 1978. 
30(2): p. 216-222. 
65. Stagno, S., et al., Breast milk and the risk of cytomegalovirus infection. New England Journal 
of Medicine, 1980. 302(19): p. 1073-1076. 
66. Medearis, D., Mouse cytomegalovirus infection II. Observations during prolonged infections. 
American Journal of Epidemiology, 1964. 80(1): p. 103-112. 
67. Ornoy, A. and O. Diav-Citrin, Fetal effects of primary and secondary cytomegalovirus 
infection in pregnancy. Reproductive Toxicology, 2006. 21(4): p. 399-409. 
68. Ahlfors, K., S.-A. Ivarsson, and S. Harris, Report on a long-term study of maternal and 
congenital cytomegalovirus infection in Sweden. Review of prospective studies available in 
the literature. Scandinavian journal of infectious diseases, 1999. 31(5): p. 443-457. 
69. Haginoya, K., et al., Abnormal white matter lesions with sensorineural hearing loss caused by 
congenital cytomegalovirus infection: retrospective diagnosis by PCR using Guthrie cards. 
Brain and Development, 2002. 24(7): p. 710-714. 
70. Boppana, S.B., et al., Neuroradiographic findings in the newborn period and long-term 
outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics, 1997. 
99(3): p. 409-414. 
71. Griffiths, P. and S. Walter, Cytomegalovirus. Curr Opin Infect Dis., 2005. 18(3): p. 241-245. 
72. Bratcher, D.F., et al., Effect of passive antibody on congenital cytomegalovirus infection in 
guinea pigs. Journal of Infectious Diseases, 1995. 172(4): p. 944-950. 
73. Tarantal, A.F., et al., Neuropathogenesis induced by rhesus cytomegalovirus in fetal rhesus 
monkeys (Macaca mulatta). Journal of Infectious Diseases, 1998. 177(2): p. 446-450. 
74. Johnson, K.P., Mouse cytomegalovirus: placental infection. The Journal of infectious diseases, 
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   Introduction | 37	  
 
	  
1969: p. 445-450. 
75. Grundy, J., J. Mackenzie, and N. Stanley, Influence of H-2 and non-H-2 genes on resistance 
to murine cytomegalovirus infection. Infection and immunity, 1981. 32(1): p. 277-286. 
76. Chalmer, J.E., J. Mackenzie, and N. Stanley, Resistance to murine cytomegalovirus linked to 
the major histocompatibility complex of the mouse. Journal of General Virology, 1977. 37(1): 
p. 107-114. 
77. Bancroft, G.J., G.R. Shellam, and J.E. Chalmer, Genetic influences on the augmentation of 
natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of 
resistance. The Journal of Immunology, 1981. 126(3): p. 988-994. 
78. Shellam, G., et al., The genetic background modulates the effect of the beige gene on 
susceptibility to cytomegalovirus infection in mice. Scandinavian journal of immunology, 
1985. 22(2): p. 147-155. 
79. Shellam, G.R., et al., Increased susceptibility to cytomegalovirus infection in beige mutant 
mice. Proceedings of the National Academy of Sciences, 1981. 78(8): p. 5104-5108. 
80. Krmpotic, A., et al., Pathogenesis of murine cytomegalovirus infection. Microbes Infect, 2003. 
5(13): p. 1263-77. 
81. Scalzo, A., et al., The effect of the Cmv-1 resistance gene, which is linked to the natural killer 
cell gene complex, is mediated by natural killer cells. The Journal of Immunology, 1992. 
149(2): p. 581-589. 
82. Scalzo, A.A., et al., Cmv-1, a genetic locus that controls murine cytomegalovirus replication 
in the spleen. The Journal of experimental medicine, 1990. 171(5): p. 1469-1483. 
83. Lee, S.-H., et al., Susceptibility to mouse cytomegalovirus is associated with deletion of an 
activating natural killer cell receptor of the C-type lectin superfamily. Nature genetics, 2001. 
28(1): p. 42-45. 
84. Daniels, K.A., et al., Murine cytomegalovirus is regulated by a discrete subset of natural 
killer cells reactive with monoclonal antibody to Ly49H. The Journal of experimental 
medicine, 2001. 194(1): p. 29-44. 
85. Arase, H., et al., Direct recognition of cytomegalovirus by activating and inhibitory NK cell 
receptors. Science, 2002. 296(5571): p. 1323-1326. 
86. Smith, H.R., et al., Recognition of a virus-encoded ligand by a natural killer cell activation 
receptor. Proceedings of the National Academy of Sciences, 2002. 99(13): p. 8826-8831. 
87. Selgrade, M.K. and J.E. Osborn, Role of macrophages in resistance to murine 
cytomegalovirus. Infection and immunity, 1974. 10(6): p. 1383-1390. 
88. Hsu, K.M., et al., Murine cytomegalovirus displays selective infection of cells within hours 
after systemic administration. Journal of General Virology, 2009. 90(1): p. 33-43. 
89. Hudson, J.B., The murine cytomegalovirus as a model for the study of viral pathogenesis and 
persistent infections. Arch Virol, 1979. 62(1): p. 1-29. 
90. Farrell, H.E., et al., Lymph node macrophages restrict murine cytomegalovirus dissemination. 
Journal of virology, 2015: p. JVI. 00480-15. 
91. Cardin, R.D., et al., The M33 chemokine receptor homolog of murine cytomegalovirus exhibits 
a differential tissue-specific role during in vivo replication and latency. J Virol, 2009. 83(15): 
p. 7590-601. 
92. Stahl, F.R., et al., Nodular inflammatory foci are sites of T cell priming and control of murine 
cytomegalovirus infection in the neonatal lung. 2013. 
38 
 
93. Shanley, J.D., E.L. Pesanti, and K.M. Nugent, The pathogenesis of pneumonitis due to murine 
cytomegalovirus. Journal of Infectious Diseases, 1982. 146(3): p. 388-396. 
94. Shanley, J.D., Host genetic factors influence murine cytomegalovirus lung infection and 
interstitial pneumonitis. J Gen Virol, 1984. 65 ( Pt 12): p. 2121-8. 
95. Shanley, J.D. and E.L. Pesanti, The relation of viral replication to interstitial pneumonitis in 
murine cytomegalovirus lung infection. Journal of Infectious Diseases, 1985. 151(3): p. 
454-458. 
96. Yeager, A.S., et al., Prevention of transfusion-acquired cytomegalovirus infections in 
newborn infants. The Journal of pediatrics, 1981. 98(2): p. 281-287. 
97. Gilbert, G., et al., Prevention of transfusion-acquired cytomegalovirus infection in infants by 
blood filtration to remove leucocytes. The Lancet, 1989. 333(8649): p. 1228-1231. 
98. Roback, J.D., et al., Transfusion‐transmitted cytomegalovirus (CMV) infections in a murine 
model: characterization of CMV‐infected donor mice. Transfusion, 2006. 46(6): p. 889-895. 
99. Prince, A.M., et al., A serologic study of cytomegalovirus infections associated with blood 
transfusions. New England Journal of Medicine, 1971. 284(20): p. 1125-1131. 
100. Yeager, A.S., Transfusion-acquired cytomegalovirus infection in newborn infants. American 
Journal of Diseases of Children, 1974. 128(4): p. 478-483. 
101. Cheung, K.-S. and D.J. Lang, Transmission and activation of cytomegalovirus with blood 
transfusion: a mouse model. Journal of Infectious Diseases, 1977. 135(5): p. 841-845. 
102. Sacher, T., et al., The major virus-producing cell type during murine cytomegalovirus 
infection, the hepatocyte, is not the source of virus dissemination in the host. Cell host & 
microbe, 2008. 3(4): p. 263-272. 
103. Henry, S.C., et al., Enhanced green fluorescent protein as a marker for localizing murine 
cytomegalovirus in acute and latent infection. Journal of virological methods, 2000. 89(1): p. 
61-73. 
104. Stoddart, C.A., et al., Peripheral blood mononuclear phagocytes mediate dissemination of 
murine cytomegalovirus. Journal of virology, 1994. 68(10): p. 6243-6253. 
105. Hudson, J., The murine cytomegalovirus as a model for the study of viral pathogenesis and 
persistent infections. Arch Virol, 1979. 62(1): p. 1-29. 
106. Mims, C.A. and J. Gould, Infection of salivary glands, kidneys, adrenals, ovaries and 
epithelia by murine cytomegalovirus. J Med Microbiol, 1979. 12(1): p. 113-22. 
107. Stahl, F.R., et al., Nodular inflammatory foci are sites of T cell priming and control of murine 
cytomegalovirus infection in the neonatal lung. PLoS Pathog, 2013. 9(12): p. e1003828. 
108. Jordan, M.C., Interstitial pneumonia and subclinical infection after intranasal inoculation of 
murine cytomegalovirus. Infect Immun, 1978. 21(1): p. 275-80. 
109. Alan J. Koffron, et al., Cellular localization of latent murine cytomegalovirus. Journal of 
virology, 1998. 72(1): p. 95-103. 
110. Farrell, H.E., et al., Alveolar macrophages are a prominent but non-essential target for 
Murine cytomegalovirus infecting the lungs. Journal of virology, 2015: p. JVI. 02856-15. 
111. Andoniou, C.E., et al., Interaction between conventional dendritic cells and natural killer 
cells is integral to the activation of effective antiviral immunity. Nature immunology, 2005. 
6(10): p. 1011-1019. 
112. Andrews, D.M., et al., Infection of dendritic cells by murine cytomegalovirus induces 
functional paralysis. Nature immunology, 2001. 2(11): p. 1077-1084. 
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   Introduction | 39	  
 
	  
113. Mercer, J., C. Wiley, and D. Spector, Pathogenesis of murine cytomegalovirus infection: 
identification of infected cells in the spleen during acute and latent infections. Journal of 
virology, 1988. 62(3): p. 987-997. 
114. Benedict, C.A., et al., Specific remodeling of splenic architecture by cytomegalovirus. PLoS 
Pathog, 2006. 2(3): p. e16. 
115. Li, Z., et al., A mouse model of CMV transmission following kidney transplantation. American 
Journal of Transplantation, 2012. 12(4): p. 1024-1028. 
116. Shanley, J.D., L. Biczak, and S.J. Forman, Acute murine cytomegalovirus infection induces 
lethal hepatitis. Journal of Infectious Diseases, 1993. 167(2): p. 264-269. 
117. Campbell, A.E., J.S. Slater, and W.S. Futch, Murine cytomegalovirus-induced suppression of 
antigen-specific cytotoxic T lymphocyte maturation. Virology, 1989. 173(1): p. 268-275. 
118. Knipe, D.M. and P.M. Howley, Cytomegaloviruses, in Fields Virology E.S. Mocarski, T. 
Shenk, and R.F. Pass, Editors. 2007, Lippincott Williams & Wilkins New York. p. 2703-2704. 
119. Reddehase, M.J., et al., Interstitial murine cytomegalovirus pneumonia after irradiation: 
characterization of cells that limit viral replication during established infection of the lungs. 
Journal of virology, 1985. 55(2): p. 264-273. 
120. Trgovcich, J., et al., Immune responses and cytokine induction in the development of severe 
hepatitis during acute infections with murine cytomegalovirus. Archives of virology, 2000. 
145(12): p. 2601-2618. 
121. Atherton, S.S., et al., Retinitis in euthymic mice following inoculation of murine 
cytomegalovirus (MCMV) via the supraciliary route. Current eye research, 1991. 10(7): p. 
667-677. 
122. Lieberman, E.B., et al., Clinicopathoiogic description of myocarditis. Journal of the American 
College of Cardiology, 1991. 18(7): p. 1617-1626. 
123. Price, P., et al., Adrenalitis and the adrenocortical response of resistant and susceptible mice 
to acute murine cytomegalovirus infection. European journal of clinical investigation, 1996. 
26(9): p. 811-819. 
124. Fitzgerald, N.A., J. Papadimitriou, and G. Shellam, Cytomegalovirus-induced pneumonitis 
and myocarditis in newborn mice. Archives of virology, 1990. 115(1-2): p. 75-88. 
125. Astrid Krmpotic, et al., Pathogenesis of murine cytomegalovirus infection. Microbes and 
infection, 2003. 5(13): p. 1263-1277. 
126. Reddehase, M.J., et al., The conditions of primary infection define the load of latent viral 
genome in organs and the risk of recurrent cytomegalovirus disease. The Journal of 
experimental medicine, 1994. 179(1): p. 185-193. 
127. Lussier, G., Encephalitis caused by murine cytomegalovirus in newborn and weanling mice. 
Veterinary Pathology Online, 1973. 10(5): p. 366-374. 
128. Lockridge, K.M., et al., Pathogenesis of experimental rhesus cytomegalovirus infection. J 
Virol, 1999. 73(11): p. 9576-83. 
129. Norvell, W.G., Porcine Cytomegalovirus (PCMV), in Herpesvirus Diseases of Cattle, Horses, 
and Pigs. Developments in Veterinary Virology, V. Ohlinger, Editor. 1989, Kluwer Academic 
Publishers: Norwell. p. 326-333. 
130. Bia, F.J., et al., Cytomegaloviral infections in the guinea pig: experimental models for human 
disease. Rev Infect Dis, 1983. 5(2): p. 177-95. 
131. Loh, H.S., et al., Pathogenesis and vertical transmission of a transplacental rat 
40 
 
cytomegalovirus. Virol J, 2006. 3: p. 42. 
132. Waterston, R.H., et al., Initial sequencing and comparative analysis of the mouse genome. 
Nature, 2002. 420(6915): p. 520-62. 
133. Messerle, M., et al., Cloning and mutagenesis of a herpesvirus genome as an infectious 
bacterial artificial chromosome. Proceedings of the National Academy of Sciences, 1997. 
94(26): p. 14759-14763. 
134. Steinman, R.M., The dendritic cell system and its role in immunogenicity. Annual review of 
immunology, 1991. 9(1): p. 271-296. 
135. Cooper, M.A., et al., NK cell and DC interactions. Trends in immunology, 2004. 25(1): p. 
47-52. 
136. Zitvogel, L., Dendritic and natural killer cells cooperate in the control/switch of innate 
immunity. The Journal of experimental medicine, 2002. 195(3): p. F9-F14. 
137. Krug, A., et al., Cutting edge: IFN-producing cells respond to CXCR3 ligands in the presence 
of CXCL12 and secrete inflammatory chemokines upon activation. The Journal of 
Immunology, 2002. 169(11): p. 6079-6083. 
138. Dalod, M., et al., Dendritic Cell Responses to Early Murine Cytomegalovirus Infection Subset 
Functional Specialization and Differential Regulation by Interferon α/β. The Journal of 
experimental medicine, 2003. 197(7): p. 885-898. 
139. Raftery, M.J., et al., Targeting the function of mature dendritic cells by human 
cytomegalovirus: a multilayered viral defense strategy. Immunity, 2001. 15(6): p. 997-1009. 
140. Loewendorf, A.I., et al., The mouse cytomegalovirus glycoprotein m155 inhibits CD40 
expression and restricts CD4 T cell responses. Journal of virology, 2011. 85(10): p. 
5208-5212. 
141. Hanson, L.K., et al., Replication of murine cytomegalovirus in differentiated macrophages as 
a determinant of viral pathogenesis. Journal of virology, 1999. 73(7): p. 5970-5980. 
142. Noda, S., et al., Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid 
progenitor cells to facilitate dissemination. Blood, 2006. 107(1): p. 30-38. 
143. Collins, T.M., M.R. Quirk, and M.C. Jordan, Biphasic viremia and viral gene expression in 
leukocytes during acute cytomegalovirus infection of mice. J Virol, 1994. 68(10): p. 6305-11. 
144. Stoddart, C.A., et al., Peripheral blood mononuclear phagocytes mediate dissemination of 
murine cytomegalovirus. J Virol, 1994. 68(10): p. 6243-53. 
145. Hengel, H., et al., Macrophages escape inhibition of major histocompatibility complex class 
I-dependent antigen presentation by cytomegalovirus. Journal of virology, 2000. 74(17): p. 
7861-7868. 
146. Orange, J.S. and C.A. Biron, Characterization of early IL-12, IFN-alphabeta, and TNF effects 
on antiviral state and NK cell responses during murine cytomegalovirus infection. The Journal 
of Immunology, 1996. 156(12): p. 4746-4756. 
147. Silvia Vidal, et al., Innate Immunity to Cytomegalovirus in the Murine Model, in 
Cytomegaloviruses: From Molecular Pathogenesis to Intervention, M.J. Reddehase, Editor. 
2013, Caister Academic Press: Norfolk, UK. p. 193-214. 
148. Ware, C.F., Network communications: lymphotoxins, LIGHT, and TNF. Annu. Rev. Immunol., 
2005. 23: p. 787-819. 
149. Schneider, K., et al., Lymphotoxin-mediated crosstalk between B cells and splenic stroma 
promotes the initial type I interferon response to cytomegalovirus. Cell host & microbe, 2008. 
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   Introduction | 41	  
 
	  
3(2): p. 67-76. 
150. Shanley, J.D., In vivo administration of monoclonal antibody to the NK 1.1 antigen of natural 
killer cells: effect on acute murine cytomegalovirus infection. Journal of medical virology, 
1990. 30(1): p. 58-60. 
151. Welsh, R., C. O'Donnell, and L. Shultz, Antiviral activity of NK 1.1+ natural killer cells in 
C57BL/6 scid mice infected with murine cytomegalovirus. Natural immunity, 1993. 13(5): p. 
239-245. 
152. Bukowski, J.F., et al., Adoptive transfer studies demonstrating the antiviral effect of natural 
killer cells in vivo. The Journal of experimental medicine, 1985. 161(1): p. 40-52. 
153. Bukowski, J.F., H. Yang, and R.M. Welsh, Antiviral effect of lymphokine-activated killer cells: 
characterization of effector cells mediating prophylaxis. Journal of virology, 1988. 62(10): p. 
3642-3648. 
154. Welsh, R., Regulation of virus infections by natural killer cells. A review. Natural immunity 
and cell growth regulation, 1986. 5(4): p. 169. 
155. Araullo-Cruz, T., M. Ho, and J. Armstrong, Protective effect of early serum from mice after 
cytomegalovirus infection. Infection and immunity, 1978. 21(3): p. 840-842. 
156. Lawson, C.M., J.E. Grundy, and G.R. Shellam, Antibody responses to murine cytomegalovirus 
in genetically resistant and susceptible strains of mice. J Gen Virol, 1988. 69(Pt 8): p. 
1987-1998. 
157. Shanley, J.D., M.C. Jordan, and J.G. Stevens, Modification by adoptive humoral immunity of 
murine cytomegalovirus infection. Journal of Infectious Diseases, 1981. 143(2): p. 231-237. 
158. Farrell, H.E. and G.R. Shellam, Protection against murine cytomegalovirus infection by 
passive transfer of neutralizing and non-neutralizing monoclonal antibodies. J Gen Virol, 
1991. 72(Pt 1): p. 149-156. 
159. Selgrade, M., et al., Humoral antibody response to individual viral proteins after murine 
cytomegalovirus infection. The Journal of Immunology, 1983. 131(6): p. 3032-3035. 
160. Mach Michael, et al., Protective humoral immunity, in Cytomegaloviruses: from molecular 
pathogenesis to intervention, Reddehase Matthias J. and Lemmermann Niels A.W., Editors. 
2013, Caister Academic Press Norfolk, UK. p. 215-231. 
161. Grundy, J.E. and C. Melief, Effect of Nu/Nu gene on genetically determined resistance to 
murine cytomegalovirus. The Journal of general virology, 1982. 61: p. 133-136. 
162. Starr, S. and A. Allison, Role of T lymphocytes in recovery from murine cytomegalovirus 
infection. Infection and immunity, 1977. 17(2): p. 458-462. 
163. Jonjić, S., et al., Site-restricted persistent cytomegalovirus infection after selective long-term 
depletion of CD4+ T lymphocytes. The Journal of experimental medicine, 1989. 169(4): p. 
1199-1212. 
164. Lucin, P., et al., Gamma interferon-dependent clearance of cytomegalovirus infection in 
salivary glands. Journal of virology, 1992. 66(4): p. 1977-1984. 
165. Doom, C.M. and A.B. Hill, MHC class I immune evasion in MCMV infection. Med Microbiol 
Immunol, 2008. 197(2): p. 191-204. 
166. Reddehase, M., et al., Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the 
immunocompromised host: CD4-helper-independent antiviral function of CD8-positive 
memory T lymphocytes derived from latently infected donors. Journal of virology, 1988. 62(3): 
p. 1061-1065. 
42 
 
167. Reddehase, M.J., W. Mutter, and U.H. Koszinowski, In vivo application of recombinant 
interleukin 2 in the immunotherapy of established cytomegalovirus infection. The Journal of 
experimental medicine, 1987. 165(3): p. 650-656. 
168. Lathbury, L.J., et al., Effect of host genotype in determining the relative roles of natural killer 
cells and T cells in mediating protection against murine cytomegalovirus infection. Journal of 
general virology, 1996. 77(10): p. 2605-2613. 
169. Carayannopoulos, L.N. and W.M. Yokoyama, Recognition of infected cells by natural killer 
cells. Current opinion in immunology, 2004. 16(1): p. 26-33. 
170. Pyzik, M., et al., Self or nonself? That is the question: sensing of cytomegalovirus infection by 
innate immune receptors. Mammalian Genome, 2011. 22(1-2): p. 6-18. 
171. Brizić, I., et al. MCMV avoidance of recognition and control by NK cells. in Seminars in 
immunopathology. 2014. Springer. 
172. Hengel, H., et al., Cytomegaloviral control of MHC class I function in the mouse. 
Immunological reviews, 1999. 168(1): p. 167-176. 
173. Lemmermann, N.A., et al., Immune evasion proteins of murine cytomegalovirus preferentially 
affect cell surface display of recently generated peptide presentation complexes. Journal of 
virology, 2010. 84(3): p. 1221-1236. 
174. LoPiccolo, D.M., et al., Effective inhibition of Kb-and Db-restricted antigen presentation in 
primary macrophages by murine cytomegalovirus. Journal of virology, 2003. 77(1): p. 
301-308. 
175. Reusch, U., et al., A cytomegalovirus glycoprotein re‐routes MHC class I complexes to 
lysosomes for degradation. The EMBO journal, 1999. 18(4): p. 1081-1091. 
176. Wagner, M., et al., Major histocompatibility complex class I allele-specific cooperative and 
competitive interactions between immune evasion proteins of cytomegalovirus. The Journal of 
experimental medicine, 2002. 196(6): p. 805-816. 
177. Ziegler, H., et al., A mouse cytomegalovirus glycoprotein retains MHC class I complexes in 
the ERGIC/cis-Golgi compartments. Immunity, 1997. 6(1): p. 57-66. 
178. Dokun, A.O., et al., Specific and nonspecific NK cell activation during virus infection. Nature 
immunology, 2001. 2(10): p. 951-956. 
179. Lee, S.-H., J.R. Webb, and S.M. Vidal, Innate immunity to cytomegalovirus: the Cmv1 locus 
and its role in natural killer cell function. Microbes and infection, 2002. 4(15): p. 1491-1503. 
180. Adams, E.J., et al., Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 
natural killer cell receptors. Proceedings of the National Academy of Sciences, 2007. 104(24): 
p. 10128-10133. 
181. Jonjić, S., et al., Immune evasion of natural killer cells by viruses. Current opinion in 
immunology, 2008. 20(1): p. 30-38. 
182. Cerwenka, A., et al., Retinoic acid early inducible genes define a ligand family for the 
activating NKG2D receptor in mice. Immunity, 2000. 12(6): p. 721-727. 
183. Lodoen, M., et al., NKG2D-mediated natural killer cell protection against cytomegalovirus is 
impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. The 
Journal of experimental medicine, 2003. 197(10): p. 1245-1253. 
184. Carayannopoulos, L.N., et al., Cutting edge: murine UL16-binding protein-like transcript 1: a 
newly described transcript encoding a high-affinity ligand for murine NKG2D. The Journal of 
Immunology, 2002. 169(8): p. 4079-4083. 
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   Introduction | 43	  
 
	  
185. Diefenbach, A., et al., Ligands for the murine NKG2D receptor: expression by tumor cells and 
activation of NK cells and macrophages. Nature immunology, 2000. 1(2): p. 119-126. 
186. Lisnić, V.J., A. Krmpotić, and S. Jonjić, Modulation of natural killer cell activity by viruses. 
Current opinion in microbiology, 2010. 13(4): p. 530-539. 
187. Lenac, T., et al., The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands 
MULT-1 and H60. The Journal of experimental medicine, 2006. 203(8): p. 1843-1850. 
188. Arapović, J., et al., Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus. 
Journal of virology, 2009. 83(16): p. 8198-8207. 
189. Krmpotić, A., et al., MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and 
NK cells in vivo. Nature immunology, 2002. 3(6): p. 529-535. 
190. Hasan, M., et al., Selective down-regulation of the NKG2D ligand H60 by mouse 
cytomegalovirus m155 glycoprotein. Journal of virology, 2005. 79(5): p. 2920-2930. 
191. Krmpotic, A., et al., NK cell activation through the NKG2D ligand MULT-1 is selectively 
prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. The Journal of 
experimental medicine, 2005. 201(2): p. 211-220. 
192. Voigt, V., et al., Murine cytomegalovirus m157 mutation and variation leads to immune 
evasion of natural killer cells. Proceedings of the National Academy of Sciences, 2003. 
100(23): p. 13483-13488. 
193. Kuper, C.F., et al., The role of nasopharyngeal lymphoid tissue. Immunol Today, 1992. 13(6): 
p. 219-24. 
194. Iwasaki, A., Mucosal dendritic cells. Annu Rev Immunol, 2007. 25: p. 381-418. 
195. Brandtzaeg, P., et al., Terminology: nomenclature of mucosa-associated lymphoid tissue. 
Mucosal Immunol, 2008. 1(1): p. 31-7. 
196. Treuting, P.M. and T.H. Morton, Oral cavity and teeth, in Comparative anatomy and 
histology: a mouse and human atlas, P.M. Treuting, et al., Editors. 2012, Academic Press 
London p. 95-110. 
197. Harkema, J.R., et al., Nose, sinus, pharynx, and laryxn, in Comparative anatomy and histology: 
a mouse and human atlas, P.M. Treuting, et al., Editors. 2012, Academic Press London p. 
71-92. 
198. Corps, K.N., et al., Neurotoxic, Inflammatory, and Mucosecretory Responses in the Nasal 
Airways of Mice Repeatedly Exposed to the Macrocyclic Trichothecene Mycotoxin Roridin A 
Dose-Response and Persistence of Injury. Toxicologic pathology, 2010. 38(3): p. 429-451. 
199. Kraal, G., Nasal-associated lymphoid tissue in Mucosal immunology, J. Mestecky, et al., 
Editors. 2005, Academic press: London. p. 415-422. 
200. William D.Rawlinson, Helen E.Farrell, and B. G.Barrell, Analysis of the complete DNA 
sequence of murine cytomegalovirus. Journal of virology, 1996. 70(12): p. 8833-8849. 
201. Dolan, A., et al., Genetic content of wild-type human cytomegalovirus. Journal of General 
Virology, 2004. 85(5): p. 1301-1312. 
202. Ho, M., Cytomegaloviruses, in in Principles and Practice of infectious Diseases, G.L. 
Mandell, J.E.Bennett, and R.Dolin, Editors. 1995, Churchhill Livingstone: New York. p. 
1351-1364. 
203. Britt, W., Human cytomegalovirus infections and mechanisms of disease, in 
Cytomegaloviruses: Molecular biology and immunology, M.J. Reddehase, Editor. 2006, 
Caister Academic Press: UK. p. 1-28. 
44 
 
204. Bale, J., et al., The pathogenesis of murine cytomegalovirus ocular infection. Anterior 
chamber inoculation. Investigative ophthalmology & visual science, 1990. 31(8): p. 
1575-1581. 
205. Dix, R.D., E.R. Podack, and S.W. Cousins, Loss of the perforin cytotoxic pathway predisposes 
mice to experimental cytomegalovirus retinitis. Journal of virology, 2003. 77(6): p. 
3402-3408. 
206. Livingston-Rosanoff, D., et al., Antiviral T cell response triggers cytomegalovirus hepatitis in 
mice. Journal of virology, 2012. 86(23): p. 12879-12890. 
207. Kasman, L., et al., A mouse model linking viral hepatitis and salivary gland dysfunction. Oral 
diseases, 2009. 15(8): p. 587-595. 
208. Pan, H.n., et al., Chronic Ethanol Consumption Inhibits Hepatic Natural Killer Cell Activity 
and Accelerates Murine Cytomegalovirus‐ Induced Hepatitis. Alcoholism: Clinical and 
Experimental Research, 2006. 30(9): p. 1615-1623. 
209. Ritter, J.T., et al., In vivo characterization of cytokine profiles and viral load during murine 
cytomegalovirus-induced acute myocarditis. Cardiovascular Pathology, 2010. 19(2): p. 83-93. 
210. Vliegen, I., et al., Mouse cytomegalovirus antigenic immune stimulation is sufficient to 
aggravate atherosclerosis in hypercholesterolemic mice. Atherosclerosis, 2005. 181(1): p. 
39-44. 
211. Tang-Feldman, Y.J., et al., Murine cytomegalovirus (MCMV) infection upregulates P38 MAP 
kinase in aortas of Apo E KO mice: a molecular mechanism for MCMV-induced acceleration 
of atherosclerosis. Journal of cardiovascular translational research, 2013. 6(1): p. 54-64. 
 
 
	  Chapter 2 
 
Aims 
46   
 
HCMV chronically infects more than 90% of the world’s population. It is harmful for 
immunocompromised individuals, such as neonates, HIV patients, and recipients of 
organ transplants, but is in general asymptomatic in the immunocompetent hosts. The 
sporadic asymptomatic HCMV transmission makes early infection hard to study. 
MCMV infection in mice is a commonly used experimental animal model for 
studying HCMV infection. Therefore, MCMV may give more insight in how HCMV 
invades in its host under natural situation.  
Natural MCMV entry routes remain ill-defined, although MCMV has been studied for 
more than 60 years. Most published studies on MCMV have utilized intraperitoneal 
inoculation, sometimes intracerebral, orbital or intravenous inoculation, but none of 
them can be considered as being natural. In general, only intranasal and oral 
inoculations are widely accepted as the route of natural infection of betaherpesviruses. 
Unfortunately, there is very limited information on how MCMV infection is 
established upon intranasal or peroral inoculation. Although a few previous published 
papers used intranasal inoculation, all inoculated mice were under anesthesia/sedation 
resulting in a lack of the sneezing reflex, and hence resulting in a direct delivery of 
virus into the lungs. This does not correlate with the natural infection. Transmission 
of MCMV by suckling virus contaminated breast milk is possible, likely due to the 
presence of milk and the neonatal Fc receptor, which may respectively provide 
additional buffering to avoid destruction by low gastric pH and capture virions bound 
by maternal antibodies. How MCMV invades the host by oral exposure is still 
unknown.     
Besides the inoculation route, the virus strain should be taken into consideration 
during in vivo studies as well. Over the past decades, most published studies used the 
MCMV Smith or K181 that is derived from the early stocks of MCMV Smith. Both 
strains are highly passaged in vivo and in vitro, and it has become apparent that such 
strains have acquired genetic and biological differences during passaging. The same 
problem has been discussed for HCMV, where serially passaged laboratory strains, 
such as the commonly used HCMV AD169, exhibit significant biological differences 
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compared to the clinical isolates of HCMV. Therefore, using serially passaged strains 
of MCMV may not be suited to extrapolate results to the real life situation. It is of 
importance that recent isolates of MCMV, which are not undergone extensive cell 
culture passaging, should be tested to give more relevant information on the 
pathogenesis of MCMV.   
Given the above observed problems, the general aim of the research carried out for 
this doctoral thesis was to obtain a good understanding of MCMV pathogenesis by 
mimicking the natural infection with a reliable and low passaged MCMV HaNa1 
isolate.    
The more specific aims were 
1) To set up an animal model to mimic natural infection of MCMV and compare the 
pathogenesis of infection with two MCMV strains (the low passaged MCMV 
HaNa1 Belgian isolate and highly passaged MCMV Smith strain) in Balb/c female 
mice using the natural route of infection (oronasally) with a low (104TCID50 per 
mouse) and high (106TCID50 per mouse) inoculation dose without 
sedation/anesthesia (Chapter 3).  
2) To elucidate the kinetics of virus dissemination throughout the body upon oronasal 
exposure through inoculation of BALB/c female mice with two MCMV strains 
(the highly passaged MCMV Smith strain and low passaged MCMV HaNa1 strain) 
(Chapter 4).  
3) To demonstrate the role of the spleen in virus dissemination in the natural primary 
infection of MCMV by inoculating intact or splenectomized Balb/c mice with 
either MCMV Smith or MCMV HaNa1 (Chapter 5). 
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Summary 
Murine cytomegalovirus (MCMV) Smith strain is widely used in mouse models to 
study HCMV infections. Due to highly serial passages, MCMV Smith has acquired 
genetic and biological changes. Therefore, a low passaged strain would be more 
relevant to develop mouse models. Here, the pathogenesis of an infection with 
MCMV Smith was compared with that of an infection with a low passaged Belgian 
MCMV isolate HaNa1 in BALB/c adult mice following oronasal inoculation with 
either a low (104 TCID50/mouse) or high (106 TCID50/mouse) inoculation dose. Both 
strains mainly replicated in nasal mucosa and submandibular glands for one to two 
months. In nasal mucosa, MCMV was detected earlier and longer (1-49dpi) and 
reached higher titers with the high inoculation dose compared to the low inoculation 
dose (14-35dpi). In submandibular glands, a similar finding was observed (high dose: 
7-49dpi; low dose: 14-42dpi). In lungs, both strains showed a restricted replication. 
Only the Smith strain established a low level of productive infection in spleen, liver 
and kidneys. The infected cells were identified as olfactory neurons and 
sustentacular cells in olfactory epithelium, macrophages and dendritic cells in NALT, 
acinar cells in submandibular glands, and macrophages and epithelial cells in lungs 
for both strains. Antibody analysis demonstrated for both strains that IgG2a was the 
main detectable antibody subclass. Overall, our results show that significant 
phenotypic differences exist between the two strains. MCMV HaNa1 has been 
shown to be interesting for use in mouse models in order to get better insights 
regarding HCMV infections in immunocompetent humans. 
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1 Introduction 
Human cytomegalovirus (HCMV), also known as human herpesvirus 5 (HHV-5), is 
the prototype member of the Betaherpesvirinae within the family of the 
Herpesviridae. It is an ubiquitous virus with a worldwide distribution [1]. It is the 
main cause of congenital infections in the world, affecting 0.5-2.0% of live births [2, 
3] and leading to central nervous damage, congenital deafness and mental retardation 
[4-7]. HCMV infection is also harmful for the immunocompromised individuals, 
such as HIV patients and recipients of organ transplants, but is in general 
asymptomatic in the immunocompetent host [8].   
Due to the strict species-specificity of HCMV, it is not possible to study this virus in 
experimental animals. Therefore, it is necessary to set up animal models for the 
study of HCMV. Up till now, a number of CMV infections in various animal species 
have been utilized for modeling HCMV infection. Among the animal CMVs, 
pathogenesis has been reported for rhesus macaque CMV, porcine CMV, guinea pig 
CMV, rat CMV and murine CMV [9-13]. The mouse model with MCMV is the most 
commonly and widely used animal model for HCMV study, due to the following 
reasons: (1) MCMV shares many features with HCMV [4], (2) the genomes of mice 
and MCMV are fully sequenced [14, 15] and (3) the small size, short life span, ease 
of handling and high reproductive rate make them most suitable.  
MCMV has been studied for more than 60 years. Most published studies used the 
MCMV Smith strain or MCMV K181 derived from the early stock of MCMV Smith 
strain [16], which were highly passaged in vitro or in vivo. It is now apparent that 
strains or variants of MCMV Smith that are in common use have acquired genetic 
and biological differences during passaging [17, 18]. The same problem has been 
discussed for HCMV, where serially passaged laboratory strains, such as the 
commonly used HCMV AD169, exhibit significant biological differences compared 
to the clinical isolates of HCMV [19, 20]. Therefore, using serially passaged strains 
of MCMV may not be able to reproduce the full range or extent of virus replication 
and clinical outcome that are associated with HCMV infections. It is important that 
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more emphasis is being placed on the use of recent isolates of MCMV and avoiding 
cell culture passaging of these isolates.  
Besides the passage history, the inoculation route is an important factor during in 
vivo studies as well. The inoculation route should mimic the natural route of MCMV 
infection. Most of the published studies on MCMV have utilized the intraperitoneal 
inoculation, sometimes intracerebral, orbital or intravenous inoculation, none of 
which can be considered as being natural [21]. Although intramuscular or 
subcutaneous inoculation mimics natural infection upon biting, only intranasal and 
oral inoculations are widely accepted as the route of natural infection. Unfortunately, 
there is very limited information on natural infection upon oronasal inoculation, with 
only a few studies on viral kinetics, organ and tissue tropism, and host response 
[22-24].    
In the present study, we have used two MCMV strains (low passaged MCMV 
HaNa1 isolate and highly passaged MCMV Smith strain) to set up mouse models 
using the natural route of infection (oronasally) with a low (104TCID50 per mouse) 
and high (106TCID50 per mouse) inoculation dose without sedation/anesthesia in 
order to compare the pathogenesis of a low passaged isolate HaNa1 and the 
well-studied Smith strain.  
2 Materials and Methods 
2.1 Ethics statement 
All animal experiments (Case number 2013-47) were approved by the local Ethical 
Committee of the Faculty of Veterinary Medicine, Ghent University.     
2.2 Cells and viruses 
Primary BALB/c mouse embryonic fibroblasts (MEFs) at passage 2 were propagated 
at 37°C and 5% CO2, in minimum essential medium with 10% fetal calf serum (FCS), 
2% lactalbumin and a mixture of antibiotics (100 U/ml penicillin, 100 µg/ml 
streptomycin and 50 µg/ml gentamicin). Viruses used in the present experiments 
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were the second passage of clone1 of the MCMV HaNa1 isolate, which was isolated 
by our laboratory from a domestic mouse, and the MCMV Smith strain at unknown 
passage. Up till now, six genes from MCMV HaNa1 have been sequenced and 
submitted to GenBank: m06 gene (accession No.: KR184668), m033 gene 
(accession No.: KR184669), mck-2 including exon1 (m131 gene) and exon2 (m129 
gene) (accession No.: KR184670), m138 gene (accession No.: KR184671), m144 
gene (accession No.: KR184672), m152 gene (accession No.: KR184673). The 
m157 gene has also been sequenced more recently and submitted to Genbank 
(accession No.: KT289520).  
2.3 Multistep growth curves of two MCMV strains in MEFs 
In order to have a better understanding of the in vitro viral replication kinetics of 
both MCMV strains, a growth curve analysis was performed. Monolayers of MEFs 
in 24-well plates were inoculated in triplicate with MCMV HaNa1 or MCMV Smith 
at 104 TCID50/well. After inoculation for 1 hour at 37°C with 5% CO2, the inoculum 
was removed, and cells were washed three times with 2ml PBS. Afterwards, 1ml of 
fresh culture medium was added per well. The supernatants (1ml) with the 
extracellular virus and the infected cells containing intracellular virus, which were 
resuspended in 1ml PBS, were collected at 1, 12, 24, 48 and 72 hpi. The virus 
inactivation curve was determined by keeping cell free virus in culture medium at 
37°C with 5% CO2. Samples were taken at different time points. The samples were 
stored at -70°C upon use at the end of the experiment. All samples were thawed and 
cleared of cellular debris, and then titrated to determine 50% tissue culture infectious 
dose (TCID50) according to the Reed and Muench formula [25].     
2.4 Animals and virus inoculation 
A total of 135 specific pathogen-free 8-week-old BALB/c female mice were used. In 
both low dose groups (36 mice/group), each mouse was inoculated with 100µl PBS 
containing 104 TCID50 MCMV HaNa1 or MCMV Smith via intranasal (25 µl) and 
peroral (75 µl) routes without sedation/anesthesia. For the intranasal inoculation, a 
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small amount of inoculum (5 µl) was repeatedly instilled in each nostril. Each 
application was done with several minutes interval. For the oral inoculation, 25 µl 
inoculum was given three times with a few minutes interval between each 
inoculation. Mice were kept in isolation and fed ad libitum. Three inoculated mice 
were euthanized at each time point (1, 3, 5, 7, 10, 14, 17, 21, 28, 35, 42 and 49 days 
post inoculation (dpi)). In both high dose groups (30 mice/group), each mouse was 
inoculated with 100µl PBS containing 106 TCID50 MCMV HaNa1 or MCMV Smith 
via intranasal (25 µl) and peroral (75 µl) routes using the same methodology. Three 
infected mice were euthanized at each time point (1, 3, 5, 7, 10, 14, 17, 21, 35 and 49 
dpi). Another 3 mice were mock inoculated with PBS and euthanized at the end of 
the experiment.   
2.5 Collection of saliva, blood and tissues 
Saliva was collected by swabs and stored in 0.3 ml of cold sterile PBS containing 1% 
fetal calf serum and a mixture of antibiotics (100 U/ml penicillin, 100 µg/ml 
streptomycin and 50 µg/ml gentamicin). Upon anesthesia with 130 µl of 10 mg/ml 
sodium pentobarbital (KELA, Belgium) per mouse, 0.5 ml blood was collected from 
the orbital sinus with a heparinized pasteur pipet and kept in an eppendorf with 0.5 
ml PBS containing 5 U/ml heparin (Leo Pharma, Zaventem, Belgium). Then, plasma 
was harvested through centrifugation (200g for 10 min) and stored at -70 °C for 
virus and antibody titration. Peripheral blood mononuclear cells (PBMC) were 
isolated on a Ficoll-Paque cushion according to manufacturer’s protocol (GE 
Healthcare), washed three times, resuspended in 0.5 ml RPMI and counted with a 
hemocytometer. The fresh PBMC were used for co-culture studies. After blood 
collection, mouse was euthanized with 200 µl of 10 mg/ml sodium pentobarbital 
(KELA, Belgium). Various tissues were collected under aseptic conditions from the 
nerve system (olfactory bulb and brain), from the respiratory system (nasal mucosa, 
nasopharynx-associated lymphoid tissues (NALT), pharynx, trachea and lungs), 
from the alimentary system (submandibular glands, esophagus and small intestines), 
from the abdominal organs (liver and kidneys), from the reproductive system (uterus 
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and ovaries) and from the lymphoid organs (thymus and spleen). One part of an 
organ was stored at -70°C for virus titration. The other part was snap frozen with 
methocel and stored at -70°C for immunofluorescence staining.  
2.6 Virus titration of tissues 
A five percent homogenate was made of all collected tissues for virus titration. 
Briefly, tissues were thawed, weighed and homogenized by using a pestle, a small 
volume of sterile sand and DPBS with 0.9 mM CaCl2, 0.5 mM MgCl2x6H2O and 
0.002% phenol red, supplemented with 2% FCS and a mixture of antibiotics (100 
U/ml penicillin, 100 µg/ml streptomycin and 50 µg/ml gentamycin). Afterwards, the 
supernatants were collected after centrifugation (2400g, 10min). Virus titration was 
performed on the second passage of MEFs. After 7 days, the presence of a 
cytopathic effect (CPE) was assessed by light microscopy (Olympus Optical Co., 
Hamburg, Germany) and virus titer was calculated as 50% tissue culture infectious 
dose (TCID50) according to the Reed and Muench formula [25].   
2.7 Co-culture of PBMC  
To examine the cell-associated viremia in PBMC, co-culture assays were performed. 
MEFs (2x105/well) were seeded in 24-well plates two days prior to co-culture. 
Freshly isolated PBMC were brought on the monolayer (PBMC from one mouse 
were equally divided into 2 wells in 24-well plate) and covered with 1ml 
carboxymethylcellulose (CMC) medium (1/4 2xMEM, 1/4 2xRPMI, 1/2 2xCMC 
supplemented with 5% FCS, 100 U/ml penicillin, 100 µg/ml streptomycin, 50 µg/ml 
gentamicin, 0.1mM non-essential amino acids (NEAA) and 1mM Sodium pyruvate), 
and the plates were centrifuged 750 g for 10 min, afterwards cultivated at 37°C in 
the incubator for 8 days. Plaques were counted with a light microscopy (Olympus 
Optical Co., Hamburg, Germany).    
2.8 Production of biotinylated polyclonal anti-MCMV antibodies (pα-MCMV 
Abs)  
Anti-MCMV Smith hyperimmune sera were prepared as described before by Nigel 
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et al. with slight modification [26]. Briefly, MCMV Smith was grown in MEFs, the 
virus was released by sonication and virus suspension was clarified to remove 
cellular debris by centrifugation (4,000g for 20min). Mice were inoculated with 106 
TCID50 of clarified MCMV Smith intraperitoneally (IP), followed by two further IP 
inoculations at 2-week intervals. Afterwards, the plasma was collected at 7 days post 
last injection. IgG was isolated from plasma using Protein G Sepharose™ 4 Fast 
Flow (GE Healthcare), and protein concentration was determined by NanoDrop 2000 
(Thermo Fisher Scientific). The purified antibodies were biotinylated with biotin 
reagents (EZ-Link® Sulfo-NHS-LC-Biotin, Thermo Fisher Scientific).  
Pα-MCMV Abs were tested for their reactivity against viral immediate early proteins, 
early proteins or late proteins by a co-localization assay of pα-MCMV Abs and 
murine monoclonal antibodies against immediate early protein (mouse 
anti-m123/IE1, CROMA101, isotype IgG1 (Capri, Croatia)), early protein (mouse 
anti-M112-113/E1, isotype IgG1 (Capri, Croatia)) and late protein (mouse 
anti-M55/gB, isotype IgG2b (Capri, Croatia)). The co-localization assay showed that 
pα-MCMV Abs recognized the viral early and late proteins but not viral immediate 
early proteins. 
2.9 Quantification of MCMV-infected cells in the nasal mucosa, lungs and 
submandibular glands  
Immunofluorescence staining was used to quantify MCMV-infected cells in tissues 
(nasal mucosa, lungs and submandibular glands) that were MCMV HaNa1/MCMV 
Smith-positive after virus titration. The number of MCMV-infected cells in the nasal 
mucosa, submandibular glands and lungs of mice inoculated with the high dose (106 
TCID50/mouse) at 3, 7, 14 and 35 dpi was calculated. Forty consecutive cryosections 
(12µm) per organ were fixed in 4% paraformaldehyde at 4°C for 10 min and 
permeabilized with 0.1% Triton X-100 (Sigma) at room temperature (RT) for 10 min. 
Tissue sections were pretreated for 30 min with 10% negative goat serum and 
followed by incubating with pα-MCMV Abs (1:30) at 37°C for 1h. The cryosections 
were washed three times with PBS and incubated with the secondary antibodies: 
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streptavidin Alexa-fluor® 488 conjugate, 1:200 (Invitrogen) at 37°C for 1h. After 
three washings, cell nuclei were stained with 10µg/ml Hoechst 33342 (Invitrogen) at 
RT for 10min. Finally, cryosections were mounted with glycerin-DABCO (Acros 
Organics).   
Infected cells within each cryosection were quantified with the Leica TCS SPE 
laser-scanning confocal microscopy (magnification 200x, Leica Microsystems, 
GmbH, Wetzlar, Germany) according to the quantification method of Beyer and 
colleagues [27]. Forty consecutive 12µm-sections were analyzed per organ. The size 
of the analyzed sections was determined by the number and size of the visual fields 
at a 200x magnification (diameter 1mm). Finally, the number of MCMV-infected 
cells was calculated as a value per 10mm2, independent of their localization and 
distribution within the cryosection.    
2.10 Identification of MCMV-infected cells in the nasal mucosa, lungs and 
submandibular glands 
Immunofluorescence double staining was used to identify MCMV-infected cells in 
the nasal mucosa, lungs and submandibular glands. Twelve µm viral antigen-positive 
cryosections of nasal mucosa, lungs and submandibular glands from 3, 7, 14 and 
35dpi were prepared following the aforementioned protocol. Sections were 
incubated at 37°C for 1h with pα-MCMV Abs (1:30) and cell markers (rabbit 
polyclonal anti-cytokeratin-18 for epithelia, 1:150 (Abcam); goat anti-olfactory 
marker protein for olfactory neurons [28], 1:500 (Wako); rat anti-mouse 
CD68/FITC-rat-anti-mouse F4/80 for tissue macrophages, 1:50 (AbD Serotec); 
hamster anti-mouse CD11c for dendritic cells, 1:50 (eBioscience); rat anti-mouse 
B220 for pan-B cells, 1:50 (Biolegend) and Alexa Fluor® 488-hamster-anti-mouse 
CD3 for T cells). The cryosections were washed three times with PBS and incubated 
at 37°C for 1h with the corresponding secondary antibodies: streptavidin-Texas 
Red-X or FITC conjugate, 1:200 (Invitrogen); FITC-goat-anti-rabbit IgG, 1:200 
(Invitrogen); Alexa Fluor® 594-rabbit-anti-goat IgG, 1:200 (Invitrogen); Alexa 
Fluor® 488-goat-anti-rat IgG, 1:200 (Invitrogen); Alexa Fluor® 
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488-goat-anti-hamster IgG, 1:200 (Jackson ImmunoResearch) and Alexa Fluor® 
488-goat-anti-rat IgG, 1:200 (Invitrogen). After washing three times, cell nuclei were 
counterstained with 10µg/ml Hoechst 33342 (Invitrogen) at RT for 10min. Finally, 
cryosections were mounted with glycerin-DABCO (Acros Organics) and analyzed 
with the Leica TCS SPE laser-scanning confocal microscopy (Leica Microsystems, 
GmbH, Wetzlar, Germany).    
2.11 Determination of total and isotype-specific anti-MCMV antibody titers  
The titer of total and isotype specific anti-MCMV antibodies were determined in 
immunoperoxidase monolayer assays (IPMA) [29]. Briefly, monolayers of 
immortalized mouse embryo fibroblasts (MEFs) [30] in 96-well plates were 
inoculated with MCMV HaNa1 or MCMV Smith (103 TCID50 per well), and 
cultivated for 3 days (37°C, 5% CO2). Afterwards, the culture medium was removed, 
and cells were washed with PBS and dried at 37°C for 1h. The plates were covered 
with plastic covers and stored at -20°C until use. Plates were thawed at RT and cells 
were fixed with 4% paraformaldehyde for 10 min at RT. The paraformaldehyde was 
removed, and cells were washed twice with PBS. Afterwards, the cells were treated 
with 100% methanol supplemented with 1% H2O2 at RT for 5min. Plates were 
washed twice with PBS and serial twofold dilutions of plasma were added and 
incubated at 37°C for 1h. Plates were washed three times with PBS. To determine 
the virus-specific immunoglobulin classes and subclasses, 50µl biotinylated 
secondary antibody (rat anti-mouse IgA biotin, 1:100, (eBioscience); rat anti-mouse 
IgM biotin, 1:100, (eBioscience); sheep anti-mouse IgG biotin, 1:100, (GE 
healthcare); rat anti-mouse IgG1 biotin, 1:100, (eBioscience); rat anti-mouse IgG2a 
biotin, 1:100, (eBioscience); rat anti-mouse IgG2b biotin, 1:100, (Biolegend); goat 
anti-mouse IgG2c biotin, 1:100, (abcam); rat anti-mouse IgG3 biotin, 1:100, 
(Biolegend)) were added respectively and incubated at 37°C for 1h. Afterwards, 
plates were washed three times and 50µl streptavidin-biotin horseradish peroxidase 
complex (1:200) was added per well and incubated at 37°C for 1h. Plates were 
washed three times and 50µl of a substrate solution of 3-amino-9-ethylcarbazole 
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(1/20) in 0.05 M acetate buﬀer, pH 5, with 0.024% H2O2 was added to each well and 
kept in RT for 30min. Finally, the reaction was stopped with sodium acetate and the 
IPMA titer was calculated as the reciprocal value of the highest serum dilution that 
induced visual staining of infected MEFs as determined by a light microscopy 
(Olympus Optical Co., Hamburg, Germany). All aforementioned biotinylated 
secondary antibodies have been validated with sera from mice inoculated with 
influenza A/New Caledonia/20/99 (NC) virus by IPMA. In addition, the specificity 
of biotinylated secondary IgG antibodies had also been assessed with a panel of 
murine anti-MCMV Smith specific IgG monoclonal antibodies with known 
subclasses (mouse anti-m112-113, CROMA 103, IgG1; mouse anti-M123, IE1.01, 
IgG2a; mouse anti-m55-MCMV, CROMA7, IgG2b; mouse anti-m04-MCMV, 
m04-KAC.10, IgG2c; all were purchased from Capri, Croatia). No apparent 
cross-reaction was found (data not shown).    
2.12 Complement-dependent neutralization test 
Hyperimmune sera to CMVs were found to mainly contain complement-requiring 
neutralizing antibodies. Assays to measure neutralizing antibody titers were 
performed as described before by Helen et al. and Lawson et al. with a few 
modifications [31, 32]. At day one, serial twofold dilutions of heat-inactivated (56°C, 
30min) plasma in MEM (from 1:2 to 1:512) were incubated with an equal volume 
containing 500 TCID50 MCMV Smith or 700 TCID50 MCMV HaNa1 for 23h at 
37°C. Meanwhile, MEFs were trypsinized and seeded in 96-well plates with 100µl 
per well at a concentration of 2.5x105 cells/ml. After 23h, 25µl of guinea pig 
complement (0.5 µg/µl) was added to the virus/serum dilution mixtures for 
incubating another 1h at 37°C in a 5% CO2 incubator. Then, the medium of cells was 
removed and the mixtures of serum/virus/complement were added to the confluent 
cell monolayers. The plates were kept for 7 days at 37°C. The neutralization titer of 
a plasma was expressed as the reciprocal of the highest serum dilution that was able 
to completely block MCMV infection in MEFs.    
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3 Results  
3.1 Growth kinetics of MCMV strains in MEFs 
In the first experiment, the in vitro viral growth characteristics of MCMV HaNa1 
and MCMV Smith were compared in MEFs, as shown in Figure 1. The study 
demonstrated that HaNa1 grew to a ~10-fold lower yield in comparison with the 
Smith strain and that HaNa1 isolate was more cell-associated than the Smith strain. 
Therefore, it can be stated that the Smith strain replicated in MEFs much more easily 
than the HaNa1 isolate.  
 
Figure 1. Growth kinetics of MCMV HaNa1 and MCMV Smith in MEFs. The virus titers 
generated in MEFs were determined, and growth curves of HaNa1 and Smith were plotted. The 
inactivation curve shows the drop of virus titers at 37 °C in culture medium due to inactivation 
events. The mean virus titer (log10 TCID50/ml) and standard deviation (n=3) were shown in the 
diagram.   
3.2 Virus titers in tissues  
Low dose - After oronasal inoculation of 104 TCID50 per mouse, MCMV HaNa1 was 
detected in the nasal mucosa from 14 till 35 dpi with the highest mean virus titer of 
103.53 TCID50/g at 14 dpi, in submandibular glands from 14 till 35 dpi with the 
highest mean virus titer of 104.93 TCID50/g at 21 dpi (Fig. 2), and in lungs and saliva 
only at one time point (14 (n=1) and 28 (n=1) dpi, respectively). The other organs 
(olfactory bulb, brain, pharynx, trachea, esophagus, small intestines, liver, kidneys, 
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uterus, ovaries, thymus and spleen) remained all negative (under the detection limit).   
MCMV Smith was detected in the nasal mucosa from 14 till 35dpi and in 
submandibular glands from 14 till 42dpi with the highest mean virus titer in the nasal 
mucosa (103.01 TCID50/g) at 14 dpi and in the submandibular glands (103.72 TCID50/g) 
at 17 dpi (Fig. 2). Lungs were positive only at 17dpi (n=2). Saliva and plasma were 
negative during the course of infection. MCMV Smith led to a productive infection 
with virus replication in the spleen at 17dpi (n=3) and 35dpi (n=1), in the liver at 
14dpi (n=2) and 17dpi (n=3), and in the kidneys at 14dpi (n=1) and 17dpi (n=3) (Fig. 
2). The other organs (olfactory bulb, brain, pharynx, trachea, esophagus, small 
intestines, uterus, ovaries and thymus) remained all negative (under the detection 
limit).  
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Figure 2. Virus titers in the nasal mucosa, lungs, submandibular glands, spleen, liver and 
kidneys. These tissues were collected from mice upon oronasal inoculation with either a low 
(104TCID50/mouse, left column) or a high (106TCID50/mouse, right column) inoculation dose. 
Virus titers (log10 TCID50/g) were measured by titration. Open circles represent HaNa1-infected 
mice and closed circles represent Smith-infected mice. The detection limit for the titration (102.1 
TCID50/g) is shown by the horizontal dotted line.  
High dose - After oronasal inoculation of 106 TCID50 per mouse, MCMV HaNa1 
was detected in the nasal mucosa from 1dpi till the end of the experiment (49dpi) 
with the highest mean virus titer of 105.07 TCID50/g at 17dpi, in submandibular 
glands from 7dpi till the end of the experiment 49dpi with the highest mean virus 
titer of 106.3 TCID50/g at 14dpi, and in lungs at 5, 7 and 14dpi with a low level of 
virus replication (Fig. 2). At none of the collected time points post inoculation, 
infectious virus was detected in saliva and plasma. The other organs (olfactory bulb, 
brain, pharynx, trachea, esophagus, small intestines, liver, kidneys, uterus, ovaries, 
thymus and spleen) remained negative throughout the experiment (under the 
detection limit).   
MCMV Smith was detected in the nasal mucosa from 1dpi till the end of the 
experiment (49dpi) with the highest mean virus titer of 103.63 TCID50/g at 14 dpi, in 
submandibular glands from 7dpi till 35dpi with the highest mean virus titer of 103.91 
TCID50/g at 14 dpi, and in lungs from 5dpi till 14dpi except 10 dpi with a low level 
of virus replication close to the virus detection limit except at 7dpi with a virus titer 
of 104.8 TCID50/g in 2 out of 3 mice (Fig. 2). MCMV Smith led to a productive 
infection with virus replication in the spleen at 7dpi (n=2) and 14dpi (n=2), in the 
liver at 7dpi (n=2) and 14dpi (n=1), and in the kidneys at 10dpi (n=2), 14dpi (n=2) 
and 17dpi (n=1) (Fig. 2). Infectious virus was not detected in saliva and plasma at 
any indicated time point. No virus was detected in the control mice. The other organs 
(olfactory bulb, brain, pharynx, trachea, esophagus, small intestines, uterus, ovaries 
and thymus) remained negative throughout the experiment (under the detection 
limit).   
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3.3 Co-culture of PBMC with MEFs 
At none of the collected time points post inoculation, cell-associated virus was 
detected by co-culture for both strains at a low inoculation dose. At a high 
inoculation dose, cell-associated virus was detected in PBMC for both strains: at 
7dpi (n=2) and 10dpi (n=1) in HaNa1-infected mice; at 7dpi (n=2) in Smith-infected 
mice. 
3.4 Quantification of MCMV-infected cells in the nasal mucosa, lungs and 
submandibular glands 
The nasal mucosa, lungs and submandibular glands from mice that received a high 
inoculation dose were collected at 3, 7, 14 and 35 dpi and the number of 
MCMV-infected cells in these organs was quantified. The same samples from 
mock-inoculated mice were negative for MCMV. Figure 3 shows the number of 
MCMV-infected cells in these organs.     
For HaNa1-infected mice, infected cells in the nasal mucosa were first detected at 
3dpi (0.09 cells per 10mm2), peaked at 7dpi (0.51 cells per 10mm2) and dropped 
sharply afterwards (at 35dpi: 0.09 cells per 10mm2). In lungs, they were first 
detected and also peaked at 7dpi (0.47 cells per 10mm2), decreased afterwards 
significantly and were undetectable at 35dpi. In submandibular glands, they were 
first noticed at 7dpi (0.13 cells per 10mm2), peaked at 14dpi (1.59 cells per 10mm2), 
and dropped sharply afterwards (0.80 cells per 10mm2 at 35dpi).    
For Smith-infected mice, MCMV-infected cells in the nasal mucosa were first 
detected at 3dpi (0.07 cells per 10mm2), peaked at 7dpi (0.23 cells per 10mm2) and 
then decreased till 35dpi (0.08 cells per 10mm2). In lungs, they were first detected 
and also peaked at 7dpi (0.72 cells per 10mm2), afterwards fell dramatically and 
were undetectable at 35dpi. In submandibular glands, they were first detected at 7dpi 
(0.08 cells per 10mm2), reached a peak at 14dpi (0.49 cells per 10mm2) and 
decreased afterwards (0.05 cells per 10mm2 at 35dpi). 
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Figure 3. Quantification of MCMV-infected cells in the nasal mucosa, submandibular 
glands and lungs. Each time point has three individual animals. Forty consecutive cryosections 
per tissue were evaluated by immunofluorescence microscopy. The number of infected cells per 
10 mm2 is shown. The average values of infected cells at different time points were connected by 
lines.  
3.5 Identification of MCMV-infected cells in the nasal mucosa, lungs and 
submandibular glands 
Identification of the MCMV-infected cells in target tissues would help us to 
understand the cell tropism of MCMV. The nasal mucosa, lungs and submandibular 
glands from mice inoculated with a high dose were collected at 3, 7, 14 and 35 dpi to 
be stained for MCMV antigens and cellular markers simultaneously. The 
morphology of MCMV-positive cells consisted of a big round or oval unstained 
nucleus surrounded by a thick rim of positive cytoplasm (Fig. 4). Since both strains 
gave similar results, only staining of cryosections from HaNa1-infected mice were 
presented here. In the nasal mucosa, the infected cells were only found in the 
olfactory epithelium and nasopharynx associated lymphoid tissue (NALT) from 3dpi 
onwards. Based on our results, viral proteins were expressed in both sustentacular 
cells and neurons in the olfactory epithelium, and in CD68/CD11c positive cells 
(macrophages/dendritic cells) but not in B220/CD3 positive cells (B cells/T cells) in 
the NALT. In lungs, epithelial cells and macrophages were susceptible cell types at 7 
and 14dpi. In submandibular glands, only epithelial cells were susceptible at 7, 14 
and 35dpi.    
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Figure 4. Identification of MCMV-infected cells in the nasal mucosa, lungs and 
submandibular glands. Nuclei were counterstained with Hoechst (Blue). Co-localization 
appears yellow in the merged images. The zoomed images show the boxed region of merged 
layers. Cryosections of the nasal mucosa were double-stained with antibodies against MCMV 
antigens (by pα-MCMV Abs) and cell markers: OMP (olfactory neuron marker), cytokeratin-18 
(epithelial marker), CD68 (tissue macrophages) and CD11c (dendritic cells). Olfactory neurons 
and sustentacular cells of the olfactory epithelium (olfactory EP) in the nasal mucosa were 
susceptible for MCMV. Infected cells of NALT in the nasal mucosa were CD68+/CD11c+. 
Epithelial cells (cytokeratin-18+) of submandibular glands were susceptible for MCMV. 
Epithelial cells (cytokeratin-18+) and macrophages (F4/80+) were positive for MCMV in lungs. 
3.6 Serology  
3.6.1 Viral-specific antibodies by IPMA 
Low dose - MCMV HaNa1-specific antibodies were first detected at 10dpi. 
Afterwards, titers rose and reached a maximal level at 21dpi; MCMV Smith-specific 
antibodies showed a similar course with the exception that they appeared later (at 
14dpi) (Fig. 5). High dose - The high dose (106 TCID50/mouse) reduced the time of 
appearance of antibodies (HaNa1 at 7dpi; Smith at 10dpi). Both reached a maximal 
level at 17dpi. 
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Figure 5. Viral-specific antibody titers by IPMA and neutralizing antibody (NA) titers by 
NA. They were determined in the Smith or HaNa1-infected mice that had been inoculated with 
either a low (104TCID50/mouse) or a high (106TCID50/mouse) inoculation dose. The average 
titers of 3 BALB/c mice at different time points were connected by lines. The detection limit was 
shown by the dotted line. 
3.6.2 Complement-dependent neutralizing antibodies by NA test 
Neutralizing antibodies without adding guinea pig complement were only detected at 
35-49dpi with low NA titers (lower than or equal to 2) for both strains (data not 
shown). Complement-dependent neutralizing antibodies from mice inoculated with a 
low inoculation dose were first detected at 14dpi, afterwards increased till the end of 
experiment at 49dpi (Fig. 5). A similar pattern was found with a high inoculation 
dose, except that neutralizing antibodies appeared earlier at 10dpi.  
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3.6.3 Subclasses determination by IPMA  
Low dose - The results of MCMV-specific Ig classes and IgG subclasses 
determination showed that only MCMV-specific IgG2a was detectable throughout 
the whole experiment, whereas the other (IgA, IgM and other IgG subclasses (IgG1, 
IgG2b, IgG2c and IgG3)) were not (Table 1). MCMV-specific IgG2a subclass was 
detected earlier in HaNa1-infected mice at 14dpi than in Smith-infected mice at 
17dpi. High dose - MCMV-specific IgG2a was the main antibody subclass (Table 2). 
MCMV-specific IgG1 and IgG2c antibodies were also detected for both strains but 
with lower titers (lower than or equal to 64) albeit at 35 and 49dpi.    
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Table 1. Course of isotype-specific anti-MCMV HaNa1 or anti-MCMV Smith antibody titers in BALB/c mice inoculated with 104TCID50 per mouse 
Strains Classes/subclasses Antibody titers 
1d 3d 5d 7d 10d 14d 17d 21d 28d 35d 42d 49d 
 
 
MCMV HaNa1 
IgA -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgM -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgG1 -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgG2a -/-/- -/-/- -/-/- -/-/- -/-/- 32/-/- 32/32/16 64/32/64 128/256/128 128/64/128 128/128/128 128/128/128 
IgG2b -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgG2c -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgG3 -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
 
 
MCMV Smith 
IgA -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgM -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgG1 -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgG2a -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 32/32/32 32/64/64 64/128/32 128/64/128 128/64/128 128/128/128 
IgG2b -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgG2c -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgG3 -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
 ‘-’ represents that the antibody titer was under the detection limit (1/16)
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Table 2. Course of isotype-specific anti-MCMV HaNa1 or anti-MCMV Smith antibody titers in BALB/c mice inoculated with 106TCID50 per mouse 
Strains Classes/subclasses Antibody titers 
1d 3d 5d 7d 10d 14d 17d 21d 35d 49d 
 
 
 
MCMV HaNa1 
IgA -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgM -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgG1 -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 128/16/64 32/64/64 
IgG2a -/-/- -/-/- -/-/- -/-/- 64/16/32 256/128/256 256/256/512 128/256/256 1024/1024/1024 256/1024/1024 
IgG2b -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgG2c -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 64/32/64 
IgG3 -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
 
 
 
MCMV Smith 
IgA -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgM -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgG1 -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/32/- 64/32/- 
IgG2a -/-/- -/-/- -/-/- -/-/- 32/-/64 64/128/128 256/128/256 512/512/256 512/512/1024 1024/512/512 
IgG2b -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
IgG2c -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 16/32/16 64/16/64 
IgG3 -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
 ‘-’ represents that the antibody titer was under the detection limit (1/16) 
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4 Discussion  
To date, MCMV has been widely used in laboratory models for studying HCMV 
infections. Almost all the laboratory research on MCMV used either the Smith or the 
Smith-derived K181 strains, which are the two standard laboratory MCMV strains 
[18]. These strains have been serially passaged in vitro or in vivo for more than 60 
years, which likely caused genetic and biological changes. Furthermore, non-natural 
inoculation routes (subcutaneously, intraperitoneally, or intravenously) have been 
utilized to inoculate animals in the previous studies, thus bypassing the mucosal sites 
of virus replication and the local immune response [4, 33]. Therefore, there is limited 
information on natural infections with low passaged MCMV. Here, an MCMV 
infection model has been established that mimics natural infection using a recently 
Belgian MCMV isolate HaNa1. We found that upon oronasal inoculation: 1) the 
nasal mucosa and submandibular glands were the main sites of productive MCMV 
replication; 2) only the Smith strain established a productive infection in spleen, 
liver and kidneys, whereas the HaNa1 isolate did not; 3) increasing the inoculation 
dose strongly elevated virus production in the nasal mucosa and submandibular 
glands, and also reduced the time of appearance of antibodies.     
In the present study, it was examined whether HaNa1 and Smith differed in viral 
growth in vitro and in vivo. The growth kinetics in vitro demonstrated that the Smith 
strain replicated to a ~10-fold higher yield than the HaNa1 isolate. In contrast to the 
in vitro situation, in the nasal mucosa and submandibular glands, HaNa1 replicated 
to higher titers than Smith in vivo. This is consistent with their passage history. The 
MCMV with more passages in cells grows better in vitro but loses part of its 
replication ability in vivo [34, 35].   
In vivo, both strains (Smith and HaNa1) were first detected in the nasal mucosa. 
Increasing the inoculation dose elevated virus production leading to early detection 
and higher virus titers. HaNa1 reached higher virus titers than Smith. In our study, 
the nasal mucosa was shown for the first time to be a susceptible organ for MCMV. 
Based on similar characteristics of human and murine CMVs, we hypothesize that 
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the nasal mucosa might also be a target organ for HCMV. In line with this, there 
have been several reports on the detection of HCMV in nasopharyngeal carcinomas, 
sinusitis and nasal polyposis [36-39]. In lungs, both strains showed a very restricted 
replication during the first three weeks after post inoculation, after which the 
infection was controlled. Our finding is consistent with a previous study [40]. The 
submandibular gland is another target organ for both strains. In contrast with the 
viral replication in the nasal mucosa, the viral replication in the submandibular 
glands always started after one week post inoculation and lasted longer than 49dpi 
post inoculation. HaNa1 reached much higher virus titers (>100 folds) than Smith. 
Similarly to the nasal mucosa, increasing the inoculation dose enhanced virus 
production in the submandibular glands. CMVs have been reported to mainly use 
salivary glands as target organ for virus persistence and shedding into saliva [33, 41, 
42]. However, in our study, HaNa1 was detected in saliva only at one time point 
within one mouse. The low level of virus titers in saliva was quite surprising, as 
CMVs are thought to transmit orally via saliva. In future studies, these conflicting 
data will be further examined.  
Cell-associated virus in PBMC was detected at 7-10dpi for both strains with a high 
inoculation dose. This shows that circulating PBMC are involved in the 
dissemination of MCMV, which corresponds with a previous study [43]. In our 
study, only the Smith strain was detectable by virus titration in spleen, liver and 
kidneys from the second week post inoculation onwards, providing evidence that 
only the Smith strain can establish a productive infection in internal organs of adult 
mice, whereas HaNa1 cannot. The latter is similar to the outcome of an HCMV 
primary infection in immunocompetent adults, during which it is only causing a 
limited virus-associated spread to the salivary glands but not to multiple internal 
organs [44].  
Quantification of MCMV-infected cells in the nasal mucosa, lungs and 
submandibular glands revealed a good correlation between virus titers and infected 
cells. Identification of MCMV-infected cells demonstrated that in the nasal mucosa, 
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olfactory neurons as well as sustentacular cells in the olfactory neuroepithelium and 
CD68/CD11c positive cells (macrophages/dendritic cells) in NALT were the main 
susceptible cell types. Targeting the olfactory neurons raised the question if CMV 
may damage the smelling [45, 46]. This will be investigated in the future. According 
to the staining results, CD68/CD11c positive cells (macrophages/dendritic cells) in 
NALT were infected from 3dpi onwards, which indicates that NALT plays a very 
important role in MCMV infection. Therefore, we presume that the virus may be 
transmitted via lymphatic circulation to draining lymph nodes, ending up in the 
blood circulation. In lungs, both epithelial cells and macrophages are susceptible to 
both MCMV strains, which are the main cause of pneumonitis caused by MCMV 
[22, 40]. It is also a frequently observed manifestation of HCMV infection [47, 48]. 
In submandibular glands, epithelial cells are the main susceptible cell type for both 
MCMV strains, which is consistent with earlier published data [49]. However, up till 
now it is unclear how the viruses reach the submandibular glands and how the virus 
becomes transferred to the epithelial cells.   
Serological analysis showed that IgG2a was the antibody subclass that was mainly 
produced except that low titers of IgG1 and IgG2c were also detected in mice 
inoculated with a high dose at 35-49dpi. IgM was not detected through the whole 
course of the experiments for both MCMV strains. This could be due to the low 
sensitivity of the MCMV-specific IPMA, which is consistent with our positive 
control (low sensitivity of the mice adapted influenza-specific IPMA), or the 
suppressive effect of MCMV on the production of IgM by T cell cytokines. T cell 
cytokines are responsible for the immunoglobulin class switching mechanism in 
mouse and human [50]. The strong induction of IgG2a is generally known to be 
mediated by interferon γ (IFNγ) [51, 52]. Because IFNγ as well as other T cell 
cytokines were not evaluated in this study, we could not assess the role of IFNγ in 
the orientation of the antibody isotype switch. The complement-dependent 
neutralization test demonstrated that complement plays a critical role in neutralizing 
MCMV since antibodies without complement/with inactivated complement did not 
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neutralize MCMV infection. Since IgG2a is the predominant viral-specific antibody, 
we can state that complement-dependent IgG2a-mediated inactivation of MCMV is 
an important anti-MCMV defense. This is consistent with the characteristics of 
antibody isotype IgG2a to fix complement in mice [53]. Neutralizing antibody titers 
were higher at 35 and 49dpi, which may explain in part the clearance of HaNa1 at 
49dpi and Smith at 35 and 49dpi in submandibular glands in the high inoculation 
dose group. Similar patterns also occurred for both strains at 42 and 49dpi in the low 
inoculation dose groups. The control of virus infection at the end of the experiments 
is also most probably mediated by the cell-mediated immunity, which is generally 
considered to be the most important factor in controlling CMV infections [54, 55].  
In summary, mouse models with MCMV mimicking natural infection were set up in 
our study. Through comparing the pathogenesis of two MCMV strains, we found 
that infections occurred via respiratory route and then local replication in tissues of 
the upper respiratory tract, after which the virus may spread via a cell-associated 
viremia to other target organs such as spleen, liver, kidneys and submandibular 
glands. Only Smith caused a productive infection in spleen, liver and kidneys, 
whereas the HaNa1 isolate did not. The latter is similar to the outcome of an HCMV 
primary infection in immunocompetent hosts; it is only causing a limited 
virus-associated spread to the salivary glands but not to multiple internal organs. 
Therefore, the newly isolated MCMV HaNa1 isolate is interesting to be used in 
mouse models in order to get better insights into HCMV natural infections in 
immunocompetent hosts via oronasal exposure. Increasing the inoculation dose 
strongly elevated virus production in the nasal mucosa and submandibular glands 
and cell-associated viremia during the early stage of infection, reduced the time of 
appearance of antibodies, and increased the level of antibodies. In this study, we 
predominantly focused on the kinetics of virus production in different organs. As 
known for a long time, CMVs spread in a strict cell-associated way. This was not 
investigated in depth in the present study. In the near future, we will focus on the 
kinetics of cell-associated motions of MCMV infected leukocytes in order to get a 
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full insight how the replications in the respiratory tract and submandibular glands are 
linked to each other. It is very important to understand how MCMV starts up 
replication in the submandibular glands and maintains its replication in this organ for 
a long period.   
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Summary   
Cytomegaloviruses may infect mammals via the oronasal route. However, up till now 
it remains unclear how this exposure leads to a general infection and shedding. To 
address this issue, BALB/c female mice were oronasally inoculated with either the 
highly passaged murine cytomegalovirus (MCMV) Smith or the low passaged 
MCMV HaNa1. Virus titration showed a productive virus replication of both strains 
in the nasal mucosa from 1 dpi until the end of the experiment (14 dpi), in lungs from 
5 until 14 dpi, and in submandibular glands from 7 until 14 dpi. In contrast to MCMV 
HaNa1, MCMV Smith also established a low level productive infection in abdominal 
organs (spleen, liver and kidneys) from 5 dpi (spleen), 7 dpi (liver), and 10 dpi 
(kidneys) until the end of the experiment. Co-culture showed that for both strains, 
cell-associated virus was detected in a non-infectious form in nasopharynx-associated 
lymphoid tissues (NALT) from 1 until 14 dpi, in submandibular lymph nodes from 3 
until 5 dpi, in deep cervical lymph nodes from 3 until 14 dpi, in mediastinal lymph 
nodes from 7 until 14 dpi, in spleen from 5 until at least 10 dpi and in the peripheral 
blood mononuclear cells (PBMC) at 7 and 10 dpi. The present study shows that upon 
oronasal exposure, MCMV first enters the nasal mucosa and NALT, from where the 
virus disseminates to the spleen possibly via the draining lymphatic system and blood; 
a subsequent cell-associated viremia transports MCMV to submandibular glands and 
for MCMV Smith also to liver and kidneys, where a second productive replication 
starts. 
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1 Introduction 
Human cytomegalovirus (HCMV) is a ubiquitous pathogen that establishes life-long, 
mainly asymptomatic infections. However, these infections may be life-threatening in 
immunocompromised individuals, such as preterm neonates [1, 2], AIDS patients [3] 
and transplant recipients [4, 5]. Due to the strict species-specificity of HCMV, it is not 
possible to study its replication in experimental models. Because of high similarities 
in CMV’s biology and disease spectrum, murine cytomegalovirus (MCMV) infections 
in mice have been most commonly and widely used as a model to understand the 
pathogenesis of HCMV infections in humans [6, 7].   
Humans can be infected with HCMV by oral exposure, such as consuming 
HCMV-contaminated breast milk [8-12] and oral uptake of HCMV-contaminated 
saliva [13, 14]. HCMV was also recently detected in the nasal mucosa of healthy 
individuals [15], infants [16], transplant recipients [17], and AIDS patients [18-20]. 
This oronasal transmission may also be the main route for MCMV infections in mice, 
since mice have been successfully infected with MCMV by oral exposure to 
MCMV-contaminated breast milk [21], by oral inoculation [22, 23], and by nasal 
exposure [24, 25]. Therefore, the oral and nasal cavities are likely to be major primary 
replication sites of CMV and shedding [13, 15, 16, 18, 20]. In our previous work, an 
MCMV infection model has been established that mimics natural infection using a 
recent Belgian MCMV isolate HaNa1 [26]. However, it remains unclear how the virus 
enters and reaches other organs such as salivary glands after natural oronasal 
exposure.  
As known for a long time, CMV spreads in a strict cell-associated way in mice and 
humans [27-29]. Different peripheral blood leukocyte (PBL) subsets have been 
involved in viremia and latency in both immune-compromised and 
immune-competent subjects [30-32]. Nonpermissive monocytes likely serve as latent 
reservoirs that support dissemination by maturing into permissive macrophages or 
dendritic cells that reactivate virus [33-35]. Besides blood circulation, the lymph 
drainage may be another important pathway for CMV dissemination as well, since 
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MCMV could be detected in draining lymph nodes [24].  
In the oral and nasal cavities, mucosal surfaces, mucosa-associated lymphoid tissues 
and mucosa-draining lymph nodes (LN) constitute the inductive sites for mucosal 
immunity against exogenous pathogens [36-38]. Since mice have no tonsils, the 
nasopharynx-associated lymphoid tissues (NALT) are the most important tissues for 
the generation of mucosal immunity after inhalation of antigens [36, 39-42]. The 
NALT is found at the base of the nasal cavity and consists of bilateral strips of 
lymphoid tissue. In human, the functional homologue of rodent NALT is the 
Waldeyer’s ring [43, 44]. As previous researchers have reported the detection of 
HCMV DNA in the Waldeyer’s ring [45, 46], the exact role of these 
mucosa-associated lymphoid tissues in the dissemination of CMV requires further 
investigation.  
In the present study, BALB/c mice were experimentally inoculated with two MCMV 
strains (the highly passaged MCMV Smith strain and the low passaged MCMV 
HaNa1 strain) to elucidate the kinetics of virus dissemination upon oronasal exposure. 
Blood, lymph nodes and other relevant organs were collected at different time points 
and used to detect infectious virus by virus titration and cell-associated virus by 
co-cultivation.  
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2 Materials and methods 
2.1 Cells and viruses 
Primary BALB/c mouse embryonic fibroblasts (MEFs) were cultivated at 37 °C with 
5% CO2, in minimum essential medium (MEM) with 10% fetal calf serum (FCS) and 
a mixture of antibiotics (100 U/ml penicillin, 100 µg/ml streptomycin and 0.5 mg/ml 
gentamicin), and were used at the second passage. Viruses used in the present 
experiments were the second passage of clone1 of the MCMV HaNa1 strain, which 
was isolated from a Belgian domestic mouse in the laboratory of the authors [26], and 
the MCMV Smith strain from ATCC was at a high passage in the continuous murine 
bone marrow stromal cell line (M2-10B4). Seven genes from MCMV HaNa1 have 
been sequenced and submitted to GenBank: m06 gene (accession No.: KR184668), 
m033 gene (accession No.: KR184669), mck-2 including exon1 (m131 gene) and 
exon2 (m129 gene) (accession No.: KR184670), m138 gene (accession No.: 
KR184671), m144 gene (accession No.: KR184672), m152 gene (accession No.: 
KR184673) and m157 gene (accession No.: KT289520). The nucleic acid/deduced 
amino acid sequence alignments between the known HaNa1 genes and the 
corresponding Smith genes were done by MEGA5.21. The results are shown in Table 
1. 
Table 1. Nucleic acid/deduced amino acid sequence identity of genes/gene products of 
MCMV strains  
Genes 
Sequence identity 
MCMV HaNa1 & MCMV Smith 
Nucleic acids  Deduced amino acids 
m06 99.8% 100% 
m33 99.7% 99.7% 
m129 100% 100% 
m131 100% 100% 
m138 99.5% 99.1% 
m144 95% 93.5% 
m152 99.2% 98.4% 
m157 95.7% 91.5% 
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2.2 Animals and virus inoculation 
Specific pathogen-free 6 to 8-week-old BALB/c female mice were used in the present 
study. Eighteen mice were inoculated with 106 TCID50 MCMV HaNa1 in 100 µl PBS 
via intranasal (25 µl) and peroral (75 µl) route without anesthesia. Since mice are 
obligate nose breathers [41] and intranasal administration of large volumes (>30µl) 
per time can result in direct delivery into lungs [47, 48], a small amount of inoculum 
(5 µl) was repeatedly instilled in each nostril. Each application was done with several 
minutes interval to avoid direct flow of the inoculum into the lungs. For the oral 
inoculation, 25 µl inoculum was given three times with a few minutes interval 
between each inoculation. Another 18 mice were inoculated with MCMV Smith using 
the same methodology. Mice were kept in isolation and fed ad libitum. For each 
MCMV strain, three infected mice were euthanized at 1, 3, 5, 7, 10 and 14 dpi. 
Another 3 mice were mock inoculated with PBS and euthanized at the end of the 
experiment.   
2.3 Collection of blood and tissues    
For blood collection, mice were anesthetized with 130 µl of 10 mg/ml sodium 
pentobarbital (KELA, Belgium). Afterwards, approximately 0.6 ml blood per mouse 
was taken from the orbital sinus with a heparinized Pasteur pipet and kept in an 
eppendorf with 0.5 ml PBS containing 5 U/ml heparin (Leo Pharma, Zaventem, 
Belgium). Plasma was collected by centrifugation (200 g for 10 min) and stored at 
-70 °C for virus titration. PBMC were isolated by density gradient centrifugation with 
Ficoll-Paque (GE Healthcare). After blood collection, mice were euthanized with 
another 200 µl of 10 mg/ml sodium pentobarbital (KELA, Belgium), and different 
tissues were collected under aseptic conditions. Tissues obtained from the respiratory 
system were nasal mucosa, pharynx, trachea, lungs, thymus, nasopharynx-associated 
lymphoid tissues (NALT) (collected as described in references [38, 49]), deep cervical 
LN and mediastinal LN. Tissues collected from the alimentary system were oral 
mucosa, submandibular glands, esophagus, small intestines, submandibular LN, 
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superficial parotid LN, Peyer’s patches and mesenteric LN. Other abdominal organs 
that were collected were spleen, liver and kidneys. The lymph nodes, thymus, PBMC 
and half of the spleen were used for co-culture (see below). From the other half of the 
spleen and the other tissues, 10% homogenates were made in PBS and stored at 
-70 °C until virus titration was performed.  
2.4 Virus titration 
MEFs were inoculated with 50 µl of 10-fold serial dilutions of the 10% tissue 
homogenates. After 1 h incubation at 37 °C, 100 µl of medium were added and the 
cells were further incubated for 7 days. After 7 days, the presence of a cytopathic 
effect (CPE) was assessed by light microscopy (Olympus Optical Co., Hamburg, 
Germany) and the virus titer was determined as 50% tissue culture infectious dose 
(TCID50) according to the method of Reed and Muench.   
2.5 Preparation of single-cell suspensions for co-culture  
As known for a long time, CMV spreads in a strict cell-associated way. In order to 
investigate the kinetics of cell-associated MCMV in different lymphoid organs, a 
co-culture assay was used in this study. For the preparation of single-cell suspensions 
from lymph nodes, two needles were used to shear lymph nodes into little pieces in 
6-well plates with 150 µl RPMI 1640 medium supplemented with 2% FCS and a 
mixture of antibiotics (100 U/ml penicillin, 100 µg/ml streptomycin and 50 µg/ml 
gentamycin). Afterwards, the cell suspensions were filtered using 100-µm-pore-size 
cell strainers (BD Biosciences, Bedford, MA) to obtain single-cell suspensions. 
Spleen and thymus were cut into small pieces and digested with trypsin for 5 min at 
37 °C. Afterwards, the digested tissue was transferred to a 100-µm-pore-size cell 
strainer. The single-cell suspensions from the spleen were centrifuged at 200 g for 10 
min. Pellets were resuspended in 3 ml of red blood cell lysis buffer (0.15 M NH4Cl, 1 
mM KHCO3, 0.1 mM EDTA, pH 7.2) and incubated on ice for 5 min. The reaction 
was stopped by adding PBS. Cells were washed once with DPBS, centrifuged, and 
resuspended in RPMI 1640 medium. MEFs (2 x 105) were seeded in 24-well plates 
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two days before the co-culture assay was performed. All PBMC and single-cell 
suspensions from lymph nodes, thymus and spleen were brought onto the monolayer 
of MEFs in the 24-well plates and covered with 1 ml carboxymethylcellulose (CMC) 
medium (1/4 2 x MEM, 1/4 2 x RPMI and 1/2 2 x CMC supplemented with 5% FCS, 
100 U/ml penicillin, 100 µg/ml streptomycin, 50 µg/ml gentamycin, 0.1 mM NEAA 
and 1 mM sodium pyruvate). Afterwards, the plates were centrifuged at 750 g for 10 
min. Subsequently, the cells were cultivated at 37 °C in an incubator for 8 days 
(lymph nodes and PBMC) or 12 days (spleen and thymus). The medium was partially 
changed every 4 days. Afterwards, the plaques were counted with a light microscope 
(Olympus Optical Co., Hamburg, Germany) to quantify the virus loads in various 
lymph nodes, spleen, thymus and PBMC.  
2.6 Ethical statement 
All animal experiments were approved by the local Ethical Committee of the Faculty 
of Veterinary Medicine, Ghent University (EC2013-47).       
3 Results    
3.1 Dissemination of the low passaged MCMV HaNa1 strain after oronasal 
inoculation  
Table 2 represents the results of virus titration of various tissues at different time 
points after oronasal inoculation of BALB/c mice with MCMV HaNa1 and MCMV 
Smith. The nasal mucosa was the first site where infectious virus was found, with a 
mean virus titer of 102.8 TCID50/g at 1 dpi. From 5 dpi onwards, infectious virus was 
additionally detected in the lungs, and later on also in the submandibular glands (7 
dpi). In all these tissues, virus replication persisted till the end of the experiment (14 
dpi), and reached the highest mean virus titers in the nasal mucosa at 7 dpi (104.5 
TCID50/g) and submandibular glands at 14 dpi (106.3 TCID50/g). Infectious virus was 
not detected in the oral mucosa, pharynx, trachea, esophagus, small intestines, spleen, 
liver, kidneys and plasma throughout the whole experiment.   
Investigation of the cell-associated virus trafficking in lymphoid organs and blood by 
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a co-culture assay (Table 3) revealed that the cell-associated virus was detected in the 
NALT as early as 1 dpi, in the submandibular LN and deep cervical LN from 3 dpi, in 
the spleen from 5 dpi, in the PBMC and mediastinal LN from 7 dpi. The 
cell-associated virus persisted in the NALT from 1 dpi until the end of the experiment 
(14 dpi), in the submandibular LN from 3 dpi until 10 dpi (except for 7 dpi), in the 
deep cervical LN from 3 dpi until the end of the experiment (14 dpi), in the 
mediastinal LN at 7 and 14 dpi, in the spleen from 5 dpi until at least 10 dpi 
(co-culture of spleen was not done after 10 dpi), and in the PBMC from 7 dpi until 10 
dpi. The other lymphoid tissues (superficial parotid LN, thymus, Peyer’s patches and 
mesenteric LN) remained negative throughout the whole experiment. Overall, the 
cell-associated virus was most frequently detected in NALT, followed by the deep 
cervical LN. 
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Table 2#: MCMV HaNa1/MCMV Smith replication in different tissues collected at 1, 3, 5, 7, 10 and 14 dpi.  
System Samples 
Virus titers (log10 TCID50/g tissue or log10 TCID50/ml plasma) (HaNa1/Smith)* 
1 dpi 3 dpi 5 dpi 7 dpi 10 dpi 14 dpi 
Respiratory system 
 
Nasal mucosa 2.6/3.3/2.6 2.6/2.0/2.0 4.0/3.8/3.6 5.0/4.0/4.6 3.3/3.8/4.6 5.0/5.0/3.3 
 2.6/2.6/3.0 -/2.0/2.3 2.8/2.6/3.3 3.3/2.6/2.3 3.8/2.3/2.3 3.8/3.3/3.8 
Pharynx -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
 -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
Trachea (pool) 
 
- - - - - - 
- - - - - - 
Lungs    -/-/- -/-/- 2.3/-/- 2.3/-/3.6 -/-/- -/-/2.6 
 -/-/- -/-/- -/2.3/- 4.8/4.8/- -/2.0/- -/-/2.3 
Alimentary system 
 
Oral mucosa (pool) 
 
- - - - - - 
- - - - - - 
Submandibular glands 
 
-/-/- -/-/- -/-/- 2.3/-/- 5.8/6.3/5.8 6.3/6.3/6.3 
-/-/- -/-/- -/-/- -/-/3.0 3.6/3.3/3.0 4.0/3.8/4.0 
Esophagus (pool) 
 
- - - - - - 
- - - - - - 
Small intestines 
 
-/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
-/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
Blood Plasma -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
 -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
Abdominal organs 
 
Spleen -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
 -/-/- -/-/- -/2.0/- 2.6/2.3/- 2.0/-/- 2.3/-/2.3 
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 Liver -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
  -/-/- -/-/- -/-/- 2.3/-/2.3 -/-/- -/-/2.3 
 Kidneys -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
  -/-/- -/-/- -/-/- -/-/- 2.3/-/2.3 2.8/-/2.3 
# : The data of Table 2 were partially adapted from our previous published paper in Veterinary Research [26]. We have the right to reproduce our data for addressing a new 
unsolved question if the correct citation details are given according to the copyright policy of Veterinary Research 
(http://www.veterinaryresearch.org/about/faq/journal-copyright-policy).  
* : data from MCMV HaNa1-infected mice were shown in regular text; data from MCMV Smith-infected mice were shown in bold/italics. 
- : under detection limit (101.8 TCID50/g tissue or 100.8 TCID50/ml plasma). At each time point, the data from three mice are given. Only trachea, oral mucosa and esophagus 
from three mice were pooled at each time point. 
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Table 3. Co-cultivation of single-cell suspensions of different lymphoid organs and PBMC from the MCMV HaNa1/MCMV Smith-infected mice with MEFs  
Samples 
Number of infected cells / all cells collected from the whole organ or all PBMC (HaNa1/Smith)* 
1 dpi 3 dpi 5 dpi 7 dpi 10 dpi 14 dpi 
NALT (pool) 19 26 34 75 53 60 
28 22 24 41 33 35 
Submandibular LN -/-/- 67/19/12 47/-/- -/-/- -/-/15 -/-/- 
-/-/- 27/-/- 56/24/- -/-/- -/-/- -/-/- 
Superficial parotid LN -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
-/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
Deep cervical LN -/-/- 23/55/22 79/52/43 38/-/- 18/-/24 -/41/- 
-/-/- 44/24/10 60/69/- -/63/14 24/23/10 44/-/- 
Mediastinal LN (pool) - - - 15 - 21 
- - - 27 38 31 
Mesenteric LN -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
-/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
Peyer’s patches (PP) -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
-/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
Thymus -/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
-/-/- -/-/- -/-/- -/-/- -/-/- -/-/- 
Spleen -/-/- -/-/- 62/49/9 25/81/114 66/46/41 ND 
-/-/- -/-/- 113/160/82 215/290/133 201/110/125 ND 
PBMC -/-/- -/-/- -/-/- -/22/43 18/-/- -/-/- 
-/-/- -/-/- -/-/- -/47/41 -/-/- -/-/- 
* : data from MCMV HaNa1-infected mice are shown in regular text; data from MCMV Smith-infected mice are shown in bold/italics. ND : not determined.    
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3.2 Dissemination of the highly passaged MCMV Smith strain after oronasal 
inoculation 
Dissemination of the highly passaged MCMV Smith strain was very similar to the 
replication pattern of the low passaged MCMV HaNa1 strain (Table 2, Bold/italic 
text). Infectious virus was first detected in the nasal mucosa (1 dpi), followed by lungs 
(5 dpi) and submandibular glands (7 dpi). Similarly to the HaNa1 strain, the Smith 
strain persisted in these tissues until the end of the experiment (14 dpi). Smith strain 
reached the highest mean virus titers at 14 dpi in the nasal mucosa (103.6 TCID50/g) 
and submandibular glands (103.9 TCID50/g). In comparison with the HaNa1 strain, a 
few clear differences were found. Only MCMV Smith caused a productive infection 
with a low level of virus replication in the spleen from 5 dpi until the end of 
experiment 14 dpi, in the liver at 7 dpi (n=2) and 14 dpi (n=1), and in the kidneys at 
10 dpi (n=2) and 14 dpi (n=2). No infectious virus was detected in the oral mucosa, 
pharynx, trachea, esophagus, small intestines, and plasma throughout the whole 
experiment.  
The results of the co-culture assay showed that dissemination of the Smith strain to 
the spleen and other lymphoid organs was comparable to the findings obtained with 
the HaNa1 strain, with the detection of cell-associated viruses in the NALT from 1 dpi 
until 14 dpi, in the submandibular LN from 3 dpi until 5 dpi, in the deep cervical LN 
from 3 dpi until 14 dpi, in the mediastinal LN from 7 dpi until 14 dpi, in the spleen 
from 5 dpi until at least 10 dpi (co-culture of spleen was not done after 10 dpi), and in 
the PBMC only at 7 dpi. The other lymphoid tissues (superficial parotid LN, thymus, 
Peyer’s patches and mesenteric LN) remained negative throughout the whole 
experiment. Overall, the amount of cell-associated virus in the spleen of MCMV 
Smith-infected mice was remarkably higher compared to the HaNa1 strain. NALT 
was the most frequent site where the cell-associated virus was detected, followed by 
the deep cervical LN.    
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4 Discussion  
CMV can certainly be transmitted from infected to susceptible hosts by oronasal route. 
However, it remains elusive how the virus spreads throughout the body upon oronasal 
exposure. In the present study, the viral dissemination was investigated. It was shown 
that a productive replication first occurred in the nasal mucosa (1 dpi), which 
coincided with the detection of cell-associated virus in the NALT. Subsequently, the 
virus was detected in the submandibular LN and deep cervical LN (3 dpi). Afterwards, 
the virus was found throughout the entire body, with detection of infectious and/or 
cell-associated viruses in the lungs (5 dpi) and spleen (5 dpi), and in PBMC, 
submandibular glands and mediastinal LN at 7 dpi. MCMV Smith, in contrast to 
MCMV HaNa1, was able to spread further to liver and kidneys with a productive 
replication.    
Based on these results, a general hypothetical model for MCMV dissemination 
throughout the body can be proposed (Fig 1). Upon natural exposure to MCMV, the 
nasal mucosa and NALT serve as portal of entry for MCMV. From these primary 
replication sites, the virus is transported in non-productively infected leukocytes to the 
draining lymph nodes (submandibular LN and deep cervical LN) and finally to the 
spleen and lungs possibly via blood. The route of antigen uptake at the surface 
mucosae and drainage to the lymphoid tissues is consistent with previous reports 
using fluorescein isothiocyanate (FITC), radiochemical 131I human serum albumin, 
horseradish peroxidase-gold complex particles and other viruses to study the patterns 
of drainage [36, 43, 50-54]. As the viremia could only be detected after the spleen 
became positive, we hypothesize that the spleen serves as a transfer hub from where a 
secondary replication is initiated in various other tissues such as submandibular 
glands (Smith and HaNa1), liver and kidneys (only Smith).   
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Figure 1. Illustration of MCMV HaNa1 and MCMV Smith dissemination upon natural 
oronasal inoculation. Stars represent infectious virus, and circles represent cell-associated virus. 
After natural oronasal inoculation, both strains first reach the nasal mucosa and NALT. 
Subsequently, both MCMV Smith and MCMV HaNa1 spread to the submandibular LN, deep 
cervical LN, lungs and spleen possibly via lymph and blood. A subsequent cell-associated viremia 
carries the virus from the spleen to various tissues such as submandibular glands (Smith and 
HaNa1), liver and kidneys (only Smith), where a secondary replication is started. Productive 
infections in abdominal organs such as spleen, liver and kidneys were only detected in MCMV 
Smith-infected mice. The mouse model pictures are derived from artist Laurie O'Keefe with her 
permission.  
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The present study provides information on the replication kinetics of MCMV in vivo. 
Findings in many but not all of the organs are consistent. In some organs, the 
variability might be an issue. However, when we put all our previous published 
studies [26, 55] and other unpublished data together, the aforementioned results are 
fully confirmed. They exclude that data from our study are coincidental findings due 
to limited animal numbers (n=3 per time point). Moreover, it is not appropriate to 
discuss and make overconclusions on individual animals in a kinetic pathogenesis 
study. For example, cell-associated virus (infected PBMC) was detected in only 4 out 
of 6 mice at 7 dpi in the present study. This is most probably due to the low sensitivity 
of co-cultivation. Indeed, in a more recent study, it was also observed that 
cell-associated virus in PBMC was only detected in 3 out of 6 inoculated mice at 7 dpi. 
However, by the use of an in-house qPCR, viral DNA could be detected in PBMC of 
all 6 inoculated mice (576-1670 copies/106 PBMC). 
According to our results, viral trafficking likely occurs in a cell-associated manner 
upon oronasal inoculation. In blood, cell-associated virus (determined by co-culture of 
PBMC) but no cell-free virus (determined by virus titration of isolated plasma) was 
detected. Our data are in line with previous studies using intraperitoneal inoculation 
[29, 56]. In addition, in various lymph nodes, cell-associated virus (determined by 
co-culture of single cells) but no cell-free virus (determined by virus titration of lysed 
single cells; data not shown) was detected. In our study, the identification of the 
carrier cells was not investigated. Earlier studies demonstrated that MCMV-encoded 
CC chemokine, MCK-2, promotes recruitment of CX3CR1hi patrolling monocytes to 
initial infection sites in the mouse, from where these cells become infected and traffic 
via the blood stream to distal sites [57, 58]. These studies indicate that CX3CR1hi 
patrolling monocytes may be important carrier cells.   
In the present study, NALT was identified as a portal of entry for MCMV upon 
intranasal inoculation. This finding is consistent with its anatomic and functional 
characteristics. In humans, the functional homologue of the rodent NALT is the 
Waldeyer’s ring [44]. Previous researchers have reported the detection of HCMV 
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DNA in the Waldeyer’s ring [45, 46], and hence, based on our results, it can be 
hypothesized that the Waldeyer’s ring may be an important entry site for HCMV upon 
natural exposure.  
The lungs are often affected by CMV. The pneumonia-causing ability of the virus has 
been studied by intranasal inoculation of anesthetized mice with MCMV. With this 
inoculation technique, it has been shown that the virus can directly flow into the lungs 
[48, 59]. Therefore, lungs are usually believed to be a primary target organ for 
MCMV via intranasal inoculation under anesthesia [25, 59]. However, it is very well 
possible that upon anesthesia, the inoculum directly flows into the lungs due to the 
absence of a sneezing reflex. Therefore, it remains to be elucidated how the virus 
reaches the lungs during a natural CMV infection. In the present study, infection of 
lungs was only detectable from 5 dpi, and no infectious virus was found in the trachea 
throughout the entire experiment. In addition, histopathological and 
immunohistochemical analysis of the lungs revealed a clear interstitial pneumonia and 
viral antigens in the interstitium (unpublished data). All these data suggest that 
infection of lungs in both MCMV Smith and HaNa1 infected mice result from the 
hematological spread of the virus, and not by inhalation as described by others for 
anesthetized mice [25, 59].  
During the entire experiment, no infectious or cell-associated virus was detected in the 
pharynx, esophagus, small intestines, Peyer’s patches and mesenteric LN. In 
consistence with a previous report [25], this illustrates that the digestive tract and 
associated lymphoid tissues are not an entrance gate for the virus. Potential 
explanations may be the absence of the Waldeyer’s ring in the pharynx of mice and/or 
presence of a low pH and proteases in the stomach, detergents in the bile and 
proteases/lipases in the small intestines. The latter conditions are too harmful for this 
enveloped virus. In order to examine if MCMV can use the oral route for infecting 
mice, a small experiment was performed in which nine mice were inoculated with 
MCMV HaNa1 and nine mice were inoculated with MCMV Smith via oral route. 
Only 2 mice became infected with MCMV HaNa1, and 3 with Smith. The poor 
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infectivity of MCMV via oral route is quite surprising, as CMV is thought to spread 
horizontally via saliva. MCMV most possibly prefers spread via nasal secretions 
because nose-to-nose contacts and smelling are important activities in the social life 
of mice.   
In contrast to MCMV HaNa1, MCMV Smith productively infects the spleen, liver and 
kidneys. Since the experimental hosts are identical, the degree of the viral replication 
(productive versus non-productive infection) is due to genetic differences between the 
two strains. One determinant of MCMV pathogenicity is MCMV-encoded chemokine 
2 (MCK-2) [57, 60]. However, this chemokine is identical between HaNa1 strain and 
Smith strain (Table 1). In order to find the answer to this question, the sequencing of 
complete genome of HaNa1 is in progress and the full genome will be compared with 
that of the Smith strain. The results may pave the way to identify pathogenicity 
determinants.    
In summary, we have shown that MCMV-infected leukocytes in blood and lymphoid 
organs contribute to virus dissemination within the host upon oronasal exposure. 
Considering that the shedding from salivary glands results from this systemic 
dissemination, further investigation of the critical role of blood, lymph nodes and 
spleen in CMV dissemination could lead to the identification of new targets to control 
viral transmission and disease. In the near future, we will focus on the role of spleen 
in MCMV dissemination in order to investigate whether MCMV exploits the spleen 
as a transfer hub for systemic dissemination upon oronasal inoculation.  
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Summary  
Murine cytomegalovirus (MCMV) infection in mice is a commonly used animal 
model for studying human cytomegalovirus (HCMV) infections. In our previous 
studies, a mouse model based on an oronasal MCMV infection was set up for 
mimicking a natural infection, and the spleen was hypothesized to regulate viremia 
and virus dissemination to distal organs such as submandibular glands. Here, the role 
of the spleen during an MCMV infection was investigated by the comparison of intact 
and splenectomized Balb/c mice. Both highly passaged MCMV Smith and low 
passaged MCMV HaNa1 were used. Various samples were collected at 7, 14, and 21 
days post inoculation (dpi) for analyses by virus isolation/titration, co-cultivation and 
qPCR. The results showed that for both virus strains, 1) cell-associated virus in 
PBMC (determined by co-cultivation) was detected in intact mice but not in 
splenectomized mice; 2) the mean viral DNA load in PBMC of splenectomized mice 
was 4.4-(HaNa1)/2.7-(Smith) fold lower at the peak viremia (7 dpi) compared with 
that of intact mice; and 3) infectious virus in the submandibular glands was detected 
later in splenectomized mice (14 dpi) than in intact mice (7 dpi). Moreover, the 
average virus titers in submandibular glands of splenectomized mice were 
10-(HaNa1)/7.9-(Smith) fold lower at 14 dpi and 1.7-(HaNa1, P = 0.45)/2.1-(Smith, P 
= 0.29) fold lower at 21 dpi compared with that of intact mice. Upon inoculation with 
MCMV Smith, infectious virus was found in the kidneys and liver of intact mice, but 
not in splenectomized mice. Taken together, all these data clearly demonstrate that 
virus dissemination to distant organs is reduced in splenectomized mice, further 
confirming the importance of the spleen as a viremia booming site for a natural 
MCMV infection.  
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1 Introduction 
Human cytomegalovirus (HCMV) is a significant viral pathogen, mainly affecting 
immunocompromised adults and developing fetuses [1]. HCMV infection in the 
immunocompetent host is usually asymptomatic or produces only mild symptoms, 
which makes early natural infection difficult to detect and study [2]. Splenomegaly is 
a common clinical finding in patients with symptomatic HCMV infection [3], but the 
exact role of the spleen in the pathogenesis of a natural HCMV infection is unknown. 
Due to the strict species specificity of cytomegaloviruses, it is difficult to study 
HCMV infection in experimental animals [1, 4]. Since HCMV shares a lot of 
similarities in pathogenesis with murine cytomegalovirus (MCMV), MCMV infection 
in mice has become a commonly used animal model for studying HCMV infection in 
humans [5, 6].  
The systemic infection upon intraperitoneal inoculation of MCMV has been widely 
used to study the pathogenesis of a cytomegalovirus [5]. MCMV can infect various 
organs such as spleen, liver, kidneys and salivary glands in mice using intraperitoneal 
inoculation [4, 7-9]. Among all these organs, the spleen is a very important target 
organ during early infection [7, 9] and, together with the salivary glands, the main 
organ for viral latency [10, 11]. MCMV infection in mice following intraperitoneal 
inoculation is thought to occur by an initial dissemination of virus from the portal of 
entry to the spleen, followed by an abundant viral replication at this site [12, 13]. 
MCMV has a broad cell tropism in the spleen, with macrophages and dendritic cells 
[14-17], sinus-lining cells and reticular fibroblasts [9, 18], endothelial cells and 
hematopoietic cells [19, 20] as targets. Subsequent to the replication in the spleen 
during which a second viremia occurs, virus is disseminated via blood leukocytes, 
ultimately reaching additional sites of infection, such as salivary glands [9, 12, 13, 21]. 
All these previous studies indicate that the spleen plays an important role in the 
pathogenesis of a systemic MCMV infection. However, it remains elusive if the 
spleen also plays a central role in virus dissemination during a more natural infection 
via the oronasal route. In our previous studies, a mouse model based on an oronasal 
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MCMV infection was set up to mimic a natural CMV infection [21, 22]. We found 
that after oronasal infection, MCMV first replicates in the nasal mucosa and 
nasopharynx-associated lymphoid tissues (NALT), and then spreads to the 
submandibular lymph nodes, deep cervical lymph nodes and the spleen via lymph and 
blood. Subsequently, a cell-associated viremia carries the virus to distal organs such 
as submandibular glands, liver and kidneys. As the cell-associated viremia was not 
detectable until the spleen became positive, it was hypothesized that the spleen serves 
as a transfer hub for virus dissemination throughout the body during natural infection.  
To investigate the role of the spleen during a natural MCMV infection, intact and 
splenectomized mice were inoculated oronasally with either the highly passaged 
MCMV Smith strain or the low passaged MCMV HaNa1 strain. Plasma and various 
organs were collected at different time points and used to detect infectious virus by 
virus titration, and the associated lymph nodes were collected and used to detect 
cell-associated virus by co-cultivation. In addition, the average MCMV DNA load in 
peripheral blood mononuclear cells (PBMC) of intact and splenectomized mice was 
determined by qPCR. 
2 Materials and methods  
2.1 Viruses, cells, and animals  
Two MCMV strains were used in this study: the second passage of clone 1 of the 
MCMV HaNa1 strain and the MCMV Smith strain at a high passage in the continuous 
murine bone marrow stromal cell line (M2-10B4) [22]. Primary Balb/c mouse 
embryonic fibroblasts (MEFs) were cultivated in minimum essential medium (MEM) 
supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, 0.5 mg/ml 
gentamicin, 2% lactalbumin and 10% fetal calf serum (FCS). MEFs were used at the 
second passage. Virus titration was performed in 96-well plates and titers were 
expressed as the viral dilution infecting 50% of the cell cultures (TCID50), following 
the methodology described by Reed and Muench [23].    
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2.2 Experimental design  
According to our previous data [21], peak infection of blood leukocytes occurs at 7 
dpi and virus can be detected in salivary glands, liver and kidneys at 14 dpi. Therefore, 
these time points were selected in the present study. Additionally, 21 dpi was selected 
to evaluate the effect of splenectomy on the course of the infection. Intact and 
splenectomized 6-week-old Balb/c female mice were used in this experiment. Nine 
intact and twelve splenectomized Balb/c mice were inoculated with 106 TCID50 
MCMV HaNa1 via intranasal (25 µl) and peroral (75 µl) route without anesthesia. 
Mice were kept in isolation and fed ad libitum. At each time point (7, 14, and 21 dpi), 
three intact and four splenectomized mice were euthanized. Another nine intact and 
nine splenectomized Balb/c mice were inoculated with MCMV Smith strain using the 
same methodology. Three intact and three splenectomized Balb/c mice were 
euthanized at 7, 14 and 21 dpi. Another three intact and three splenectomized Balb/c 
mice were mock inoculated with PBS and euthanized at the end of the experiment.   
2.3 Collection of blood and tissues  
For blood collection, each mouse was anesthetized by intraperitoneal administration 
with 130 µl of 10 mg/ml sodium pentobarbital (KELA, Belgium). According to a 
previously described method [22], 0.6 ml blood per mouse was taken from the orbital 
sinus with a heparinized Pasteur pipet and kept in an eppendorf with 0.5 ml PBS 
containing 5 U/ml heparin (Leo Pharma, Zaventem, Belgium). Plasma was collected 
through centrifugation (200xg for 10 min) and stored at -70 °C until virus titration. 
PBMC were isolated by density gradient centrifugation with Ficoll-Paque (GE 
Healthcare) and resuspended in 0.5 ml RPMI. After blood collection, mice were 
euthanized by intraperitoneal administration with another 200 µl of 10 mg/ml sodium 
pentobarbital (KELA, Belgium), and different tissues were collected under aseptic 
conditions. Tissues obtained from the respiratory system and draining lymphoid 
tissues were nasal mucosa, lungs, nasopharynx-associated lymphoid tissues (NALT), 
deep cervical lymph nodes (LN), and mediastinal LN. Tissues associated with the 
alimentary system that were collected were submandibular glands and submandibular 
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LN. Other abdominal organs that were sampled were spleen, liver, and kidneys. The 
different lymph nodes, 400 µl out of a total of 500 µl PBMC of each mouse, and half 
of the spleen were used for co-cultivation. From the other half of the spleen and the 
other tissues, 10% homogenates (w/v) were made in PBS and stored at -70 °C until 
virus titration was performed. Another 100 µl of PBMC were used to quantify the 
average MCMV DNA copies present in PBMC.    
2.4 Virus titration  
Fifty µl of tenfold serial dilutions of the supernatants of the homogenates were used to 
inoculate monolayers of MEFs. After incubation at 37 °C for 1 h, 100 µl of medium 
were added and the cells were further incubated for 7 days. After 7 days, the presence 
of cytopathic effect (CPE) was assessed by light microscopy (Olympus Optical Co., 
Hamburg, Germany) and the virus titer was determined as TCID50 according to the 
method of Reed and Muench [23].  
2.5 Preparation of single-cell suspensions for co-cultivation 
As already known for a long time, CMV spreads in a strict cell-associated way 
[24-26]. In order to investigate the cell-associated virus in different lymphoid organs, 
co-cultivation was used in this study. For the preparation of single-cell suspensions 
from lymph nodes, two needles were used to tear the lymph nodes into pieces in 
6-well plates with 150 µl RPMI 1640 medium supplemented with 2% FCS and a 
mixture of antibiotics (100 U/ml penicillin, 100 µg/ml streptomycin and 50 µg/ml 
gentamycin) [21]. Afterwards, the cell suspensions were filtered using 
100-µm-pore-size cell strainers (BD Falcon) to obtain single-cell suspensions. 
Splenocytes were isolated by cutting the spleen with scissors into small pieces, 
followed by trypsin digestion for 5 min at 37 °C. Afterwards, splenocytes were 
filtered through a 100-µm-pore-size cell strainer (BD Falcon), followed by lysis of red 
blood cells.   
PBMC (400µl out of a total of 500 µl), single-cell suspensions from lymph nodes and 
half of the spleen per mouse were separately added to a monolayer of MEFs and were 
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later covered with 1 ml carboxymethylcellulose (CMC) overlay medium (1/4 2 x 
MEM, 1/4 2 x RPMI and 1/2 2 x CMC totally supplemented with 5% FCS, 100 U/ml 
penicillin, 100 µg/ml streptomycin, 50 µg/ml gentamycin, 0.1 mM NEAA and 1 mM 
sodium pyruvate). Afterwards, the plates were centrifuged at 750xg for 10 min. 
Subsequently, the cells were cultivated at 37 °C in an incubator for 8 days (lymph 
nodes and PBMC) or 12 days (spleen). The medium was partially changed every 4 
days. Afterwards, the numbers of plaques were counted using a light microscope 
(Olympus Optical Co., Hamburg, Germany) to quantify the viral loads in various 
lymph nodes, spleen and PBMC.  
2.6 Quantification of MCMV DNA in PBMC using qPCR   
2.6.1 Generation of standard DNA for absolute quantification of the viral load    
DNA was extracted from MCMV HaNa1 stock viruses using the QIAamp DNA mini 
kit (Qiagen, California, USA). Real-time qPCR forward 
(5’-GTGCGTTCTTCGTGGAGC-3’) & reverse (5’-CGCCTTTGTCTACGGTGT-3’) 
primers were designed in a conserved region of the m152 gene, based on the 
nucleotide sequence of HaNa1 strain (accession No.: KR184673) using the 
Primer3Plus website. First, these primers were used to amplify the nucleotide 
sequence fragment of m152 gene in a 50 µl PCR reaction mixture containing 10 µl 
OneTaq Standard reaction buffer (New England Biolabs Inc., Massachusetts, USA), 1 
µl dNTPmix, 1 µl forward primer (10 µM), 1 µl reverse primer (10 µM), 0.25 µl 
OneTaq DNA-polymerase (New England Biolabs Inc.), 32.75 µl DNase/RNase free 
H20, and 4 µl DNA. The PCR was performed by an initial incubation at 95 °C for 3 
min to activate the enzyme with 35 amplification cycles consisting of denaturation at 
95 °C for 20 s, annealing at 55 °C for 30 s and extension at 72 °C for 2 min. A final 
extension step was done for 10 min at 72 °C and stored at 12 °C until further 
processing. Amplification products were separated on a 1% agarose gel and identified 
with UV after incubation with ethidium bromide. Fragments with the correct length 
were excised and purified from the gel using the Nucleospin® Gel and PCR Clean-up 
kit (Macherey-Nagel, Düren, Germany), and the nucleotide sequence was 
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characterised using Sanger Sequencing (performed by the GATC Biotech Company, 
Konstanz, Germany). The concentration of DNA was determined using 
spectrophotometry (Nanodrop 2000 system, Thermo Scientific). Ten-fold serial 
dilutions of the template DNA were made over a range of 6 log units (106-101) for the 
generation of the standard curve.  
2.6.2 Real time qPCR 
At each time point (7, 14, and 21 dpi), 100 µl of PBMC was used for DNA extraction, 
using the QIAamp DNA mini kit (Qiagen, California, USA) according to the 
manufacturer's instructions. Assays were prepared in 96-well optical reaction plates 
(Life technologies) in a total volume of 20 µl including 10 µl PrecisionPLUS 2x 
qPCR MasterMix with SYBR Green, ROX and inert blue dye (PrimerDesign Ltd., 
Southampton, UK), 50 nM forward primer 5’-GTGCGTTCTTCGTGGAGC-3’, 50 
nM reverse primer 5’-CGCCTTTGTCTACGGTGT-3’, 6.8 µl LiChrosolv water, and 
3 µl sample DNA or diluted DNA standard (see above). Thermal cycling started with 
an enzyme activation at 95 °C for 2 min, followed by 40 cycles of each 15 s at 95 °C 
and 60 s at 60 °C. A first-derivative melting curve analysis was performed by heating 
the mixture to 95 °C for 15 s, then cooling to 60 °C for 1 min, and heating back to 
95 °C at 0.3 °C increments. Amplification and melting curve analysis were carried out 
in a Step One Plus™ real-time PCR system (Applied Biosystems, Life Technologies 
Corporation, Carlsbad, CA, USA). Each sample was measured twice and the average 
DNA copy number was used for quantification analysis.  
2.7 Statistical analyses  
Data from experimental groups were analyzed using the Mann-Whitney U test of 
GraphPad Prism v.5.0 software (GraphPad Software Inc., San Diego, CA, USA). P 
values ≤ 0.05 were considered as significant.   
2.8 Ethical statement 
All animal experiments were approved by the local Ethical Committee of the Faculty 
of Veterinary Medicine, Ghent University (EC2015-57).    
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3 Results 
3.1 Organ specific differences in viral load between intact and splenectomized 
Balb/c mice inoculated with MCMV HaNa1 or MCMV Smith, as determined by 
virus titration 
Figure 1 (top panel) represents infectious virus titers in various tissues at different 
time points after oronasal inoculation of intact and splenectomized Balb/c mice with 
MCMV HaNa1. Infectious virus was detected in the nasal mucosa at 7, 14, and 21 dpi 
for mice with and without spleen. In the intact mice, the average virus titers in the 
nasal mucosa were 102.6 TCID50/g at 7 dpi, 103 TCID50/g at 14 dpi, and 103.7 TCID50/g 
at 21 dpi. Compared with intact mice, the average virus titers in the nasal mucosa of 
splenectomized mice tended to be higher (103 TCID50/g at 7 dpi, 104 TCID50/g at 14 
dpi, and 104.5 TCID50/g at 21 dpi), but this was not significantly different. In the 
submandibular glands, infectious virus was detected at 7 dpi (1 out of 3), 14 dpi (3 out 
of 3), and 21 dpi (3 out of 3) in intact mice, but only at 14 dpi (4 out of 4) and 21 dpi 
(4 out of 4) in splenectomized mice. The average virus titer was 10 times lower (P = 
0.0001) at 14 dpi in splenectomized mice (105.7 TCID50/g) compared to intact mice 
(106.7 TCID50/g). Also at 21 dpi the virus titer was somewhat lower (105.5 TCID50/g 
versus 105.7 TCID50/g) but not significantly different (P = 0.45). Infectious virus was 
not detected in the spleen (intact mice), liver, kidneys and plasma (both intact and 
splenectomized mice) throughout the whole experiment.  
112 
 
 
Figure 1. MCMV HaNa1 (top) and MCMV Smith (bottom) replication in various tissues 
from intact/splenectomized mice collected at 7, 14 and 21 dpi. At each time point, the data 
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   MCMV exploits spleen as a transfer hub for dissemination | 113 
 
	  
from intact or splenectomized mice are given. Each open circle or triangle corresponds to one 
mouse. The center bar indicates the mean. The detection limit for the titration assay (101.8 
TCID50/g tissue or 100.8 TCID50/ml plasma) is shown by the horizontal dashed line. *, P < 0.05.  
Figure 1 (bottom panel) represents the results of the virus titration of various tissues at 
different time points after oronasal inoculation of intact and splenectomized Balb/c 
mice with MCMV Smith. Infectious virus was detected in the nasal mucosa of both 
types of mice at 7, 14, and 21 dpi. In the intact mice, the average virus titers in the 
nasal mucosa were 102.1 TCID50/g at 7 dpi, 102.6 TCID50/g at 14 dpi, and 103.2 
TCID50/g at 21 dpi. Compared with intact mice, the average virus titers in the nasal 
mucosa of the splenectomized mice were higher (102.7 TCID50/g at 7 dpi, 103.6 
TCID50/g at 14 dpi and 103.6 TCID50/g at 21 dpi). A significant difference was only 
reached at 14 dpi (P = 0.0089). In the submandibular glands, infectious virus was 
detected at 7 dpi (1 out of 3), 14 dpi (3 out of 3) and 21 dpi (3 out of 3) in intact mice, 
but only at 14 dpi (3 out of 3) and 21 dpi (3 out of 3) in splenectomized mice. In intact 
mice, the average virus titers in the submandibular glands were 103.9 TCID50/g at 14 
dpi and 102.6 TCID50/g at 21 dpi. Compared with intact mice, the average virus titer in 
the submandibular glands of splenectomized mice was nearly 8 times lower at 14 dpi 
(103.0 TCID50/g) (P = 0.0048) and 2 times lower at 21 dpi (102.3 TCID50/g) (P = 0.29). 
In intact mice, infectious virus was also detected in other organs, such as lungs (1 out 
of 3 mice at 7 dpi), spleen (2 out of 3 at 7 dpi), liver (1 out of 3 at 7 dpi and 2 out of 3 
at 14 dpi) and kidneys (2 out of 3 at 14 dpi). For splenectomized mice, no infectious 
virus was detected in lungs, liver and kidneys throughout the whole experiment. No 
virus was detected in any tissue of mock-inoculated mice.  
3.2 Detection of cell-associated virus in lymph nodes and blood in intact and 
splenectomized Balb/c mice inoculated with MCMV HaNa1 or MCMV Smith  
Figure 2 (top panel) shows the number of infected cells determined by co-cultivation 
of cells derived from lymph nodes and blood of intact and splenectomized Balb/c 
mice inoculated with MCMV HaNa1. Cell-associated virus was detected in pooled 
NALT for both types of mice at 7, 14, and 21 dpi, in submandibular LN at 14 (2/3) 
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dpi for intact mice and at 7 (3/3) dpi for splenectomized mice, in deep cervical LN at 
7 (1/3), 14 (2/3) and 21 (2/3) dpi for intact mice and at 7 (3/4) and 14 (2/4) dpi for 
splenectomized mice, in the pooled mediastinal LN at 7 and 14 dpi for both types of 
mice, in the spleen at 7 (3/3) and 14 (3/3) dpi for intact mice, and in PBMC at 7 (2/3) 
dpi only for intact mice. 
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Figure 2. Co-cultivation of cell suspensions of different lymphoid organs and PBMC from 
MCMV HaNa1 (top) and Smith (bottom)-inoculated intact/splenectomized mice with MEFs. 
Each open circle or triangle corresponds to one mouse. The center bar indicates the mean. NALT 
and mediastinal LN are respectively pooled together for co-cultivation. 
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The results of the co-culture assay show that dissemination of the MCMV Smith 
strain to lymphoid organs in intact and splenectomized mice (Fig. 2, bottom panel) 
was similar to the findings obtained with the MCMV HaNa1 strain, with the detection 
of cell-associated virus in the pooled NALT at 7, 14, and 21 dpi, in the submandibular 
LN at 7 (2/3) and 21 (2/3) dpi for intact mice and at 7 (3/3) and 14 (1/3) dpi for 
splenectomized mice, in the deep cervical LN at 7 (2/3), 14 (3/3), and 21 (1/3) dpi for 
intact mice and at 7 (2/3) and 14 (2/3) dpi for splenectomized mice, in the pooled 
mediastinal LN at 7 and 14 dpi for both types of mice, in the spleen at 7 (3/3) and 14 
(3/3) dpi for the intact mice, and in PBMC at 7 (1/3) dpi only for the intact mice. 
Overall, the amount of cell-associated virus in the spleen of MCMV Smith-inoculated 
intact mice was remarkably higher (p < 0.5) compared to that of the MCMV 
HaNa1-inoculated intact mice.    
3.3 Quantification of MCMV DNA load in PBMC of intact and splenectomized 
Balb/c mice inoculated with MCMV HaNa1 or MCMV Smith, as determined by 
qPCR   
Figure 3 shows the mean virus DNA load in PBMC of MCMV HaNa1 and MCMV 
Smith-inoculated intact and splenectomized mice. Ten-fold serial dilutions of the 
template DNA were made over a range of 6 log units (106-101) for the generation of 
the standard curve (efficiency: 105.4 %; R2: 0.981). In the MCMV HaNa1-inoculated 
intact and splenectomized mice, the average MCMV DNA copy numbers were higher 
at 7 dpi compared to 14 and 21 dpi. The average DNA copies in PBMC of 
splenectomized mice (3.0 x 102 DNA copies/106 cells) were significantly lower (P = 
0.022) compared with that of inoculated intact mice (1.3 x 103 DNA copies/106 cells), 
whereas no significant differences were found at 14 and 21 dpi.  
Similar results were found in the MCMV Smith-inoculated intact/splenectomized 
mice. The average viral DNA copies were the highest at 7 dpi for both types of 
inoculated mice, but a significantly lower amount (P = 0.0468) was found in 
splenectomized mice (3.9 x 102 DNA copies/106 cells) compared to intact mice (1.0 x 
103 DNA copies/106 cells). Only a very low load was found at 14 and 21 dpi, and no 
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significant difference were noticed between intact and splenectomized mice at these 
time points.  
Figure 3. Quantification of MCMV DNA load in PBMC by qPCR from HaNa1-(left) and 
Smith-(right) inoculated intact/splenectomized mice were quantified. Each open circle or 
triangle corresponds to one mouse. The center bar indicates the mean. *, P < 0.05.  
4 Discussion  
Intraperitoneal inoculation of mice with MCMV has identified the spleen as an 
important target organ for early replication, systemic spread, and latency [7, 9-11]. 
Using oronasal inoculation (the natural infection route), our previous research also 
highlighted the spleen as a key determinant for virus dissemination during natural 
infections. Indeed, we showed that viremia and subsequent dissemination of the virus 
to distal organs (such as the liver, kidneys, and submandibular glands) was only 
detectable after replication had occurred in the spleen [21]. By comparing MCMV 
dissemination in intact and splenectomized mice, the present study confirmed the role 
of the spleen as transfer hub for virus dissemination during infection with both 
MCMV Smith and HaNa1. For both virus strains, a cell-associated viremia was 
detectable by co-cultivation in intact mice, but not in splenectomized mice. To 
exclude that this was a coincidental finding (since a cell-associated viremia was not 
detected in all intact mice and a rather limited number of animals were used), MCMV 
DNA load was determined in PBMC with qPCR. These data confirmed the restricted 
viremia in splenectomized mice.  
For both virus strains, virus in the submandibular glands of splenectomized mice was 
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detected later and at lower titers compared with that of intact mice. For the Smith 
strain, infectious virus in liver and kidneys of splenectomized mice were not detected, 
whereas virus was frequently isolated in these organs of intact mice. For HaNa1, 
infectious virus in liver and kidneys was never detected in both intact and 
splenectomized mice, which is in line with our previous reports [21, 22], 
demonstrating that MCMV HaNa1 cannot lead to a productive infection in spleen, 
liver and kidneys in adult mice. Taken all data together, it can be concluded that the 
spleen can be considered as a key determinant for virus dissemination during natural 
infections. The precise mechanism for limiting virus dissemination over the body in 
splenectomized mice may be due to the reduction of numbers of MCMV infected 
leukocytes in blood by splenectomy. It is very well possible that these cells are 
patrolling monocytes. This hypothesis is supported by previous studies demonstrating 
that a larger number of patrolling monocytes are found in the spleen compared to 
blood [27, 28] and that these patrolling monocytes are hijacked by MCMV as 
immune-privileged vehicles for dissemination to salivary glands and other tissues [10]. 
Although patrolling monocytes can also be found in various lymph nodes [28, 29], the 
size of a spleen is remarkably larger compared with that of other lymphoid tissues, 
which leads to a higher number of infected patrolling monocytes in the spleen than in 
lymph nodes. This may be an additional explanation why the spleen is more important 
as a source of infected leukocytes in the blood and for virus dissemination.  
For both virus strains, virus titers in the portal of entry (nasal mucosa) were higher in 
splenectomized mice compared with intact mice. This may be due to a reduced T 
cell-mediated immune response to MCMV infection after splenectomy, as the role of 
splenic effective T cells in providing protection against MCMV infection was 
demonstrated by several previous studies [30-33], and the numbers of effective T cells 
in lymph and blood circulation are reduced by splenectomy [31-34].  
In order to detect and quantify cell-associated virus in various lymphoid tissues, a 
co-cultivation assay was used in the present study. Similar patterns were found for 
both virus strains except that the average number of cell-associated virus was lower in 
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NALT and deep cervical LN, but was remarkably higher in the spleen of 
Smith-inoculated mice compared with that of HaNa1-inoculated mice. The former 
finding may be due to the more extensive replication of HaNa1 in the nasal mucosa 
and the submandibular gland and the draining of these regions to NALT and deep 
cervical LN [35, 36]. The higher number of cell-associated virus in the spleen of 
Smith-inoculated intact mice may be explained by the finding that only the Smith 
strain causes a clear productive infection in the spleen and that both productively and 
latently infected cells are detected with the co-cultivation assay. In contrast to the 
higher number of virus-infected cells in the spleen of Smith-inoculated intact mice, 
cell-associated viremia and average viral DNA in PBMC were less pronounced for the 
Smith strain compared with the HaNa1 strain. Although hypothetical, this may be due 
to the fact that the Smith strain is causing a more productive infection in the spleen, 
leading to the death of the infected cell, whereas HaNa1 infection of the spleen may 
promote latently infected cells which are staying alive and may enter the blood 
circulation.  
In conclusion, all these data suggest that the spleen serves as a viremia booming site 
for MCMV infections activating virus dissemination to distal organs such as salivary 
glands, liver and kidneys. These data identify the spleen as the target organ for a 
control of MCMV transmission.  
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  Chapter 6 
 
General discussion
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An HCMV infection is in general asymptomatic in immunocompetent hosts but 
harmful for immunocompromised individuals [1, 2]. The asymptomatic nature of 
HCMV infection makes the study of early infections hard to do. Further, due to its 
strict species-specificity, it is not possible to study the pathogenesis of infections with 
this virus in experimental animals. MCMV infection in mice is a widely used animal 
model for studying HCMV infection [3]. As such, MCMV models may provide 
insights in the way HCMV initiates replication in its host in a natural situation.  
The routes of a natural MCMV entry remain illusive, despite the fact that MCMV has 
been investigated for several decades. In most previous published studies on MCMV 
pathogenesis, the intraperitoneal, intracerebral, orbital and intravenous inoculation 
routes have been utilized, but none of them can be recognized as a natural infection 
route [4]. In general, the routes of intranasal and peroral inoculation are nearly and 
widely accepted as the natural infection routes. Nonetheless, limited data on infection 
via intranasal and peroral inoculation are available so far. Even if intranasal 
inoculation was used in a few previous published papers, all mice were sedated or 
anesthetized [5, 6]. Concerning this, the aforementioned intranasal inoculation was 
not accepted as being natural. Oral inoculation of MCMV has also been investigated 
by suckling virus contaminated breast milk [7], but it was not demonstrated how 
infection was initiated in these animals.   
Likewise, the virus strain is another factor, which should be taken into consideration 
during in vivo studies. Two laboratory strains of MCMV, Smith and K181, are in 
widespread use over the past decades [8]. Both strains have been extensively passaged 
in vivo or in vitro since their first isolation. Serial in vivo or in vitro passage is known 
to affect genome stability, thus leading to biological differences [9, 10]. The same 
issue has been addressed for HCMV [11, 12]. Hence, MCMV strains with serial 
passages may not generate closely correlated results in regard to the full range of virus 
replication and clinical outcome that are associated with CMV infections. It is critical 
that isolates of MCMV without undergoing extensive in vivo/ in vitro passages should 
be investigated to give more relevant data on the pathogenesis of CMV infections. 
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Therefore, in the present thesis, the pathogenesis of MCMV infection with the low 
passaged MCMV HaNa1 isolate was compared with that of highly passaged MCMV 
Smith, using oronasal inoculation without anesthesia to mimic natural infection.  
This thesis provided detailed information on how MCMV disseminates throughout the 
body upon oronasal inoculation, and highlighted some important differences between 
the low passaged HaNa1 and highly passaged Smith strains. A hypothetical model 
depicting this dissemination is given in Figure 1 and discussed in detail below.  
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Figure 1. Illustration of MCMV HaNa1 and MCMV Smith dissemination upon natural 
oronasal inoculation and function of spleen in this process. The size of stars and enclosed 
circles respectively represent infectious virus and cell-associated virus production. For intact mice 
with natural oronasal inoculation, both virus strains (HaNa1 and Smith) first reach the nasal 
mucosa and NALT. Subsequently, both virus strains spread to the submandibular LN, deep 
cervical LN, lungs and spleen possibly via lymph and blood circulation. Afterwards, the spleen 
regulates a subsequent cell-associated viremia carrying the virus to various tissues such as 
submandibular glands (for both Smith and HaNa1), liver and kidneys (only for Smith), where a 
secondary replication is initiated. Productive infections in abdominal organs such as spleen, liver 
and kidneys were only detected in MCMV Smith-infected adult mice. For splenectomized mice 
inoculated with the same inoculation technique, splenectomy leads to an obviously less efficient 
virus dissemination manifested by a more restricted viremia detected at 7 dpi, significantly lower 
virus titers in the submandibular glands at 14 dpi for both virus strains, and additionally no 
infectious virus detected in the spleen, liver and kidneys at 7, 14 and 21 dpi for Smith. These data 
confirm that the spleen plays a vital role in regulating viremia and virus dissemination upon 
oronasal inoculation. The mouse model pictures are derived from artist Laurie O'Keefe with her 
permission.  
1) The nose serves as portal of entry for MCMV 
The nasal mucosa was demonstrated for the first time as a vital susceptible organ for 
MCMV. According to our in vivo results, upon oronasal inoculation, infectious and 
cell-associated virus was first detected in the nasal mucosa and NALT respectively 
from 1 dpi onwards for both virus strains with high inoculation dose. Manifestation of 
earlier detection and higher virus titers resulted from increasing the inoculation dose. 
HaNa1 reached to higher virus titers than Smith in the nasal mucosa. Cell-associated 
virus persisted in NALT until at least 14 dpi, which indicated that NALT plays a 
critical role in MCMV infection in general. We assume that the virus in NALT may 
be transmitted via lymphatic drainage to the draining lymph nodes, ending up in the 
blood circulation. NALT is identified as portal of entry for MCMV upon intranasal 
inoculation. This finding is in line with its anatomic and functional characteristics. 
The Waldeyer’s ring in human is the equivalent of NALT in rodent [13]. In addition, 
HCMV DNA has been detected in the Waldeyer’s ring [14, 15], and hence, the 
Waldeyer’s ring can be hypothesized to be a vital entry site for HCMV upon natural 
exposure. For both virus strains, infected cells in the nose were identified as 
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macrophages and dendritic cells in the NALT, and as olfactory neurons and 
sustentacular cells in olfactory epithelium. Virus getting into the NALT is thought to 
occur via several routes: 1) transcytosis through microfold cells; 2) transport across 
the columnar epithelial cells, and 3) direct luminal sampling via DC dendrites [16]. 
The presence of heparan sulfate might be a potential explanation for virus infection in 
olfactory epithelium and absence of infection in respiratory epithelium. Heparan 
sulfate contributes to MCMV binding and entry, and virions unable to bind to heparan 
sulfate show poor host entry [17]. The respiratory epithelial cells only express 
heparan sulfate basolaterally [18], where it is inaccessible to virions from the lumen 
of the nose. The olfactory epithelium that contains olfactory neurons and sustentacular 
cells, unlike the nasal respiratory epithelium, expresses heparan sulfate both apically 
and basolaterally [18, 19]. Therefore, virions may easily bind to the heparan sulfate at 
the apical side and enter both cell types. This mechanism of virus infecting olfactory 
epithelium has also been reported for murid herpesvirus-4 [18, 19]. In addition, 
infecting the olfactory neurons raised the question whether CMV may damage the 
function of smell [20, 21]. This will be an interesting direction in the future 
investigation. The nasal mucosa is hypothesized to be a target organ for HCMV 
according to the similarities between human and murine CMV. Indeed, several reports 
on the detection of HCMV in nasopharyngeal carcinomas, sinusitis and nasal 
polyposis are consistent with this [22-25].    
2) Virus dissemination occurs from the nose to various tissues/organs from 3 dpi 
via non-productively infected leukocytes  
Cell-associated virus was first detected in the submandibular LN and deep cervical 
LN at 3 dpi. Subsequently, the virus was disseminated throughout the entire body, 
with detection of infectious and/or cell-associated virus in the lungs and spleen at 5 
dpi, and in PBMC, mediastinal LN and submandibular glands at 7 dpi.  
Both virus strains showed a very restricted replication in lungs since the infection was 
controlled in the first three weeks post inoculation. Our finding is in line with a 
previous study [26]. Moreover, cell-associated virus can only be detected in 
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mediastinal LN from 7 dpi onwards after the lungs become infected (5 dpi), which is 
in line with the drainage of mediastinal LN. CMV infected the lungs often leading to 
pneumonia, which has been demonstrated by intranasal inoculation of anesthetized 
mice with MCMV. It has been confirmed that the virus can directly flow into the 
lungs with this inoculation method [5, 27]. Hence, lungs are widely considered to be a 
primary target organ for MCMV via intranasal inoculation under anesthesia [5, 6]. In 
the present study, infectious virus was first detected in the lungs at 5 dpi, and not 
detected in the trachea throughout the entire experiment. Additionally, a clear 
interstitial pneumonia and viral antigens in the interstitium were examined in the 
lungs by histopathological and immunohistochemical analysis (unpublished data). 
Taken all these data together, the infection of lungs with both Smith and HaNa1 
strains is associated with the hematological spread of the virus, and not due to 
inhalation as described by others for anesthetized mice [5, 6]. Viral antigen positive 
cells in lungs were identified as epithelial cells and macrophages for both MCMV 
strains [5, 26]. According to a more recent published study, it was precisely 
demonstrated that type 2 alveolar epithelial cells, but not type 1 alveolar epithelial 
cells, can be productively infected, and alveolar macrophages can phagocytose virus 
or debris of infected cells but are not productively infected [28].  
Cell-associated virus was detected in PBMC at 7-10dpi for both strains with a high 
inoculation dose. This suggests that circulating PBMC are involved in the 
dissemination of MCMV, which is in line with a previous study [29]. Since the 
viremia could only be detected after the spleen became positive, the spleen is 
hypothesized to serve as a transfer hub for regulating viremia and virus dissemination 
over the body such as submandibular glands (for both HaNa1and Smith), liver and 
kidneys (only for Smith). This hypothesis was further confirmed by comparing 
MCMV dissemination in intact and splenectomized mice upon oronasal inoculation. 
Our data showed that for both virus strains, a cell-associated viremia was detectable 
by co-cultivation assay using PBMC of intact mice, but not of splenectomized mice. 
To exclude that this was a coincidental finding (since a cell-associated viremia was 
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not detected in all intact mice and a rather limited number of animals were used), the 
MCMV DNA load in PBMC was examined with qPCR. The restricted viremia was 
found in splenectomized mice. For both virus strains, virus in the submandibular 
glands of splenectomized mice was detected later and at lower titers compared with 
that of intact mice. For Smith, infectious virus in liver and kidneys of splenectomized 
mice was not detected, even though virus was frequently isolated from these organs of 
intact mice. For HaNa1, infectious virus in liver and kidneys was never detected in 
both intact and splenectomized mice, which is consistent with our previous reports 
[30, 31]. Taken all data together, it was concluded that the spleen can be regarded as a 
key determinant for regulating viremia and virus dissemination during natural 
infections. The precise mechanism for regulating viremia and limiting virus 
dissemination over the body in splenectomized mice may result from the reduction of 
numbers of MCMV infected leukocytes in blood by splenectomy. These cells possibly 
are patrolling monocytes. This hypothesis is supported by previous studies 
demonstrating that a larger number of patrolling monocytes are found in the spleen 
compared to blood [32, 33] and that these patrolling monocytes are hijacked by 
MCMV as immune-privileged vehicles for dissemination to salivary glands and other 
tissues [34]. Although patrolling monocytes can also be found in various lymph nodes 
[33, 35], the spleen is remarkably larger compared with that of other lymphoid tissues, 
which leads to a higher number of infected patrolling monocytes in the spleen than in 
lymph nodes. This may be an additional explanation why the spleen is more important 
as a source of infected leukocytes in the blood and for virus dissemination. 
Intriguingly, the spleen is also involved in the systemic transmission of murid 
herpesvirus-4 [36], but its exact role in virus dissemination may be different from 
MCMV. In the future, it is very interesting to compare the mechanisms involved in 
systemic spread by both MCMV and murid herpesvirus-4. 
The submandibular gland is another main target organ for both strains. The viral 
replication in the submandibular glands always initiated one week later compared 
with that in the nasal mucosa and lasted longer than 49 days post inoculation. The 
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similar pattern in the nasal mucosa was also found in the submandibular glands. 
Namely, HaNa1 reached much higher virus titers than Smith, and increasing the 
inoculation dose enhanced virus production in the submandibular glands. The 
susceptible cell type in submandibular glands for both MCMV strains was identified 
as epithelial cells, which is in line with earlier published data [37]. CMVs have been 
reported to mainly use salivary glands as target organ for virus persistence and 
shedding into saliva for horizontal transmission [38-40]. Nevertheless, in our study, 
only HaNa1 was detected in saliva at only one time point within one mouse. The low 
level of virus titers in saliva was quite surprising, as CMVs are thought to be 
transmitted orally via saliva. These conflicting data will be further examined in future 
studies. Moreover, it is still unclear how the virus initiates replication in the 
submandibular glands.  
MCMV Smith productively infects the spleen, liver and kidneys in adult mice 
compared with MCMV HaNa1. Since the experimental hosts are identical, the genetic 
differences between HaNa1 and Smith result in the different degree of viral 
replication (productive versus non-productive infection). MCMV-encoded chemokine 
2 (MCK-2) has been identified as a determinant of MCMV pathogenicity [41, 42]. 
However, this chemokine is identical between HaNa1 and Smith and cannot explain 
the difference. In order to find an answer to this question on the strain difference, the 
full sequence of the MCMV HaNa1genome should be determined and compared with 
that of the Smith strain. The results may pave the way to identify pathogenicity 
determinants. The outcome of MCMV HaNa1 infection is more similar to that of an 
HCMV primary infection in immunocompetent adults, during which the virus is 
causing a limited virus replication in the salivary glands but not in multiple internal 
organs [43]. Therefore, MCMV HaNa1 is an interesting strain to be used in mouse 
models in order to get better insights into HCMV natural infections in 
immunocompetent hosts via oronasal exposure.   
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3) MCMV does not replicate in the digestive tract and associated lymphoid 
tissues 
No infectious or cell-associated virus was detected in the pharynx, esophagus, small 
intestines, Peyer’s patches and mesenteric LN throughout the entire experiment. Our 
date demonstrate that the digestive tract and associated lymphoid tissues are not 
efficient entrance sites for the virus, which is consistent with a previous published 
report [6]. Potential explanations may be the absence of the Waldeyer’s ring in the 
pharynx of mice and/or presence of a low pH and proteases in the stomach, detergents 
in the bile and proteases/lipases in the small intestines. The latter conditions are too 
detrimental for this enveloped virus. In order to determine whether MCMV can 
effectively establish infections using peroral inoculation, a small experiment was 
carried out in which nine mice inoculated with MCMV HaNa1 and nine mice 
inoculated with MCMV Smith were via oral route. Only 2 mice were infected with 
MCMV HaNa1, and 3 with Smith. The poor infectivity of MCMV via oral route 
further confirmed that peroral inoculation is far less efficient to establish infections 
than intranasal inoculation. MCMV most possibly prefers spread via nasal secretions 
because nose-to-nose contacts and smelling are important activities in the social life 
of mice.   
4) MCMV-infected mice specifically mount an IgG2a antibody response 
Serological analysis revealed that IgG2a was the mainly produced antibody subclass 
throughout the entire experiment except that IgG1 and IgG2c were also detected with 
lower titers in mice inoculated with a high dose at 35-49dpi. IgM was not detected 
during the entire experiments for both MCMV strains. This could result from the low 
sensitivity of the MCMV-specific IPMA, or the suppressive effect of MCMV on the 
production of IgM by T cell cytokines. T cell cytokines determine the 
immunoglobulin class switching mechanism in mouse and human [44]. In general, 
interferon γ (IFNγ) plays a vital role in mediating the strong induction of IgG2a [45, 
46]. The role of IFNγ in the orientation of the antibody isotype switch could not be 
assessed since IFNγ and other T cell cytokines were not determined in this study. The 
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complement-dependent neutralization assay demonstrated that complement is 
essential in neutralizing MCMV since antibodies without complement/with 
inactivated complement did not neutralize MCMV infection. The 
complement-dependent IgG2a-mediated inactivation of MCMV plays a vital role in 
anti-MCMV defense, as IgG2a is the predominant viral-specific antibody. This is 
consistent with the characteristics of antibody isotype IgG2a to fix complement in 
mice [47]. Neutralizing antibody titers were high at the end of the experiment, which 
may partially explain the clearance of both virus strains in the submandibular glands 
at the late stage of infection. Likewise, the cell-mediated immunity most probably 
mediate the control of virus infection at the end of the experiments, which is generally 
considered to be the most important factor in controlling CMV infections [48, 49].  
In conclusion, our mouse models with two virus strains reveal that the nasal mucosa 
and NALT serve as portals of entry for MCMV, provides new insights into the 
dissemination of MCMV upon oronasal exposure, suggests that the Waldeyer’s ring 
may be an important entry site for HCMV upon natural exposure because of its 
equivalent role with NALT in mouse, and also demonstrates that the spleen serves as 
a transfer hub for regulating viremia and virus transmission. These new insight can be 
valuable to control viral transmission and disease upon natural MCMV/HCMV 
infection.    
 
134 
 
References 
1. Knipe, D.M. and P.M. Howley, Cytomegaloviruses, in Fields Virology E.S. Mocarski, T. 
Shenk, and R.F. Pass, Editors. 2007, Lippincott Williams & Wilkins New York. p. 2703-2704. 
2. Ho, M., Cytomegaloviruses, in in Principles and Practice of infectious Diseases, G.L. 
Mandell, J.E.Bennett, and R.Dolin, Editors. 1995, Churchhill Livingstone: New York. p. 
1351-1364. 
3. Krmpotic, A., et al., Pathogenesis of murine cytomegalovirus infection. Microbes Infect, 2003. 
5(13): p. 1263-77. 
4. JB., H., The murine cytomegalovirus as a model for the study of viral pathogenesis and 
persistent infections. Arch Virol., 1979 62(1): p. 1-29. 
5. Jordan, M.C., Interstitial pneumonia and subclinical infection after intranasal inoculation of 
murine cytomegalovirus. Infect Immun, 1978. 21(1): p. 275-80. 
6. Stahl, F.R., et al., Nodular inflammatory foci are sites of T cell priming and control of murine 
cytomegalovirus infection in the neonatal lung. PLoS Pathog, 2013. 9(12): p. e1003828. 
7. Wu, C.A., et al., Transmission of murine cytomegalovirus in breast milk: a model of natural 
infection in neonates. J Virol, 2011. 85(10): p. 5115-24. 
8. Alec J. Redwood, Geoffery R. Shellam, and Lee M. Smith, Molecular evolution of murine 
cytomegalovirus genomes, in cytomegaloviruses: From molecular pathogenesis to 
intervention, Matthias J. Reddehase, Editor. 2013. p. 23-37. 
9. Hudson, J.B., D.G. Walker, and M. Altamirano, Analysis in vitro of two biologically distinct 
strains of murine cytomegalovirus. Arch Virol, 1988. 102(3-4): p. 289-95. 
10. Smith, L.M., et al., Laboratory strains of murine cytomegalovirus are genetically similar to 
but phenotypically distinct from wild strains of virus. J Virol, 2008. 82(13): p. 6689-96. 
11. Prichard, M., et al., A review of genetic differences between limited and extensively passaged 
human cytomegalovirus strains. Reviews in medical virology, 2001. 11(3): p. 191-200. 
12. Cha, T.-a., et al., Human cytomegalovirus clinical isolates carry at least 19 genes not found in 
laboratory strains. Journal of virology, 1996. 70(1): p. 78-83. 
13. Ogasawara, N., et al., Epithelial barrier and antigen uptake in lymphoepithelium of human 
adenoids. Acta Otolaryngol, 2011. 131(2): p. 116-23. 
14. David, D., Z. Ravid, and A. Morag, Detection of human cytomegalovirus DNA in human 
tonsillar lymphocytes. J Med Virol, 1987. 23(4): p. 383-91. 
15. Berger, C., et al., Distribution patterns of beta- and gamma-herpesviruses within Waldeyer's 
ring organs. J Med Virol, 2007. 79(8): p. 1147-52. 
16. Nacer, A., et al., Imaging murine NALT following intranasal immunization with 
flagellin-modified circumsporozoite protein malaria vaccines. Mucosal Immunol, 2014. 7(2): 
p. 304-14. 
17. Price, P., et al., MHC proteins and heparan sulphate proteoglycans regulate murine 
cytomegalovirus infection. Immunology and cell biology, 1995. 73(4): p. 308-315. 
18. Milho, R., et al., A Heparan-Dependent Herpesvirus Targets the Olfactory Neuroepithelium 
for Host Entry. PLoS pathogens, 2012. 8(11): p. e1002986. 
19. Gillet, L., B. Frederico, and P.G. Stevenson, Host entry by gamma-herpesviruses—lessons 
from animal viruses? Current opinion in virology, 2015. 15: p. 34-40. 
 
	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   	   General discussion | 135 
 
	  
20. Wachowiak, M. and L.B. Cohen, Representation of odorants by receptor neuron input to the 
mouse olfactory bulb. Neuron, 2001. 32(4): p. 723-35. 
21. Firestein, S., How the olfactory system makes sense of scents. Nature, 2001. 413(6852): p. 
211-218. 
22. Chan, B.W., J.K. Woo, and C.T. Liew, Cytomegalovirus infection of the nasopharynx. J Clin 
Pathol, 2002. 55(12): p. 970-2. 
23. Kulkarni, A.A., et al., Cytomegalovirus nasal polyp after renal transplant. J Assoc Physicians 
India, 2003. 51: p. 614-5. 
24. Marks, S.C., S. Upadhyay, and L. Crane, Cytomegalovirus sinusitis. A new manifestation of 
AIDS. Arch Otolaryngol Head Neck Surg, 1996. 122(7): p. 789-91. 
25. Yoskovitch, A. and H. Cantrell, Cytomegalovirus infection presenting as chronic sinusitis and 
nasal polyposis: a case report. Ear, nose, & throat journal, 1998. 77(1): p. 35-38. 
26. Stahl, F.R., et al., Mck2-dependent infection of alveolar macrophages promotes replication of 
MCMV in nodular inflammatory foci of the neonatal lung. Mucosal Immunol, 2014. 
27. Tan, C.S., B. Frederico, and P.G. Stevenson, Herpesvirus delivery to the murine respiratory 
tract. J Virol Methods, 2014. 206: p. 105-14. 
28. Farrell, H.E., et al., Alveolar macrophages are a prominent but non-essential target for 
Murine cytomegalovirus infecting the lungs. Journal of virology, 2015: p. JVI. 02856-15. 
29. Sin, J.I., et al., IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 
enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 
challenge. J Immunol, 1999. 162(5): p. 2912-21. 
30. Zhang, S., et al., Pattern of circulation of MCMV mimicking natural infection upon oronasal 
inoculation Virus research, 2015. 
31. Zhang, S., et al., Comparison of the pathogenesis of the highly passaged MCMV Smith strain 
with that of the low passaged MCMV HaNa1 isolate in BALB/c mice upon oronasal 
inoculation. Veterinary Research, 2015. 46(1): p. 94. 
32. Swirski, F.K., et al., Identification of splenic reservoir monocytes and their deployment to 
inflammatory sites. Science, 2009. 325(5940): p. 612-616. 
33. Shi, C. and E.G. Pamer, Monocyte recruitment during infection and inflammation. Nature 
Reviews Immunology, 2011. 11(11): p. 762-774. 
34. Daley-Bauer, L.P., et al., Cytomegalovirus Hijacks CX3CR1 hi Patrolling Monocytes as 
Immune-Privileged Vehicles for Dissemination in Mice. Cell host & microbe, 2014. 15(3): p. 
351-362. 
35. Yang, J., et al., Monocyte and macrophage differentiation: circulation inflammatory monocyte 
as biomarker for inflammatory diseases. Biomark Res, 2014. 2(1): p. 1. 
36. Frederico, B., et al., A murid gamma-herpesviruses exploits normal splenic immune 
communication routes for systemic spread. Cell host & microbe, 2014. 15(4): p. 457-470. 
37. Mims, C.A. and J. Gould, Infection of salivary glands, kidneys, adrenals, ovaries and 
epithelia by murine cytomegalovirus. J Med Microbiol, 1979. 12(1): p. 113-22. 
38. Astrid Krmpotic, et al., Pathogenesis of murine cytomegalovirus infection. Microbes and 
infection, 2003. 5(13): p. 1263-1277. 
39. Campbell, A.E., V.J. Cavanaugh, and J.S. Slater, The salivary glands as a privileged site of 
cytomegalovirus immune evasion and persistence. Medical microbiology and immunology, 
2008. 197(2): p. 205-213. 
136 
 
40. Lagenaur, L.A., et al., Structure and function of the murine cytomegalovirus sgg1 gene: a 
determinant of viral growth in salivary gland acinar cells. J Virol, 1994. 68(12): p. 7717-27. 
41. Fleming, P., et al., The murine cytomegalovirus chemokine homolog, m131/129, is a 
determinant of viral pathogenicity. Journal of virology, 1999. 73(8): p. 6800-6809. 
42. Wagner, F.M., et al., The viral chemokine MCK-2 of murine cytomegalovirus promotes 
infection as part of a gH/gL/MCK-2 complex. 2013. 
43. Britt, W., Human cytomegalovirus infections and mechanisms of disease, in 
Cytomegaloviruses, M. J.Reddehase, Editor. 2006, Caister Academic press: Great Britain. p. 
1-28. 
44. Murphy, K., The humoral immune response, in Janeway's  immunobiology. 2012, Garland  
Science,  Taylor  &  Francis  Group: USA p. 387-428. 
45. Finkelman, F., et al., IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral 
immune responses. The Journal of Immunology, 1988. 140(4): p. 1022-1027. 
46. Snapper, C.M. and W.E. Paul, Interferon-gamma and B cell stimulatory factor-1 reciprocally 
regulate Ig isotype production. Science, 1987. 236(4804): p. 944-7. 
47. Klaus, G.G., et al., Activation of mouse complement by different classes of mouse antibody. 
Immunology, 1979. 38(4): p. 687-95. 
48. Fujita, Y., C.M. Rooney, and H.E. Heslop, Adoptive cellular immunotherapy for viral diseases. 
Bone Marrow Transplant, 2008. 41(2): p. 193-8. 
49. Scalzo, A.A., et al., The interplay between host and viral factors in shaping the outcome of 
cytomegalovirus infection. Immunology and cell biology, 2006. 85(1): p. 46-54. 
	  Summary-samenvatting 
Summary 
Human cytomegalovirus (HCMV) is a betaherpesvirus that causes subclinical 
infections in immunocompetent hosts but clinically significant diseases in 
immunocompromised patients. HCMV can certainly be transmitted from infected to 
susceptible hosts via the oronasal route. However, it remains elusive how the virus 
spreads throughout the body during a natural infection. Due to the strict 
species-specificity of HCMV, it is impossible to study the pathogenesis of HCMV 
infections in experimental animals. Therefore, animal CMV infection models are used. 
Murine cytomegalovirus (MCMV) infection in mice is a widely used animal model to 
study HCMV infection. However, knowledge about the invasion strategies of MCMV 
upon oronasal exposure was lacking.  
In Chapter 1, an overview of the current knowledge on MCMV was given. First, an 
introduction was given on the history, the classification, the virus characteristics, and 
the replication cycle of MCMV. Further, the epizootiology, the pathogenesis of 
MCMV infection and the immune response during an infection of MCMV were 
reviewed. Finally, the anatomy of oral & nasal cavities and lymph nodes associated 
with alimentary & respiratory tracts in mice were briefly introduced.  
In Chapter 2, the aims of the studies described in the thesis were presented. The first 
aim was to set up animal models for mimicking natural infection of MCMV in order 
to compare the pathogenesis of MCMV infection with two strains (the low passaged 
MCMV HaNa1 isolate and highly passaged MCMV Smith strain) in Balb/c female 
mice. The second aim was to elucidate the kinetics of virus dissemination throughout 
the body upon oronasal exposure. The third and last aim was to demonstrate the role 
of the spleen in virus dissemination during a natural primary MCMV infection. 
In Chapter 3, the pathogenesis of an infection with the highly passaged MCMV 
Smith strain was compared with that of an infection with a low passaged Belgian 
MCMV isolate HaNa1 in BALB/c adult mice following oronasal inoculation with 
138 
 
either a low (104 TCID50/mouse) or high (106 TCID50/mouse) inoculation dose. Both 
strains were mainly replicating in nasal mucosa and submandibular glands for one to 
two months. In nasal mucosa, MCMV was detected earlier and longer (1-49dpi) and 
reached higher titers with the high inoculation dose compared to the low inoculation 
dose (14-35dpi). In submandibular glands, a similar finding was observed (high dose: 
7-49dpi; low dose: 14-42dpi). In lungs, both strains showed a restricted replication. 
Only the Smith strain established a low level of productive infection in spleen, liver 
and kidneys. The infected cells were identified as olfactory neurons and sustentacular 
cells in olfactory epithelium, macrophages and dendritic cells in NALT, acinar cells in 
submandibular glands, and macrophages and epithelial cells in lungs for both strains. 
Antibody analysis demonstrated for both strains that IgG2a was the main detectable 
antibody subclass. Overall, our results showed that significant phenotypic differences 
exist between the two virus strains. MCMV HaNa1 is a promising strain to use in 
mouse models in order to get better insights for HCMV infections in 
immunocompetent humans.  
In Chapter 4, virus titration showed a productive virus replication of both HaNa1 and 
Smith in the nasal mucosa from 1 dpi until the end of the experiment (14 dpi), in 
lungs from 5 until 14 dpi, and in submandibular glands from 7 until 14 dpi. In contrast 
to MCMV HaNa1, MCMV Smith also established a low level productive infection in 
abdominal organs (spleen, liver and kidneys) from 5 dpi (spleen), 7 dpi (liver), and 10 
dpi (kidneys) until the end of the experiment. Co-culture showed that for both strains, 
cell-associated virus was detected in a non-infectious form in nasopharynx-associated 
lymphoid tissues (NALT) from 1 until 14 dpi, in submandibular lymph nodes from 3 
until 5 dpi, in deep cervical lymph nodes from 3 until 14 dpi, in mediastinal lymph 
nodes from 7 until 14 dpi, in spleen from 5 until at least 10 dpi and in the peripheral 
blood mononuclear cells (PBMC) at 7 and 10 dpi. This study showed that upon 
oronasal exposure, MCMV first enters the nasal mucosa and NALT, from where the 
virus disseminates to the spleen possibly via the draining lymphatic system and blood; 
a subsequent cell-associated viremia transports MCMV to submandibular glands and 
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for MCMV Smith also to liver and kidneys, where a second productive replication 
starts.  
In Chapter 5, the role of the spleen during an MCMV infection was investigated by 
the comparison of intact and splenectomized Balb/c mice. Both highly passaged 
MCMV Smith and low passaged MCMV HaNa1 were used. Various samples were 
collected at 7, 14, and 21 days post inoculation (dpi) for analyses by virus 
isolation/titration, co-cultivation and qPCR. The results showed that for both virus 
strains, 1) cell-associated virus in PBMC (determined by co-cultivation) was detected 
in intact mice but not in splenectomized mice; 2) the mean viral DNA load in PBMC 
of splenectomized mice was 4.4-(HaNa1)/2.7-(Smith) fold lower at the peak viremia 
(7 dpi) in contrast to that of intact mice; and 3) infectious virus in the submandibular 
glands was detected later in splenectomized mice (14 dpi) than in intact mice (7 dpi). 
Moreover, the average virus titers in submandibular glands of splenectomized mice 
were 10-(HaNa1)/7.9-(Smith) fold lower at 14 dpi and 1.7-(HaNa1)/2.1-(Smith) fold 
lower at 21 dpi compared with that of intact mice. Upon inoculation with MCMV 
Smith, infectious virus was found in the kidneys and liver of intact mice, but not in 
splenectomized mice. Taken together, all these data clearly demonstrate that virus 
dissemination to distant organs is reduced in splenectomized mice, further confirming 
the importance of the spleen as a viremia booming site for a natural MCMV infection.  
In Chapter 6, all data obtained in the present thesis were reviewed and discussed. A 
general hypothetical model for MCMV dissemination throughout the body was 
proposed: upon oronasal exposure to MCMV, the nasal mucosa and NALT serve as 
portal of entry for MCMV. From these primary replication sites, the virus is 
transported in non-productively infected leukocytes to the draining lymph nodes 
(submandibular LN and deep cervical LN) and finally to the spleen and lungs possibly 
via lymph and blood circulation. In the spleen, a subsequent cell-associated viremia is 
regulated, from where a second replication is initiated in various tissues such as 
submandibular glands (for both Smith and HaNa1), liver and kidneys (only for 
Smith).  
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Samenvatting  
Human cytomegalovirus (HCMV) is een betaherpesvirus dat over het algemeen 
subklinische infecties veroorzaakt in immunocompetente individuen. In 
immunogecompromitteerde patiënten daarentegen kan het HCMV aanleiding geven 
tot klinisch significante ziekten. Het HCMV wordt overgedragen van geïnfecteerde 
gastheren op gevoelige gastheren via de oronasale route maar hoe het virus zich 
verspreidt doorheen het lichaam na blootstelling tijdens een natuurlijke infectie is nog 
niet geweten. De strikte gastheerspecificiteit van HCMV maakt het moeilijk om de 
pathogenese van humane cytomegalovirus infecties te bestuderen in experimentele 
diermodellen. Vandaar dat er momenteel gebruikt gemaakt wordt van 
infectiemodellen met dierlijke cytomegalovirussen. Infectie van muizen met het 
muriene cytomegalovirus (MCMV) is een goed diermodel voor de studie van HCMV 
infectie, maar de invasie strategie van het MCMV na oronasale trasmissie is eveneens 
ongekend.  
Hoofdstuk 1 geeft een literatuuroverzicht van de huidige kennis van het MCMV 
waarbij eerst de historie, classificatie, virus eigenschappen en replicatie van het 
MCMV geïntroduceerd werden. Daarnaast werden ook de epizoötiologie en de 
pathogenese van MCMV infectie alsook de immune response tegen het MCMV 
gereviseerd . Tot slot, werd ook kort de anatomie van de orale en nasale caviteit en 
lymfeknopen geassocieerd aan het spijsverterings- en ademhalingsstelsel in de muis 
kort besproken.  
In hoofdstuk 2 werden de doelstellingen van deze thesis geformuleerd. Een eerste 
doelstelling was het ontwikkelen van een diermodel waarin een natuurlijke infectie 
met MCMV nagebootst word om zo de pathogenese van twee MCMV stammen te 
kunnen vergelijken, namelijk de “low-passaged” MCMV HaNA1 stam en de 
“highly-passaged” MCMV Smith stam, in vrouwelijke Balb/c muizen. Een tweede 
algemene doelstelling was om de kinetiek van virus disseminatie doorheen het 
lichaam na oronasale bloostelling te achterhalen. Een derde en laatste doelstelling was 
het ontrafelen van de rol die de milt speelt in virus disseminatie gedurende natuurlijke, 
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primaire MCMV infectie.  
In Hoofdstuk 3 werd de pathogenese van de hoge passage MCMV-Smith stam 
vergeleken met die van het lage passage Belgische HaNa1-isolaat. Hiervoor werden 
volwassen BALB/c-muizen oronasaal geïnoculeerd met ofwel een lage (104 
TCID50/muis) of hoge (106 TCID50/muis) inoculatiedosis. Beide stammen repliceerden 
voornamelijk in de nasale mucosa en submandibulaire klieren gedurende één tot twee 
maanden. In de nasale mucosa werd MCMV vroeger en langer gedetecteerd (1-49 dpi) 
en bereikte hogere titers bij de hoge inoculatiedosis vergeleken met de lage 
inoculatiedosis (14-35 dpi). In de submandibulaire klieren werd een gelijkaardige 
bevinding gedaan (hoge dosis: 7-49 dpi; lage dosis: 14-42 dpi). In de longen, 
vertoonden beide stammen een beperkte replicatie. In de lever, milt en nieren kon 
alleen bij de Smith-stam een beperkte productieve infectie waargenomen worden. 
Voor beide stammen konden de geïnfecteerde cellen als volgt geïdentificeerd worden: 
de olfactorische neuronen en sustentaculaire cellen in het olfactorisch epitheel, de 
macrofagen en dendritische cellen van het neus-geassocieerd lymfoïd weefsel, de 
acinaire cellen in de submandibulaire klieren en in de longen macrofagen en 
epitheelcellen. Uit antistofanalyse bleek IgG2a voor beide stammen de belangrijkste 
detecteerbare antistofsubklasse te zijn. Onze resultaten tonen aan dat er significante 
fenotypische verschillen bestaan tussen beide virusstammen. Hier werd aangetoond 
dat MCMV-HaNa1-infectie in muizen een interessant model is om een beter inzicht te 
verwerven in HCMV-infecties bij immunocompetente mensen. 
In Hoofdstuk 4 toonde virustitratie een productieve virale replicatie aan van zowel 
HaNa1 als Smith in de nasale mucosa vanaf 1 dpi tot het einde van het experiment (14 
dpi), in de longen vanaf 5 tot 14 dpi en in de submandibulaire klieren vanaf 7 tot 14 
dpi. In tegenstelling tot MCMV-HaNa1, veroorzaakte MCMV-Smith wel een 
beperkte productieve infectie in abdominale organen (milt, lever en nieren) vanaf 5 
dpi (milt), 7 dpi (lever) en 10 dpi (nieren) tot het einde van het experiment. 
Co-culturen toonden aan dat bij beide stammen cel-geassocieerd virus in een 
niet-infectieuze vorm aanwezig was in het neus-geassocieerd lymfoïd weefsel van dag 
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1 tot 14 post infectie, in de submandibulaire lymfeknopen van 3 tot 5 dpi, in de diepe 
cervicale lymfeknopen van 3 tot 14 dpi, in de mediastinale lymfeknopen van 7 tot 14 
dpi, in de milt van 5 tot minstens 10 dpi en in de perifere bloed mononucleaire cellen 
(PBMC) vanaf 7 tot 10 dpi. Deze studie toont aan dat, na oronasale blootstelling, 
MCMV eerst de nasale mucosa en het neus-geassocieerd lymfoïd weefsel 
binnentreedt en van hieruit – mogelijks via de drainerende lymfe en het bloed - spreidt 
naar de milt; een hieruit volgende cel-geassocieerde viremie transporteert MCMV 
naar de submandibulaire klieren, alsook naar de lever en nieren bij MCMV-Smith, 
waar een secondaire productieve replicatie plaatsvindt. 
In Hoofdstuk 5 werd de rol van de milt tijdens een MCMV infectie onderzocht door 
gebruik te maken van intacte en gesplenectomeerde Balb/c muizen. De MCMV Smith 
stam, die al veel passages heeft doorgemaakt, en de MCMV HaNa1 stam, die slechts 
enkele passages heeft doorgemaakt, werden beiden gebruikt. Op 7, 14 en 21 dagen 
post inoculatie (dpi) werden verschillende stalen verzameld voor virusisolatie/-titratie, 
co-cultivatie en qPCR. De resultaten tonen aan dat voor beide stammen, 1) 
cel-geassocieerde viremie in PBMC (bepaald met co-cultivatie) werd gevonden bij 
intacte muizen maar niet in gesplenectomeerde muizen; 2) de gemiddelde virale 
DNA-load in PBMC van gesplenectomeerde muizen was 4.4-(HaNa1)/2.7-(Smith) 
keer lager tijdens de piek viremie (7dpi) dan in die van intacte muizen; en 3) 
infectieus virus werd later gevonden in de submandibulaire klieren bij 
gesplenectomeerde muizen (14dpi) dan in bij intacte muizen (7dpi). Bovendien waren 
de gemiddelde virus titers in de submandibulaire klieren van gesplenectomeerde 
muizen 10-(HaNa1)/7.9-(Smith) keer lager op 14dpi en 1.7-(HaNa1)/2.1-(Smith) keer 
lager op 21dpi dan bij intacte muizen. Na inoculatie met MCMV Smith stam werd er 
infectieus virus gevonden in de nieren en lever van intacte muizen, maar niet die van 
in gesplenectomeerde muizen. Samengevat tonen al deze data aan dat virus 
disseminatie naar perifere organen verminderd is in gesplenectomeerde muizen, wat 
het belang van de milt als viremie-booming-site tijdens een natuurlijke MCMV 
infectie bevestigt.  
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Hoofdstuk 6 geeft een overzicht van alle resultaten, en worden alle data nog eens 
besproken. Een algemeen hypothetisch model voor de spreiding van MCMV in het 
lichaam wordt weergegeven: na een oronasale blootstelling aan MCMV, dienen de 
nasale mucosa en NALT als intredepoort voor MCMV. Van deze primaire plaats van 
replicatie, wordt het virus getransporteerd in niet-productieve geinfecteerde 
leukocyten naar de drainerende lymfeknopen (submandibulaire LN en de diepe 
cervicale LN) om finaal de milt en longen te bereiken via de lymfe- en bloedcirculatie. 
In de milt ontstaat er een volgende cel-geassocieerde viremie, waardoor een 
secundaire replicatie kan optreden in verschillende weefsels zoals de submandibulaire 
klieren (voor beide Smith en HaNa1), lever en nieren (enkel voor Smith).   
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